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CH3C(OCH3)3 = Trimethyl orthoacetate 
COSY = Correlation spectroscopy 
CS = Chondroitin sulfate 
CSA = (+)-camphor-10-sulfonic acid  
DCC = Dicyclohexylcarbodiimide 
DEA = Diethylamine 
DeS = Dermatan sulfate 
DIPEA = N,N-Diisopropylethylamine 
DMA = N,N-Dimethylacetamide 
DMF = N,N-Dimethylformamide 
DMI = 1,3-Dimethyl-2-imidazolidinone 
DMTr = Dimethoxytrityl 
DMTMM = 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride 
EDC = N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride 
fCS = Fucosylated chondroitin sulfate 
GalA = Galacturonic acid 
GlcA = Glucuronic acid 
GalNAc = N-Acetyl-galactosamine 
GlcNAc = N-Acetyl-glucosamine 
HA = Hyaluronic acid 
HMBC = Heteronuclear multiple bond correlation 
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HP = Heparin 
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HS = Heparan sulfate 
HSQC-DEPT = Heteronuclear Single Quantum Coherence-
Distorsionless Enhancement by Polarization Transfer 
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correlation spectroscopy  
HyCl = Benzethonium chloride 
KS = Keratan sulfate 
NHS = N-hydroxysuccinimide 
NIS = N-iodosuccinimide 
NOESY = Nuclear Overhauser enhancement spectroscopy 
MES = 4-morpholineethanesulfonic acid 
MMTr = Monomethoxytrityl 
PhC(OCH3)3 = Trimethyl orthobenzoate 
PSS = Propylene glycol alginate sodium sulfate 
pyBOP® = (Benzotriazol-1-yloxy)tripyrrolidinophosphonium 
hexafluorophosphate 
SLS = Static light scattering 
TOCSY = Total correlation spectroscopy 
TBA = Tetrabutylammonium 
TBAF = Tetrabutylammonium fluoride 
TBDMS = tert-Butyldimethylsilyl 
TBDPS = tert-Butyldiphenylsilyl 
TBTU = O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium 
tetrafluoroborate 
Thr = Threonine 
TMSOTf = Trimethylsilyl trifluoromethanesulfonate 
Tr = Triphenylmethyl
  
 
ABSTRACT
  
 IX 
 
ABSTRACT 
Polysaccharides are polymeric carbohydrates, usually formed of 
repeating units (either mono-, or higher oligosaccharides) joined 
together by glycosidic bonds. Some of these macromolecules are 
characterized by high natural availability (starch, cellulose, glycogen 
and chitin among others) and they have also a great biological 
importance, since they can be a source of energy for animal species. 
Moreover, they are structural elements of cellular walls and 
identification sites of cellular surfaces. An important class of 
polysaccharides is that of glycosaminoglycans animal sourced 
biomacromolecules that play a pivotal role in several biological 
processes. CS is included into the family of sulfated GAGs and is 
involved in the treatment of osteoarthritis and osteoarthrosis. From the 
structural point of view it is composed of a disaccharide repeating unit 
containing GlcA and GalNAc linked together through β-(13) and β-
(14) glycosidic bonds, and displaying different sulfation patterns 
after in vivo polymerization. Indeed, depending on the position of 
sulfate groups, different disaccharide subunits could be described 
(Figure I).  
 
 X 
 
 
Figure I: Disaccharide subunits in natural CSs 
Nonetheless, the low abundance of raw material, the labourious 
downstream purification and the growing application of this 
polysaccharide as a drug, led to development of a non-animal derived 
CS with a well-defined sulfation pattern, starting from Escherichia coli 
O5:K4:H4 sourced unsulfated chondroitin, through the optimization of 
a suitable sequenece of regioselective steps for its structural 
modification. This was based on the selective protection of O-4,6-
GalNAc diol with a cyclic group (beznylidene), followed by acylation 
of O-2,3-GlcA diol on the polysaccharide backbone. By conducting 
benzylidenation and acetylation reactions one- or two pots, CSs with 
different sulfation patterns were obtained. In particular, sulfate groups 
randomly distributed either at position O-4 or at position O-6 of 
GalNAc units (CS-A,C) were obtained through the two-pots strategy, 
whereas the presence of additional sulfate groups was found at position 
O-3 of GlcA units when the protection reactions were conducted in 
one-pot fashion. This difference was ascribed to the formation of 
interglycosidic acetals during the insertion of benzylidene ring on O-
4,6-GalNAc diol. These unusual acetals were rather acid-labile and 
could be not conserved after reaction work-up, thus, at the end of the 
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semi-synthetic strategy, a chondroitin polysaccharide bearing sulfate 
groups exclusively on GalNAc units was afforded. Differently, 
stabilization in alkaline environment of the labile interglycosidic 
acetals by the two-pots strategy and their following oxidative cleavage 
allowed the semi-synthesis of CS species possessing sulfate groups not 
only on GalNAc units but also at position O-3 of some GlcA ones. It is 
worth noting that the detailed understanding of the factors influencing 
finely tailored chemical modifications on microbial sourced chondroitin 
is rather valuable because it allows the preparation of biologically 
relevant CSs from non-animal sources and with different, but highly 
controlled sulfation patterns. Indeed, CS-A,C is employed for several 
biomedical applications, as well as CSs possessing GlcA units 
decorated at O-3 position with sulfate groups are interesting for their 
neurite outgrowth promotion in the central nervous system. 
To GAGs family belongs also fCS. It is a glycosaminoglycan extracted 
from sea cucumbers (Echinodermata) and composed of a chondroitin 
sulfate backbone, substituted at position O-3 of GlcA units with heavily 
sulfated L-fucose side branches (Figure II). 
 
 
Figure II: Natural fucosylated chondroitin sulfate  
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fCS shows several biological properties, above all anticoagulant and 
antithrombotic activities that are tied to the branches of sulfated fucose 
on CS backbone. As heparin, fCS exerts these two activities by a 
serpin-dependent mechanism, in which thrombin inhibition is mediated 
by AT and HC-II. Importantly, and in contrast to heparin, fCS inhibits 
Xase factor and furthermore the Xa itself, through a serpin-independent 
mechanism too. 
These peculiar properties position fCS to potentially substitute heparin 
as anticoagulant and antithrombotic agent; indeed, fCS is currently 
under investigation in clinical trials as a new antithrombotic drug. In 
order to overcome the serious downsides of using animal-sourced 
polysaccharides for therapeutic purposes, such as ethical problems, 
contamination risks and discrepancies in composition, a regioselective 
modification of a chondroitin polysaccharide, obtained by fed-batch 
fermentation of E. coli O5:K4:H4, was developed, with the final aim to 
produce a safer and highly controllable fCS-based drug candidate. 
Derivatization started by esterification (either methylation or n-
dodecylation) of carboxylic acid of GlcA subunits, to make chondroitin 
more soluble in aprotic solvents, then O-4,6 diol of GalNAc was 
protected by introduction of a benzylidene ring. The obtained 
derivatives were used as polysaccharide acceptors for glycosylation 
reactions, by coupling with suitable per-O-benzylated fucosyl donors 
under several conditions, trying to achieve a regiochemical and 
stereochemical control of glycosidic bond formation. Fucosylated 
products were further modified, obtaining at the end of semi-synthetic 
route fCS polysaccharides bearing persulfated Fuc branches.  
In order to obtain different sulfation patterns on Fuc units, the semi-
synthetic strategy was upgraded, with the synthesis of new suitably 
protected fucosyl donors, for achieving polysaccharides with a even 
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higher control of regio- and stereoselectivity of Fuc branching and 
sulfation patern on the chondroitin backbone. Moreover, modification 
on polysaccharide backbone aforded a diferent glycosyl acceptor, 
useful to further enlarge the library of the semi-synthesized fucosylated 
chondroitin sulfate and chondroitin sulfates (fC and fCS, respectively) 
polysaccharides (Figure II) for future detailed structure-activity 
relationship investigations. 
 
 
Figure III: Library of regioselectively semi-synthesized fC and fCS 
polysaccharides  
 
 
They were preliminarily assayed for anticoagulant activity, displaying 
an AT-dependent activity against factor Xa in the same range of low 
molecular mass fCS species obtained by partial depolymerization of 
natural polysaccharides. For HC-I mediated factor Ia activity, data 
were very close to heparin for fCSs with Fuc branches on the GlcA 
units, regardless of their sulfation patern, whereas two of the three 
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fCSs with Fuc branches on the GalNAc units, as well as unsulfated 
polysaccharides, displayed a much reduced anticoagulant activity. 
Among biological properties of fCS polysaccharides, it is worth noting 
that the inhibition of P- and L-selectin interaction with sialyl Lewis(x), 
is stronger than the heparin one. Interestingly, oligosaccharides 
prepared by depolymerization of fCS from Holoturia forskali still 
maintained a high affinity for P- and L-selectins, but displaying a lower 
adverse effects than native polysaccharide. In order to evaluate the 
same inhibition activity of depolymerized fucosylated chondroitin 
sulfate (dfCS) from natural sources, a semi-synthetic fCS 
polysaccharide was submitted to β-eliminative depolymerization to 
give a oligosaccharide to be tested for its interaction with P- and L- 
selectins by STD-NMR techniques, displaying a slightly minor affinity 
with respect to that obtained from the natural one.  
Chondroitin polysaccharide obtained from the fed-batch fermentation 
of E.coli O5:K4:H4 is, from a structural point of view, similar to the 
backbone of Colwellia psychrerythraea 34H capsular polysaccharide 
(CPS) displaying an unprecedented cryoprotectant function, and 
consisting of a tetrasaccharide repeating units composed of two 
aminosugars and two uronic acids, with one of the two latter bearing a 
L-threonine as substituent. In order to better understand the structure-
cryoprotectant function relationship of this polysaccharide, microbial 
sourced chondroitin was coupled with L-threonine (Figure IV) under 
several conditions, producing a semi-synthetic derivative that displayed 
a ice recrystallization inhibition much lower than the C. 
psychrerythraea CPS. A combined NMR-molecular dynamic study of 
its 3D structure showed a rather far arrangement between the two 
polysaccharides, thus demonstrating that threonine decoration of 
biomacroolecules is not a sufficient element for gaining ice 
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ricrystalization inhibition in spite of several examples of Thr-rich 
(glycol)-proteins and polysaccharides with cryoprotectant activity in 
Nature. 
 
 
Figure IV: units of CPS from C. psychrerythraea 34H (top) and its 
semi-synthetic mimic obtained from microbial chondroitin (botom) 
 
 
Another polysaccharide that was subjected to regioselective 
modifications is alginate, that consists of 14-linked β-D-mannuronic 
acid (M) and its C-5 epimer α-L-guluronic acid (G) units. This natural 
copolymer is an important component of algae such kelp, and is also an 
exopolysaccharide of bacteria including Pseudomonas aeruginosa. 
Alginates are widely used in food, cosmetic and pharmaceutical 
industry. The sulfation of these polysaccharides exhibits compounds 
with carboxylic and sulfate groups close to each others as in heparin 
ones. Randomly sulfated alginates show anticoagulant activity, so 
regioselective modification of the polysaccharide backbone may help to 
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understand the relationship between structure and properties in alginate 
sulfates. Indeed, a semi-synthetic sulfated alginate derivative 
(propylene glycol alginate sodium sulfate, PSS), has been employed as 
anti-cardiovascular disease drug in China, without control of degree of 
sulfation. Due to incomplete solubility and highly heterogeneous 
structure of natural alginic acids the strategy to obtain a 
regioselectively sulfated alginate polysaccharide was applied to β-D-
polymannuronic acid, that is the simplest polysaccharide possessing the 
most homogeneous structure of all alginic acids. It was protected at O-
2,3 diol by either application of an orthoester or benzylidene ring and in 
the latter case, the polymannuronic acid was derivatized at carboxylic 
function too in order to enhance its solubility in aprotic solvent. At the 
end of the semi-synthetic route compounds with different sulfation 
pattern were obtained, but with unclear and probably not complete 
regioselectivity. Therefore, further optimization on semi-synthetic 
strategy is needed for the production of regioselectively sulfated 
alginates and for the evaluation of their structure-activity relationships. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Carbohydrates and polysaccharides 
Carbohydrates are by far the most abundant organic molecules found in 
Nature, and nearly al organisms synthesize and metabolize 
carbohydrates. (Gazarian et al., 2011) They are the most information-
rich class of biomacromolecules and with huge structural diversity 
compared to DNA or proteins. In monosaccharide structure, for 
example, the total number of isomer permutations for an hexamer with 
an “alphabet” of 20 monosaccharides achieves the astounding number 
of 1.44·1015 structures, whereas from 20 aminoacids and 4 nucleotides, 
under the same conditions, only 206 and 46 structures could be 
obtained, respectively. (Gabius et al., 2000) This characteristic explains 
the high complexity both in structural characterization (Figure 1) and in 
the synthesis of carbohydrates. 
 
Figure 1: Comparison between the site of oligomerization explaining 
the structural diversity among nucleotides, aminoacids and 
monosaccharides 
 4 
 
Main biological activities of glycans regard structural properties and 
specific interaction with other molecules, such as intrinsic and extrinsic 
glycan-binding proteins (GBPSs), of which the formers are typically 
involved in cell-cell interactions and the latters consist mainly of 
interactions with pathogens (Figure 2). (Varki et al., 2009) 
 
 
Figure 2: General classification of biological roles of glycans. 
(Gagneux et al., 1999) 
 
 
Among intrinsic GBPSs, it is worth mentioning the lectins, that are 
involved in a wide variety of cell-cell recognition, signaling and 
adhesion processes and in intracellular targeting of newly 
biosynthesized proteins. (Weiss et al., 1996) The selectins are cell 
surface lectins able to recognize fucosylated, sialylated and sulfated 
ligands expressed on scaffold glycoproteins serving as functional 
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counter-receptors. They play a significant role in inflammation, 
immunological responses, and homing of lymphocytes and bone 
marrow stem cells, as well as in atherosclerosis, ischemia-reperfusion 
injury, inflammatory diseases, and metastatic spreading of some 
cancers. (Ley, 2001) 
Polysaccharides are polymeric carbohydrates, usually formed of 
repeating units (either mono-, or higher oligosaccharides) joined 
together by glycosidic bonds. These structures are often linear, but may 
contain various degrees of branching. Polysaccharides are often quite 
heterogeneous, containing slight modifications of the repeating unit. 
Depending on the structure, these macromolecules can have distinct 
properties from their monosaccharide building blocks. Polysaccharides 
are called homopolysaccharides when all monosaccharides in them are 
the same, on the other hand, when more than one type of 
monosaccharides is present, they are called heteropolysaccharides. 
Some of these macromolecules are characterized by high natural 
availability (starch, cellulose, glycogen, chitin, among others) and they 
also have a great biological importance, since they can be a source of 
energy for animal species. Moreover, they are structural elements of 
cellular walls and identification sites of cellular surfaces.  
 
 
1.2 Sulfated polysaccharides and glycosaminoglycans 
An important class of polysaccharides is that comprising the sulfated 
ones, that mainly occur in many seaweeds and animal species. The 
former class includes sulfated polysaccharides that can be classified 
depending on their structure, in sulfated fucans – polysaccharides with 
heterogeneous structures composed of L-fucose with different degrees 
of sulfation (Pomin et al., 2008) -, carrageenans and agarans, that show 
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linear polysaccharide backbones composed almost exclusively of L- 
and/or D-galactose and 3,6-anhydro-D- or L-galactose units sulfated to a 
various extent (Campo et al., 2009), and ulvans, that are usually 
constituted of 3-O-sulfated-L-rhamnose residues linked to xylose 
(either sulfated or not at its O-2 position) or to an uronic acid such as D-
glucuronic or L-iduronic acid. (Lahaye et al., 2007) Some of these 
sulfated polysaccharides have been found also in animals, especially 
sulfated fucans and galactans have been isolated from several marine 
invertebrates, showing a more regular structure than their analogues 
from seaweeds. (Pomin, 2009) The most important animal sourced 
sulfated polysaccharides are GAGs, that are linked to variously 
composed proteoglycans in the extracellular matrix and, as other 
glycoconjugates, they play an important role in biological processes 
(Figure 3). (Esko et al., 2009)  
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Figure 3: Some of the most important proteoglycans  
 
 
Moreover, GAGs have been found on the surface of some pathogenic 
microorganisms, allowing them to escape hosts’ immune response. 
(Raedts et al., 2011) 
From a structural point of view, GAGs are high densely charged 
negative heteropolysaccharides, consisting of a disaccharide repeating 
unit composed of a hexose (galactose) or an uronic acid (D-glucuronic 
or L-iduronic) acid and an aminosugar (glucosamine or galactosamine). 
(Mende et al., 2016) They could be decorated with acetyl groups on the 
nitrogen atom of aminosugars or sulfated at hydroxyls and/or again on 
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nitrogen atom of aminosugars. GAGs include HP, HS, CS, fCS, DeS 
and KS, whereas hyaluronic acid is the only unsulfated one.  
Sulfated polysaccharides and GAGs are known for their broad range of 
biological activities. (a) Pomin, 2015. b) Ngo et al., 2013. c) Jiao et al., 
2011. d) Campo et al., 2009. e) Lahaye et al., 2007. f) Toida et al., 
2003.) Some of them are already employed in therapeutic treatments 
(e.g. heparin and chondroitin sulfate for their activity as anticoagulant 
and for therapy of articular cartilage osteoarthritis, respectively), and a 
wide number of novel drugs, medical devices and nutraceuticals based 
on the bioactivities of sulfated polysaccharides are currently under 
development (a) Zhao et al. 2015. b) Scott et al., 2013. c) Patel, 2012. 
d) Pomin et al., 2008. e) Yamada et al., 2008.) 
Their biological functions are mainly related to specific cell-cell and 
cell-extracellular matrix interactions (a) Lim et al., 2015. b) Esko et al., 
2009. c) Bishop et al., 2007.) that are generally mediated by the 
formation of carbohydrates-protein complexes. Moreover, it has been 
suggested that the sulfation pattern sequence might be able to encode 
functional information to this aim. The sulfation code has been not 
unveiled yet, except for few cases, where its function in blood clotting 
control (van Boeckel et al., 1993) and adhesion of pathogens (a) Martín 
et al., 2013. b) Achur et al., 2003.), guiding neuronal growth (a) 
Swarup et al., 2013. b) Rogers et al., 2011. c) Gama et al., 2006.) or 
inducing cancer cell apoptosis (Poh et al., 2015) have been elucidated. 
 
 
1.3 Synthesis of carbohydrates 
A plethora of protecting groups employed in organic chemistry are 
commonly used in synthetic carbohydrate chemistry, although their 
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application on polysaccharides is rather limited. They could be divided 
in two categories: permanent (they remain through all the synthesis and 
are removed at the end of it) and temporary protecting groups (that are 
removed during the synthesis to free reactive position of the substrate). 
In carbohydrate chemistry a large amount of protecting groups are 
usually needed, above all to pursue a regioselective protection. Their 
insertion and removal, as well as, their stability and orthogonality often 
recall the reaction conditions already developed for non carbohydrate 
molecules, but several protecting groups developed ad hoc for sugar 
species have been reported too. (Wuts et al., 2014) 
The regioselective protection may involve well-defined hydroxyl 
position(s) in each repeating unit avoiding, at the same time, any 
alteration of glycosidic linkages and any labile decoration on the 
polysaccharide backbone during the protection-deprotection reactions. 
From a regioselective point of view, modification of polysaccharides is 
completely different from monomeric molecules. Indeed, when the 
protection or deprotection reaction gives a non quantitative 
modification of small molecules, the desired derivative could be 
purified from other components of the mixture, whereas in 
polysaccharides any purification is impossible, due to the covalent 
bond between correctly and uncorrectly modified monosaccharide 
units. (Cumpstey, 2013) Protecting groups are, without doubts, useful 
to protect reactive functions of the molecules, but they can also 
enhance or decrease the reactivity and participate in the reactions, thus 
affecting their kinetic, regiochemical and stereochemical aspects. 
The most important protecting groups in the synthesis of carbohydrates 
are hydroxyls protecting groups. Moreover, carboxy- and amino-
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protecting groups for uronic acid and aminosugars-containing 
polysaccharides, respectively, are highly important too. 
 
1.3.1 Hydroxyl protecting groups 
Due to the large number of hydroxyls on carbohydrates, this kind of 
protecting groups are the most widely employed. Ethers and esters are 
usually introduced to protect them, adopting very often benzyl ethers 
and acetate or benzoyl esters for a permanent protection, due to their 
stability and efficient introduction/removal methods. On the contrary, a 
wide number of temporary protecting groups has been reported in 
literature and new protection strategies are continuously developed. In 
order to obtain regioselectively protected polysaccharides, it could be 
considered that the order of reactivity of hydroxyls is tied to both  their 
steric hindrance and to a primary OH > equatorial OH > axial OH 
scale, although the differentiation of secondary hydroxyls on the basis 
of their nucleophilicity is often difficult. 
 
1.3.1.1 Ether-type protecting groups 
The most common ether-type protecting groups are depicted in Figure 
4 and consist of both ethereal (such as methyl, benzyl, trityl) and silyl 
ether functionalities, such as TBDMS and TBDPS ethers. 
 
 
 
 11 
 
 
 
Figure 4: Commonly used ether and silyl ether protecting groups 
 
 
These protecting groups have been applied not only in the synthesis of 
oligosaccharides and glycoconjugates, but also for the structural 
modification of polysaccharides. For example, the insertion of methyl 
and other alkyl ethers on celulose was performed in the presence of 
alkyl halides under basic conditions investigating diferent solvents 
such as DMI/LiCl, (Takaragi et al., 1999) DMA/LiCl (McCormick et 
al., 1987), DMSO/LiCl mixtures (Petrus et al., 1995) and 
SO2/DEA/DMSO system (Isogai et al., 1986) afording 2,3,6-tri-O-
alkylated celulose quantitatively. 
Benzyl ethers are widely used as permanent protecting group for their 
wel-known stability. Their insertion can be performed under strongly 
basic conditions as reported for benzylation of chitin employing sodium 
hydride (Umemura et al., 2012) or sodium hydroxide as base (Somorin 
et al., 1979), afording a perbenzylated or selectively O-6 protected 
polysaccharide, respectively. Benzyl ethers are usualy removed under 
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hydrogenolytic, reductive (Na/ liquid ammonia) (Iseloh et al., 2002) or 
oxidative conditions (Adinolfi et al., 1999).  
Trityl ethers regioselectively react with polysaccharides in a weakly 
basic environment preferentially at primary positions due to their 
bulkiness, as reported for cellulose, (Green, 1963) chitin (Umemura et 
al., 2012) and chitosan. (Holappa et al., 2005) Trityl ethers can be 
easily cleaved by acid hydrolysis. 
TBDMS and TBDPS are the most widely used silyl ethers and their 
insertion can be performed under less basic conditions than ethers. 
They are largely employed for derivatization of polysaccharides, 
especially to convert alcohol moieties into more lipophilic and often 
more reactive groups, as reported, for example, on cellulose, (a) Richter 
et al., 2003. b) Groth et al., 2001. c) Baumann et al., 2000.) obtaining 
per-O-silylated derivatives. TBDMS groups were also regioseletively 
inserted on cellulose either at position O-6 or both at positions O-2 and 
O-6, in dependence of the employed reaction conditions. (a) Koschella 
et al., 1997. b) Klemm et al., 1995.) Removal of silyl ethers protecting 
groups can be easily achieved with fluoride ions (TBAF/THF).  
 
1.3.1.2 Ester protecting groups 
The most common ester protecting groups are showed in Figure 5. 
Carboxylate esters can be obtained using carboxylic acid as acylating 
agents in the presence of strong acid or nucleophile catalysts. Much 
more frequently, their activated derivatives, such as acid chlorides or 
anhydrides either under acid or basic conditions, are employed.  
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Figure 5: Commonly used ester protecting groups 
 
 
When the reaction is conducted in basic conditions, a stoichometric 
amount of a base, such as pyridine or triethylamine has to be used. 
(Cumpstey, 2013) 
Ester protected polysaccharides were prepared on starch (Grote et al., 
2005) and celulose (McCormick et al., 1987) under basic conditions, 
obtaining in both cases an almost quantitative degree of substitution. 
Moreover, alginates were tested for hydroxyl protection by 
esterification too. (Pawar et al., 2011) Regioselective esterification at 
the primary position of a polysaccharide was investigated mainly on 
celulose, displaying a lower degree of substitution than ether 
protection. (Fox et al., 2011) 
 
1.3.1.3 Acetal and ketal protecting groups 
Benzylidene and isopropylidene are example of acetal and ketal-type 
protecting groups, respectively. They are suitable for the contemporary 
protection of two hydroxyl groups. They are introduced under acid 
conditions in the presence of aldehyde/ketone or acetal/ketal reagents, 
respectively and can form five-membered rings on 1,2-cis-diol and/or 
six-membered ones on 1,3-trans diols. They can be removed by acid 
hydrolysis afording the free hydroxyls, but, in the case of a 
benzylidene ring, several other methods for their regioselective opening 
could be applied. (Ohlin et al., 2011) Reductive opening of acetals 
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relies on a combination of a hydride reagent with a Lewis (or a proton) 
acid. In the case of benzylidene cycles installed at 4,6-positions of a 
sugar, the most common methods employed for opening to 6-O-benzyl 
protected derivatives use NaCNBH3-HCl-THF, (a) Garegg et al., 1982. 
b) Garegg et al., 1981.) and BH3·NMe3-AlCl3-THF mixtures. (Ek et al., 
1983) Instead, for the reductive opening to 4-O-benzyl derivatives, a 
LiAlH4-AlCl3 system in ethereal solvent is widely used, (Liptak et al., 
1975) although the employment of BH3·THF in THF with several 
different acids is a common method too. (a) Shie et al., 2009. b) 
Daragics et al., 2009. c) Tani et al., 2007. d) Shie et al., 2005. e) Wang 
et al., 2002. f) Jiang et al., 1998.) Benzylidene acetals can be also 
opened under oxidative, non regioselective conditions, obtaining, - for 
example, from, 4,6-rings – both, either a 4-O-benzoylated and a 6-O- 
protected derivative. (Adinolfi et al., 1999) 
 
 
1.3.2 Carboxylic acid protecting groups 
Natural polysaccharides can present carboxylic functions in their 
structure. The uronic acid species can be protected at C-6 position by 
formation of esters, reacting either as an electrophile or as a 
nucleophile. In the first case the activation could occur in strongly acid 
conditions, followed by the reaction with an alcohol to give the ester. 
Alternatively, the carboxylic acid can be transformed in a carboxylate 
ion and then, reacts with an alkylating agent to give the ester, as 
published for alginates (a) Pawar et al., 2013. b) Pelletier et al., 2000.) 
and pectins. (Pappas et al., 2004)  
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1.3.3 Glycosidic bond formation 
Some branched polysaccharides display several biological functions, 
including anti-tumour and immunostimulating activities. (Kurita et al., 
2011) Thus, introduction of branches on some specific linear 
polysaccharides could be useful for developing polysaccharide-based 
drugs. Recently, it has been developed a strategy for the regioselective 
glycosylation of polysaccharides, such as chitin-celulose hybrids 
(Ishimaru et al., 2014) and chitin polysaccharides (a) Kurita et al., 
2003. b) Kurita et al., 1998.) with oxazoline or orthoester 
monosaccharide derivatives as branching reagents, but exclusively at 
O-6 primary position. 
To this aim, the formation of new glycosydic bonds is achieved by 
glycosylation. This key reaction occurs between a glycosyl donor that 
acts as an electrophile, and a glycosyl acceptor that acts as a nuclophile. 
The former is fuly protected with the presence of a leaving group (LG) 
at its anomeric position, whereas the later presents al the positions 
protected but often only one free hydroxyl group (Scheme 1). 
 
  
Scheme 1: Standard glycosylation reaction mechanism 
 
 
The reaction needs the presence of a promoter (it is usualy used in 
catalytic amount) to take place. It activates the glycosyl donor assisting 
the departure of the leaving group. Other additives such as molecular 
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sieves or any base or acid that may act as scavengers could be also used 
depending on the specific conditions employed for the glycosylation. 
Protecting groups on the donor and acceptor backbones participate in 
the reaction and this feature is due to their electronic properties; thus, 
according to these, the armed-disarmed concept (Mootoo et al., 1988) 
displayed that a glycosyl donor with ester-type protecting groups is 
electronically deactivated (disarmed) over the same glycosyl donor 
bearing ether-type protecting groups, that is electronically activated 
(armed). (Demchenko, 2008) The difference in reactivity could be 
attributed to the electron-withdrawing effect of ester-type protecting 
groups that decrease the electron density and the nucleophilicity of 
leaving groups. Moreover, it has been discovered that glycosyl donors 
with a 2-O-benzyl-3,4,6-tri-O-acyl protecting group pattern are even 
more deactivated than the corresponding disarmed peracyl derivatives. 
(Kamat et al., 2005)  
This different behaviour could be attributed to the higher stabilization 
of the carbocationic intermediate, via the acyloxonium ion of the 
peracetylated donor, with respect to the oxocarbenium stabilization of 
2-O-benzyl-3,4,6-tri-O-acyl one, (Demchenko, 2008) taking into 
account of “O-2/O-5 cooperative effect”, (Kamat et al., 2005) although 
the nature of this latter has not been completely understood yet.  
 
1.3.3.1 Stereochemistry of glycosidic bond formation 
The O-glycosylation is a challenging aspect of synthetic carbohydrate 
chemistry for the necessity to form either α- or β-glycosydic bond, with 
a complete control of stereochemistry. In the presence of a participating 
protecting group at C-2 such as an acyl one, after the activation of a 
glycosyl donor and the subsequent exit of the leaving group, an 
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oxonium ion is formed. It reacts with the carboxylic oxygen of the acyl 
group, carying out the anchimeric efect, and thus forming a 
dioxolenium ion. This later is atacked by the glycosyl acceptor 
afording the 1,2-trans-glycosidic bond; thus, in the case of gluco-
configured donor a β-anomer is formed, whereas in the case of a 
manno-configured one a α-anomer is obtained. A side reaction could 
occur employing a glycosyl donor with a participating protecting group 
at C-2, such as the formation of an orthoester that could be, anyway, a 
reversible process when strong Lewis and Brønsted are used as 
promoters (Scheme 2).  
 
 
Scheme 2: Anchimeric efect in the control of stereochemistry of 
glycosidic bond formation  
 
 
The control of stereoselectivity in a glycosylation reaction, can be also 
achieved by the solvent (solvent efect), in the case of anchimeric efect 
absence. Using polar solvents, the mechanism is a pure SN1, with the 
formation of a solvated oxonium ion, that with the employment of 
nitrile-type solvents is solvated preferentialy at α-face, forming the 
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kinetically controlled (for the reverse anomeric effect) α-nitrilium-
nitrile complex, that affords a β-configured glycoside. With ether-type 
solvents the oxonium ion is solvated at β-face, forming the 
thermodynamically controlled β-ethereal complex, that affords a α-
configured glycoside (Scheme 3).  
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Scheme 3: Solvent control on stereochemistry of glycosidic bond 
formation 
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1.3.3.2 Glycosyl donors and activation conditions 
Glycosyl donors are classified depending on the leaving group linked to 
the anomeric position. The most commonly used are glycosyl halides, 
thioglycosides, trichloro- and N-phenyl-trifluoroacetimidates (Figure 
6), although their number and activation methods are continuously in 
progress (a) Satoh et al., 2013. b) Zhu et al., 2009.) 
 
 
Figure 6: Typical glycosyl donors 
 
 
Glycosyl halides were the first donors described in glycosylations, 
(Michael, 1879) with glycosyl bromides that are generaly more 
reactive than glycosyl chlorides. Glycosylations employing them are 
performed in the presence of heavy metal salts as promoter in 
stoichometric amount (Koenigs-Knor reaction). (a) Koenigs et al., 
1901. b) Wulf et al., 1974. c) Igarashi, 1977.) Up to now a wide 
variety of promoters to activate glycosyl halides have been developed 
such as AgClO4 and AgOTf and combination thereof. (Sherman et al., 
2001) Besides heavy metals, Lewis acids such as SnCl4, BF3∙OEt2 
(Ogawa et al., 1976) or ZnCl2 (Higashi et al., 1990) have been also 
introduced as promoters. Glycosyl fluorides are more stable than 
chloride and bromide ones and for long time they were not considered 
suitable glycosyl donors due to their unreactivity under Koenigs-Knor 
conditions. Their use was lately introduced (Mukaiyama et al., 1981) 
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employing over the years different kind of promoters for the activation, 
although the commonly used one is BF3∙OEt2. (Toshima, 2000) Despite 
glycosyl iodides had been already known (Fischer et al., 1910), they 
were considered too unstable to be synthetically useful (Meloncelli et 
al., 2009) and only recently it has been shown that they can offer some 
advantages with respect to glycosyl bromides and chlorides in terms of 
time, efficiency and selectivity (a) Ranade et al., 2013. b) van Well et 
al., 2005.) O-Glycosyl imidates donors (trichloro- and N-phenyl-
trifluoroacetimidates) (Schmidt et al., 1980) represent a very versatile 
method for glycosylation. This is ascribed to the catalytic amounts of 
promoter that are needed for their activation, differently from most 
glycosyl donors that, instead, require a stoichometric quantity. 
Both trichloro- and  N-phenyl-trifluoroacetimidate donors are relatively 
stable under basic or neutral conditions, but they easily react in the 
presence of catalytic amounts of a Brønsted or Lewis acid. For the first 
class of donor, typically TMSOTf (a) Grundler et al., 1984. b) Schmidt 
et al., 1982.) and BF3·OEt2 are involved in the activation and the 
imidate leaving group is expelled as trichloroacetamide after this step. 
Beside the above mentioned promoter, other several ones have been 
developed, including metal triflates [Sm(OTf)3, (Adinolfi et al., M.; 
2000) Sn(OTf)2, (a) Bartek et al., 1998. b) Castro-Palomino et al., 
1995.) Yb(OTf)3, (a) Adinolfi et al., 2001. b) Adinolfi et al., 2002.) 
Cu(OTf)2 (Yamada et al., 2002) and Bi(OTf)3 (Adinolfi et al., 2006)], 
acid molecular sieves (Adinolfi et al., 2003) and I2/Et3SiH system. 
(Adinolfi et al., 2002) Another technical development regarding the 
trichloroacetimidate donors is the inverse procedure (Schmidt et al., 
1991) for their activation, where the glycosyl donor is added to a 
mixture of a glycosyl acceptor and the promoter. According to this, it is 
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assumed that the highly reactive glycosyl trichloroacetimidates might 
react with the acceptor immediately after their activation with the 
promoter, because the last might be complexed in solution to 
heteroatoms of the acceptor. Glycosyl N-phenyl-trifluoroacetimidates 
can be activated under the same conditions of trichloroacetimidates, but 
they often require stronger conditions and both their higher stability 
(Yu et al., 2010) and the less amount of byproducts than the later could 
be ascribed to their enormous fame, in spite of their rather recent 
discovery. (Yu et al., 2001) 
The ease of synthesis and their stability make thioglycosides the most 
used donors in carbohydrates chemistry. Indeed, they display not only 
long shelf-lives, but they can be also decorated with several protecting 
groups, that can be efectively introduced and removed, leaving the 
thioglycoside function intact. Despite their stability, thioglycosides can 
be activated using mild thiophilic reagent (typicaly soft electrophiles) 
obtaining a sulfonium ion, that is a beter leaving group than the SR 
moiety, and thus afords the oxonium ion. This later can react with the 
glycosyl acceptor, then forming a glycosydic bond (Scheme 4). 
 
 
Scheme 4: Thioglycoside activation 
 
 
A very common activation method for thioglycosides relies on the 
employment of N-iodosuccinimide (NIS) as iodine-containing 
compound in the presence of triflic acid (TfOH) (Veeneman et al., 
1990) or with Lewis acids such as TMSOTf, BF3·OEt2 or AgOTf. 
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(Konradsson et al., 1990) Even though the versatility of thioglycosides 
is very well documented, they can present some disadvantages, the 
most important one is the necessity of stoichiometric amounts of 
promoter that could lead to side reactions in the glycosylations. 
 
 
1.3.4 Sulfation decoration of polysaccharides 
The biological importance of sulfate-bearing polysaccharides has given 
a great impulse to the production of chemically or chemoenzymatically 
sulfated polysaccharides from natural unsulfated ones. Indeed, after the 
introduction of sulfate groups, they often acquire biological activities. 
Sulfation is usually performed under non regioselective conditions, thus 
achieving derivatives that present sulfate groups randomly distributed 
on the polysaccharide backbone. Moreover, under harsh conditions, 
persulfated polymers could be obtained but some of them can induce 
some very adverse side effects in humans. (a) Guerrini et al., 2008. b) 
Kishimoto et al., 2008.) The regioselective sulfation of polysaccharides 
has been reported both in enzymatic and chemical way, although the 
former method is limited by the low scale of reactions reported up to 
now and by the selective employment on GAGs, that are usually 
already sulfated. It can be, therefore, more advisable to develop also 
chemical methods for the regioselective introduction of sulfate groups 
into different polysaccharide backbones.  
The already reported methods for the regioselective sulfation of 
polysaccharides rely on protection-sulfation-deprotection strategies, 
employing both esters and ethers as protecting groups. Bulky pivaloyl 
esters, for example, were inserted on the reactive primary hydroxyl of 
curdlan (Gao et al, 1997) and carrageenan (de Araùjo et al., 2013), 
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afording, after sulfation and global deprotection, in the former case 
polysaccharides composed of a 2,4-O-disulafted glucose repeating unit 
and in the later 2,4-O-disulfated galactose and 2,4,6-O-trisulfated 
galactose together with 2-O-sulfated anhydrogalactose (Scheme 5). 
 
 
Scheme 5: Three-steps (protection/sulfation/deprotection) strategies 
using ester protecting groups on polysaccharides. 
 
 
Moreover, other ester groups, such as benzoyl and trifluoroacetyl, were 
used to regioselectively protect the primary O-6 hydroxyl of hyaluronic 
acid (Becher et al., 2010) and celulose (a) Zhang et al., 2013. b) 
Baumann et al., 2000. c) Klemm et al., 1995.) Besides, also some bulky 
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ether groups, such as Tr, MMTr and DMTr were used as protecting 
groups in the regioselective sulfation of polysaccharides, showing their 
advantages to be removed orthogonally with respects to the other 
protecting groups. Indeed, primary alcohol protection with Tr, MMTrCl 
or DMTrCl was employed for the regioselective sulfation of chitosan 
(Nishimura et al., 1998) and cellulose. (Heinze et al., 2000) 
The longest and up to now most sophisticated multi-step sequences for 
the regioselective sulfation of polysaccharides have been developed for 
the production of CS (a) Laezza et al., 2014. b) Bedini et al., 2012. c) 
Bedini et al., 2011. d) Bianchi et al., 2012. e) Zoppetti et al., 2004.) and 
fCS (a) Laezza et al., 2016. b) Laezza et al., 2015) polysaccharides with 
different sulfation patterns. Some of them will be discussed in full 
details in Chapter II. 
 
 
1.3.5 Conjugation of polysaccharides with amines 
Uronic acids can react as electrophiles in the presence of amines to give 
amides. This reaction can be achieved using several coupling agents (as 
it will be discussed in more detail in Chapter IV), such as water-soluble 
EDC as published for alginates uronic acid modification. (Yang et al. 
2011) Moreover, the same modification could be achieved employing 
organic salts, that are suitable for organic solvent. (Vallée et al., 2009) 
 
 
1.4 Aim of the thesis 
The aim of this thesis is the development of new synthetic organic 
chemistry strategies for the regioselective modifications of some 
polysaccharides. This includes: 
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 A semi-synthetic strategy for the obtainment of CS and fCS 
polysaccharides by regioselective sulfation and insertion of L-
fucose branches on microbial sourced chondroitin 
polysaccharide (Chapter II) 
  A preliminary study on interaction between selectins and one 
of the obtained fCS derivatives (Chapter III) 
 The semi-synthesis of mimics of CPS from Colwellia 
psychrerythraea – a psychrophilic bacterium - by regioselective 
decoration of a microbial sourced chondroitin polysaccharide 
with L-threonine units and their antifreeze properties evaluation 
(Chapter IV) 
 A study of regioselective sulfation of a polymannuronic acid 
alginate (Chapter V) 
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CHAPTER 2 
 
REGIOSELECTIVE SULFATION AND 
FOCUSYLATION OF MICROBIAL SOURCED 
CHONDROITIN POLYSACCHARIDE 
 
2.1 Introduction 
Sulfation is a very important decoration. In fact GAGs could be divided 
into two families depending on the presence or the absence of sulfate 
group. HA is the only unsulfated glycosaminoglycan, whereas sulfated 
ones include HP, HS, CS, fCS, DeS and KS. (Bedini et al., 2016) 
CS is widely distributed in mammals and invertebrates, as well as in 
some bacteria (Bedini et al., 2016) and is involved in different 
physiological and pathological processes. It is composed of a 
disaccharide repeating unit containing β-D-glucuronic acid and N-
acetyl-galactosamine linked through β-(13) and β-(14) glycosydic 
bonds. After in vivo polymerization it affords a polysaccharide that can 
show different sulfation patterns. Based on positions of sulfate groups, 
several disaccharide subunits could be, indeed, described: the positions 
O-4 and/or O-6 on GalNAc residue are commonly sulfated, differently 
from positions O-2 or O-3 of the GlcA residue that are rarely sulfated. 
(Pomin, 2013) (Figure 7)  
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Figure 7: Disaccharide subunits in natural CSs 
 
 
CS isolated from natural sources (Shi et al., 2014) has applications in 
medicine for treatment of osteoarthritis and osteoarthrosis (Bishnoi et 
al., 2016), but further potential employments have been proposed 
depending on different sulfation patterns. (a) Schiraldi et al., 2010. 
b)Yamada et al., 2008.) Nonetheless, the low abundance of raw 
material, the laborious downstream purification and the growing 
application of CS as drug led to development of chemical and 
chemoenzymatic (a) Bedini et al., 2013. b) Scott et al., 2013.) fine 
manipulation of its structure, mainly towards the modification of 
sulfation pattern. (Bedini et al., 2016)   
To GAGs family belongs also fCS. It is extracted from sea cucumbers 
(Echinoidea, Holothureidea) and presents a linear disaccharide 
backbone composed of GlcA and GalNAc units, linked together 
through β-(13) and β-(14) alternating glycosidic bonds. Depending 
on the different varieties of sea cucumbers from various seawaters, the 
disaccharide repeating unit could be characterized by the presence of 
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both differently distributed sulfate groups and differently sulfated L-
fucose branches. (a) Myron et al., 2014. b) Chen et al., 2011.) 
Single L-fucose branch per repeating unit is α-glycosidically linked at 
position O-3 of GlcA units, its presence is probably necessary to 
prevent the action of chondroitin sulfate-related enzymes, excreted 
from marine microorganisms. It has been also suggested that 
polysaccharides with high extent of sulfate groups are required in 
marine environments. (Myron et al., 2014) Moreover, some slightly 
different structural features have been recently suggested for fCS 
extracted from Apostichopus japonicus, Actinopyga mauritania, and 
Ludwigothurea grisea. In the former two cases a random fucosylation 
at either GlcA O-3 or GalNAc O-4/O-6 position has been proposed, (a) 
Ustyuzhanina et al., 2016. b) Yang et al., 2015.), whereas in the latter 
fCS a α-Fuc-(13)-Fuc disaccharide branch was found. (Santos et al., 
2015) Several different sulfation patterns for both GlcA- and GalNAc-
linked Fuc branches have been found (Figure 8).  
 
 
 
Figure 8: Sulfation patterns found in natural fCSs  
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fCS presents biological activities related to angiogenesis, 
atherosclerosis,  cancer metastasis, cellular growth, hyperglycemia, 
fibrosis, viral infection, and, above all, coagulation and thrombosis. 
(Pomin, 2014)  
The anticoagulant and antithrombotic activities are strictly related to 
the presence of sulfated L-fucose branches, indeed, partially 
defucosylated and desulfated derivatives have no anticoagulant or 
antithrombotic activities. (a) Monteiro-Machado et al., 2015. b) 
Mour o et al., 1998. c) Mourao et al., 1996.) Moreover, the highest 
anticoagulant activities have been found for 2,4-di-O-sulfated fucose-
containing fCS, although the independence of the anticoagulant and 
antithrombotic ones from the different sulfation pattern of Fuc branches 
has been recently proposed. (a) Santos et al., 2015. b) Myron et al., 
2014.) Anticoagulant and antithrombotic activities are mediated by AT 
and HCII ( our  o  et al., 1996) in a serpin-dependent mechanism, but, 
differently from heparin, fCS showed also a serpin-independent one, 
when it was tested on AT- and HC-II free plasmas, inhibiting, indeed 
the generation of factor Xa by the intrinsic tenase complex in a more 
potent way than thrombin formation in the prothrombinase complex. 
(Glauser et al., 2008) Moreover, it seems to retain also the 
antithrombotic activity when it is orally uptaken. (Fonseca et al., 2006)  
The most used drug for anticoagulant treatment is unfractionated 
heparin, which long-term therapy displays several limitations, as well 
as a high tendency to pathogenic contamination due to heparin 
extraction from animal sources. ( our  o , 2015) The introduction of 
ultra-low-molecular weight heparins (ULMWH) reduced these 
problems, but the development of a safer and more potent 
antithrombotic and anticoagulant drug is an engaging challenge. 
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(Mackman, 2008) To this aim, the anticoagulant and antithrombotic 
activities showed by fCS have drawn attention, although the even more 
strict regulation for animal-derived drugs and the high variability of 
sulfation pattern in polysaccharide of animal origin require a severe 
control of its sulfation level. Indeed in 2008 a contamination of heparin 
lots by oversulfated chondroitin sulfate provoked 149 deaths (a) 
Kishimoto et al., 2008. b) Guerrini et al., 2008.) Moreover, natural fCS 
polysaccharides exhibit adverse effects, such as platelet aggregation, 
factor XII activation and bleeding, (Fonseca et al., 2010) differently 
from low molecular weight fCS polysaccharides. For this reason, 
strategies to mild and regioselective depolymerization to obtain shorter 
fCS molecules without removal of sulfate groups and fucose branches 
(a) Li et al., 2016. b) Liu et al., 2016. c) Zhao et al., 2015. d) Gao et al., 
2015. e) Wu et al., 2015. f) Zhao et al., 2013.) or total synthesis of di- 
and trisaccharide fragments of fCS were recently developed. (a) 
Vinnitskiy et al., 2017. b) Ustyuzhanina et al., 2015. c) Tamura et al., 
2013) Using the former strategy, it has been discovered that the 
minimum lenght that is responsible for the intrinsic tenase complex 
inhibition is a nonasaccharide. (Zhao et al., 2015)  
An alternative approach to non-animal sourced CS and fCS species is 
here proposed by accomplishing the chemical regioselective 
fucosylation and/or sulfation of a microbial-sourced chondroitin 
polysaccharide (a) Laezza et al., 2016. b) Laezza et al., 2015. c) Laezza 
et al., 2014.)  
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2.2 Results and discussion 
 
2.2.1 Regioselective sulfation of microbial sourced 
chondroitin 
An interesting approach to produce CS polysaccharides with a well-
defined sulfation pattern from microbial sourced chondroitin (Cimini et 
al., 2010) relies on regioselective protection of polysaccharide 
backbone, followed by sulfation of free hydroxyls and then global 
deprotection. The semi-syntheses reported up to now all started with 
protection of the GalNAc O-4,6 diol by a cyclic acetal (benzylidene) 
(Bedini et al., 2011) or by an orthoester (Jacquinet et al., 2009) (1 and 3 
respectively, Scheme 6) followed by acetylation of O-2,3 GlcA diol. 
The cycles were, successively, both opened under no regioselective 
conditions (Adinolfi et al., 1999) obtaining derivatives 2 and 5 
protected by acyl groups either at position O-4 or O-6 of GalNAc on 
disaccharide unit. Sulfation of free hydroxyls and global deprotection 
finally afforded semi-synthetic CS polisaccharides. The application of 
different cyclic protecting group seemed to influence the sulfation 
pattern, with the presence of sulfate groups at positions O-4 or O-6 of 
GalNAc units (CS-A,C) (Bedini et al., 2011) in the case of a 
benzylidene-based strategy. Alternatively, diol protection by a 
orthoester ring afforded a CS polysaccharide with the uncommon 
feature (Sugahara et al., 2000) of an additional sulfate group at position 
O-3 of some GlcA units. (Bedini et al., 2012) 
Here the two protection sequences were carefully investigated in order 
to explain the different output on CS sulfation pattern. The starting 
material used for the semi-synthesis of CS polysaccharides was 
obtained after a downstream purification (Cimini et al., 2010) of a fed-
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batch fermentation of Escherichia coli O5:K4:H4. Unsulfated 
chondroitin polysaccharide was, in this way, obtained with 89-94% 
purity grade free of any toxic lipopolysaccharide contaminant after 
NMR evaluation and capillary electrophoresis. (Restaino  et al., 2009) 
The presence of a sulfate group at position O-3 of some GlcA units 
obtained at the end of the orthoester route, was firstly hypothesized to 
be produced after a non-quantitative acetylation on derivative 1 
(Scheme 6).  
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Scheme 6: Orthoester and benzylidene routes for the semi-synthesis of 
CSs from unsulfated chondroitin 
 
 
Nonetheless, even by accomplishing the protection of free hydroxyls of 
1 with acyl groups under several powerful conditions, the final CS 
polysaccharide still presented to a certain extent an additional sulfate 
group at O-3 of GlcA unit in every case.  
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Benzylidene and orthoester routes presented differences not only in the 
cyclic protecting group used for the O-4,6 diol on GalNAc units, but 
also in the work-up employed for the reactions. Indeed, in the 
benzylidene strategy the polysaccharide was isolated after each step by 
precipitation, on the contrary the first three steps of the orthoester route 
were conducted one-pot with only a final purification of the 
intermediate polysaccharide 2 by dialysis (Scheme 6). In order to 
reduce as many differences as possible between the two semi-synthetic 
strategies, the isolation of orthoester-protected intermediate 1 was 
pursued by precipitation. Unfortunately, all the efforts afforded a 
product showing very complex NMR spectra that was not possible to 
characterize in details, differently from benzylidene-protected 
polysaccharide 3, that displayed benzylidene methine proton (δH = 5.53 
ppm) and N-acetyl (δH = 1.76 ppm) signals with a 1:3 integral ratio in 
its 1H-NMR spectrum (overlapped to ist HSQC-DEPT spectrum in 
Figure 9).  
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Figure 9:1H and 1H-13C HSQC-DEPT NMR spectra (600 MHz, 
DMSO-d6, 298 K) of polysaccharide 3  
 
 
The higher lability of the orthoester moiety prevented the isolation of 
the polysaccharide intermediate 1. Thus, it was necessary to get the 
benzylidene strategy as closest as possible to the orthoester one, instead 
of opposite. To this aim, benzylidenation and acetylation steps were 
conducted one-pot without the precipitation of the partially protected  
polysaccharide intermediate 3. The benzylidene ring was then cleaved 
under oxidative conditions (Adinolfi et al., 1999) and, by sulfation of 
free hydroxyls and then global deprotection, the semi-synthetic 
pathway was completed without any other difference respect to the 
original benzylidene route (Scheme 6), (Bedini et al., 2011) affording 
in this case a CS polysaccharide possessing sulfate groups at positions 
O-4 or O-6 of GalNAc units and also at O-3 of some GlcA units, as 
through the orthoester route. This result was clearly showed in its 
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HSQC-DEPT spectrum (Figure 10) by the presence of two downfield-
shifted carbinolic CH signals (δH = 4.75, δc = 77.2 ppm and δH = 4.36, 
δc = 81.9 ppm) – indicating (Sugahara et al., 1996) a sulfation at H-4 of 
GalNAc and H-3 of GlcA units, respectively – and of one group of 
downfield-shifted CH2 signals (δH = 4.17-4.22, δC = 66.9, 68.0 ppm) 
attribuible to sulfated H-6 of GalNAc units. 
 
 
 
Figure 10: Zoom of 1H and 1H-13C HSQC-DEPT NMR spectra (600 
MHz, D2O, 298 K) of semi-synthetic CS polysaccharide obtained 
through one-pot benzylidene (80°C)-acetylation route (the integral 
intensities of cross-peaks enclosed in the continous regions were used 
for the evaluation of the relative amount of sulfated and non-sulfated 
monose units: see Table 1).  
 
 
CH2-6
GalNAc-6SCH-4
GalNAc-4S CH-4
GalNAC-6S
CH-3
GlcA
CH-3
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This result was firstly ascribed to a non-quantitative acetylation at O-3 
position of GlcA caused by the change of solvent from the two-pot 
(acetylation in CH3CN) to the one-pot sequence (acetylation in DMF-
CH3CN or DMF only). To verify this hypothesis, purified intermediate 
3 was protected by acetylation in DMF, instead of CH3CN. By 
concluding the synthetic route as indicated in Scheme 6, the obtainment 
of a CS-A,C polysaccharide without any NMR-detectable GlcA-3S unit 
was afforded. Hence, a DMF effect operating during the acetylation 
step had to be discarded. Alternatively, the presence of some GlcA-3S 
units obtained after one-pot benzylidenation/acetylation strategy, could 
be attributed to the formation of unstable benzylidene acetals involving 
position O-3 of some GlcA units that could survive when no work-up 
was performed (Scheme 7). Instead, they might degrade after 
benzylidenation work-up by precipitation due to the presence of acid 
functional groups on the polysaccharide backbone (3, Scheme 6). 
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Three different labile benzylidene moieties were hypothesized. An 
interglycosidic acetal involving O-3 and O-6 of some GalNAc and 
GlcA units, respectively, could have been formed in competition with a 
classical intraglycosidic 4,6-O-benzylidene, (6a, Scheme 7) as reported 
on some di- and trisaccharides (a) Manzo et al., 2000. b) Sakairi et al., 
1998. c) Sakairi et al., 1993. d) Jaramillo et al., 1988. e) Alonso-Lopez 
et al., 1987. f) Fanton et al., 1981.) and on cyclodextrins. (Sakairi et al., 
1996) Differently, to the best of our knowledge, no examples has been 
reported on polysaccharides yet. Moreover, an interglycosidic 
benzylidene acetal has been demonstrated to be selectively cleaved 
under mild acid conditions in the presence of six-membered 
intraglycosydic 4,6-benzylidene cycles (Sakairi et al., 1998), as 
observed also in our case, as only the latter kind of benzylidene was 
obtained by precipitation of derivative 3 in the two-pot benzylidene-
acetylation strategy (Scheme 6). The interglycosidic benzylidene ring 
in 6a could be also cleaved under oxidative conditions (Adinolfi et al., 
1999) together with the six-member one, in order to obtain a free 
hydroxyl group at position O-3 of some GlcA units (7a, Scheme 7), 
that after sulfation and global deprotection afforded CS-8a.  
A second possibility for a labile benzylidene acetal including O-3 of 
some GlcA units was supposed to be a 2,3-trans-configured ring (6b), 
as described for gluco-configured hexoses. (a) Français et al., 2007. b) 
Thiem et al., 1978.) It might have been oxidatively cleaved as well, 
nevertheless the presence of some GlcA-3S in the final CS product 
might display that this cleavage proceeded with a marked 
regioselectivity, leaving principally a free hydroxyl group at position 
O-3 and a benzoate ester at O-2 (7b). Anyway, this hypothesis is in 
contrast with the oxidative opening of a 2,3-benzylidene ring on a 
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gluco-derivative under Hanessian-Hullar conditions that furnished an 
equimolar mixture of O-2 and O-3 alcohol products (Thiem et al., 
1978). A labile acyclic acetal was, also, hypothesized, (6c) as reported 
for secondary glucose hydroxyls on acetalation of dextrans. (a) 
Broaders et al., 2009. b) Bachelder et al., 2008.) It could be opened 
under oxidative conditions, by NaBrO3/Na2S2O4 treatment, affording a 
free alcohol at O-3 position of some GlcA units. Nonetheless the 
amount of acyclic acetal was observed to be approximately zero when 
acetalation of dextran was performed with PhCH(OCH3)2. (Cui et al., 
2012) 
The hypothesis of these three labile acetals formation was tested by 
firstly neutralizing the carboxylic acid functions of GlcA and the 
residual CSA catalyst that usually co-precipitated with the 
polysaccharide. This was done by quenching the benzylidenation 
reaction of chondroitin with a stoichiometric excess of triethylamine 
(Et3N) before precipitation work-up.  
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Scheme 8: Isolation of intermediate 9a/9b/9c by precipitation from the 
reaction mixture and quenched with Et3N. 
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The obtained product 9a/9b/9c (Scheme 8) afforded at the end of the 
semi-synthetic steps, as expected, a polysaccharide displaying sulfate 
groups not only on GalNAc but also at position O-3 of some GlcA 
units. This confirmed that the stabilization in an alkaline environment 
of a labile acetal on some GlcA units controls the sulfation pattern of 
the final CS product. 
In order to increase the production of the labile acetal, benzylidene 
conditions were slightly modified. The reaction was conducted under 
Ar atmosphere by employing freshly dried DMF and PhCH(OCH3)2 to 
avoid hydrolysis of the labile acetal by moisture. Moreover, the 
reaction was conducted at temperatures lower than 80°C, following the 
benzylidenation step by the standard strategy (Scheme 7), and 
evaluating the relative sulfation degree at O-3 position of GlcA units 
with respect to unsulfated GlcA ones in the final CS polysaccharides, 
by integration of HSQC-DEPT spectrum (Figure 11). (Guerrini et al., 
2005)  
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Figure 11: Zoom of 1H and 1H-13C HSQC-DEPT NMR spectra (600 
MHz, D2O, 298 K) of CS obtained with the semi-synthetic strategy 
based on one-pot benzylidenation (rt)-acetylation (the integral 
intensities of cross-peaks enclosed in the dotted regions were used for 
the evaluation of the relative amount of sulfated and non-sulfated 
monose units: see Table 1). 
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Figure 12: Zoom of 1H and 1H-13C HSQC-DEPT NMR spectra (600 
MHz, D2O, 298 K) of CS obtained with the semi-synthetic strategy 
based on one-pot orthoesterification (rt)-acetylation (the integral 
intensities of cross-peaks enclosed in the dotted regions were used for 
the evaluation of the relative amount of sulfated and non-sulfated 
monose units: see Table 1).  
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Table 1: Amount of sulfated and non-sulfated monose units in semi-
synthetic CSs depending on reaction conditions for GalNAc 4,6-diol 
protection 
 
Entry T [°C]a GlcA-3Sb/GlcA GalNAcc/G
alNAc-4 or 
6S 
GalNAcc-
4S/GalNAc-6S 
1 80 0.29 ~0d 0.34 
2 50 0.27 ~0d 0.46 
3 RT 0.50 2.04 ~0e 
4f RT 0.50 ~0d 0.59 
aReferred to benzylidenation reaction conducted one-pot with acetylation, except 
where differently indicated 
bRatio evaluated by integration of CH-3 signal of GlcA-3S (δH = 4.36, δC = 81.9 
ppm), and GlcA (δH = 3.58, δC = 74.4 ppm) units in the HSQC-DEPT spectrum (600 
MHz, D2O, 298 K) (see Figure 10)  
cRatio evaluated by integration of CH-4 signal of GalNAc (δH = 4.12, δC = 68.4 ppm), 
GalNAc-4S (δH = 4.75, δC = 77.2 ppm), and GalNAc-6S (δH = 4.17, δC = 68.1 ppm) 
units in the HSQC-DEPT spectrum (600 MHz, D2O, 298 K) (see Figure 10) 
dCH-4 signal of unsulfated GalNAc units non detectable in the HSQC-DEPT 
spectrum (see Figure 10) 
eCH-4 signal of GalNAc-4S not detectable in HSQC-DEPT spectrum (see Figure 10) 
fOrthoesterification-acetylation semi-synthetic protocol (Bedini et al., 2012) 
 
 
By conducting the benzylidenation at 50°C, no increase of GlcA-3S 
was detected, whereas at rt the ratio GlcA-3S/GlcA increased, giving 
the same value observed for the one-pot orthoesterification-acetylation 
strategy (Figure 12 and Table 1). (Bedini et al., 2012) Nonetheless, by 
lowering the benzylidenation reaction at rt, the amount of unsulfated 
GalNAc increased, because of a non-quantitative benzylidenation of 
GalNAc O-4,6 diol at rt. The resulting free hydroxyls were then 
acetylated and deprotected only in the final step, thus avoiding 
sulfation.  
In order to understand which kind of labile benzylidene was 
responsible for GlcA-3S units in the CSs, it was necessary a 2D-NMR 
characterization of polysaccharide intermediate 9a/9b/9c, isolated by 
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precipitation work-up after the benzylidenation reaction conducted at rt 
and quenched with Et3N. The intermediate gave rather clear 2D-NMR 
spectra in a 4 mM NaOD solution in D2O, even if the labile acetals 
formed could be underestimated (Figures 13 and 14). 
 
 
Figure 13: Zoom of 1H and 1H-13C HSQC-DEPT  NMR spectra (600 
MHz, 4mM NaOD in D2O, 298 K) of polysaccharide 9a 
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Figure 14: Zoom of 1H, and 1H-13C HMBC NMR spectra (600 MHz, 
4mM NaOD in D2O, 298 K) of polysaccharide 9a 
 
 
The HSQC-DEPT spectrum displayed three different benzylidene 
methine signals, where the most intense one (δH = 5.78, δc = 101.6 
ppm) correlated with two signals in the HMBC spectrum. The first one 
at δC = 69.5 ppm, was an antiphase signal in the HSQC-DEPT spectrum 
respect to the other integral intensities of cross-peaks and easily 
attributable to the methylene group at position O-6 of GalNAc (δH = 
4.25, δC = 69.5 ppm). The second one could be ascribed to the CH at 
position O-4 of GalNAc (δH = 4.58, δC = 75.7 ppm) by HSQC-DEPT, 
COSY and TOCSY analysis, thus allowing the assignment of the most 
intense benzylidene methine signal to the 4,6-O-benzylidene ring on 
GalNAc. Also the most 1H-downfield shifted benzylidene methine 
signal showed in the HSQC-DEPT spectrum (δH = 6.26, δC = 36.9 ppm) 
correlated with two densities in the H B C spectrum. These were at δC 
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= 67.3 and δC = 62.7 ppm, corresponding, respectively, to the signal of 
CH at position O-4 of GalNAc units in the HSQC-DEPT spectrum  (δH 
= 4.49, δC = 67.3 ppm) and to a signal in antiphase with respect to the 
other integral intensities of cross-peaks and attributable to GalNAc 
methylene group (δH = 3.95, δC = 62.0 ppm). These signals could be 
assigned to an interglycosidic 4,6-O-acetal connecting two GalNAc 
units of the same or two different polysaccharide chains, because the 
absence of any shift of carbon signals (Mucci et al., 2000) reminiscent 
of the NMR behaviour of CH2 and CH groups involved in acyclic 
acetals in disaccharide derivatives. (a) Lipták et al., 2002. b) Barili et 
al., 1997.) Nevertheless, the presence of both or only one kind of 
connection has not been investigated, yet. The third most 1H-upfield 
shifted benzylidene methine signal (δH = 5.32, δC = 91.4 ppm) 
suggested the formation of an interglycosidic benzylidene acetal 
between GalNAc-O-6 and GlcA-O-3 positions (9a, Scheme 8) in 
analogy with the interglycosidic 4,6-O-benzylidene associated to the 
most 1H-downfield benzylidene methine proton (δH = 6.26 ppm). This 
was hypotesized by the correlation of benzylidene methine signal with 
two integral intensities of cross-peaks in the H BC  spectrum at δC = 
62.7 and δC = 75.1 ppm, respectively (Figure 14). The former 
corresponded in the HSQC-DEPT spectrum to a signal (δH = 3.65 ppm) 
in antiphase with respect to the other integral intensities of cross-peaks 
and thus again attributable to a GalNAc methylene group. Even if it 
was no possible to assign unambiguously the latter cross-peak in the 
HSQC-DEPT spectrum, due to overlapping with integral intensities of 
cross-peaks related to the major underivatized and six-membered 
benzylidene benzylidene protected disaccharide units, its carbon 
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chemical shift value (δC = 75.1 ppm) was rather similar to the CH at 
position O-3 of an underivatized GlcA unit (δH = 3.60, δC = 73.7 ppm). 
The O-6 GalNAc–O-3 GlcA connection could involve adjacent monose 
along the polysaccharide chain or far way ones in the same chain or in 
the two different ones. It is worth noting that the analysis of these 2D 
spectra allowed to discard the alternative hypotheses for the obtainment 
of CS polysaccharides sulfated at position O-3 of GlcA units (9b and 
9c, Scheme 8). Indeed, literature data showed rather upfield shifted 
values (δc ~ 50-53 ppm) for the methoxy group of acyclic benzylidene 
moieties on sugars (a) Fascione et al., 2010. b) Mulard et al., 1994.), 
thus making the hypothesis of acyclic acetal formation at position O-3 
of some GlcA (9c, Scheme 8) inadmissible. A trans-2,3-benzylidene 
moiety one (9b) could be discarded as well, because the integral 
intensities of cross-peaks at δC = 62.0 and 62.7 ppm in the HMBC 
spectrum were compatible with neither C-2 nor C-3 of trans-configured 
benzylidene protected GlcA units. (Thiem et al., 1978) In conclusion, 
NMR data obtained from HSQC-DEPT and HMBC spectra were 
compatible only with the formation of interglycosidic benzylidenes as 
labile acetal motifs. Connections between position O-6 of some 
GalNAc units and position O-4 of other GalNAc as well as O-3 of 
GlcA  ones were proposed. The former allowed the sulfation of O-4 or 
O-6 of GalNAc, whereas the latter connection accounted for the 
sulfation at O-3 of GlcA units in the CSs obtained at the end of the one-
pot benzylidene-acetylation route.  
To summarize, a proposed mechanism for the formation of 
interglycosidic acetals in competition with a classical six-membered 
intraglycosidic one during the benzylidenation reaction is displayed in 
Scheme 9. 
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Scheme 9: Proposed mechanism for competitive formation of intra- vs. 
interglycosidic benzylidene acetals on chondroitin. 
 
 
α,α-Dimethoxytoluene is firstly attacked by the primary, most reactive 
hydroxyl of GalNAc units, to give acyclic acetal 10, that can be then 
intramolecularly transacetalated by hydroxyl at position 4 either of the 
same GalNAc unit, to obtain a six-membered intraglycosidic 
benzylidene ring 3, or of another GalNAc along the same or another 
polymeric strand as well as by OH-3 of GlcA to give interglycosidic 
acetal moieties (11 and 12, respectively). The higher lability of the 
latters allowed their conversion into the former by another 
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intramolecular transacetalation, when the benzylidenation reaction was 
conducted under thermodynamic control conditions. Indeed, at high 
temperatures (50-80°C) a lower GlcA-3S/GlcA ratio was detected at 
the end of the semi-synthesis with a benzylidenation conducted at rt.  
 
 
2.2.2 Semi-synthesis of fucosylated chondroitin sulfate  
The key step for the obtainment of fCS polysaccharides from microbial 
sourced chondroitin was the insertion of Fuc branches on the linear 
polymer backbone of chondroitin by glycosylation reaction. 
The only chemical O-glycosylation of polysaccharides reported by far 
regarded, to the best of our knowledge, the coupling between suitably 
protected polysaccharide derivatives with glycosyl orthoester or 
glycosyl oxazoline donors under rather harsh conditions to give 
products displaying mono- or disaccharide branches 1,2-trans-linked 
exclusively to the O-6 position of polysaccharide backbone. (a) 
Ishimaru et al., 2014. b) Kurita et al., 2011. c) Kurita et al., 2003. d) 
Kurita et al., 1998.) This route could not be useful for chondroitin 
fucosylation to give fCS, because α-Fuc branches are usually 1-2-cis-
linked to a secondary position (GlcA-O-3) of the chondroitin backbone 
(Figure 8). Although recently enzymatic (a) Lezyk et al., 2016. b) 
Benesova et al., 2013. c) Sakurama et al., 2012. d) Serna et al., 2011. e) 
Cobucci-Ponzano et al., 2009. f) Wada et al., 2008. g) Cobucci-
Ponzano et al., 2008. h) Farkas et al., 2000.) and chemical methods (a) 
Daly et al., 2013. b) Fujiwara et al., 2011. c) Adinolfi et al., Synlett 
2004. d) P rion et al., 2003. e) Vermeer et al., 2001. f) Schmid et al., 
1998.) for fucosylation of mono- and oligosaccharide derivatives have 
been published, glycosylation reactions involving deoxyhexosyl donors 
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are generally known to be rather challenging, due to the lower electron-
withdrawing effect because of the absence of one (or more) hydroxyls. 
(Comegna et al., 2007) This feature could lower the yield of the 
glycosylation, especially with poorly reactive glycosyl acceptors as 
polysaccharide derivatives, because the leaving group on 
deoxyglycosyl donor could release too early the anomeric position. 
The semi-synthetic route started with the esterification of chondroitin 
(obtained from E. coli fermentation as described in paragraph 2.2.1) in 
order to afford polysaccharide derivatives soluble in aprotic solvents. 
Quantitative methylation was accomplished by stirring twice a 
methanolic suspension of the polysaccharide in the presence of acetyl 
chloride at rt overnight (Scheme 10). It was not possible to evaluate the 
DS of 13 by comparison of integration values of acetyl and methoxy 
signals (δH = 2.02 and 3.85 ppm) in 
1H-NMR spectrum due to the 
overlapping of OCH3 with some carbinolic signals. However, this was 
circumvented by HSQC-DEPT integration, that gave an almost 
quantitative DS (0.92). Alternatively, chondroitin derivatization at 
carboxylic function with a long alkyl chain (n-dodecyl) was 
accomplished on tetrabutylammonium salt 14 (Valoti et al., 2012) 
under conditions optimized for alginate esterification. (Pawar et al., 
2013) Thus, a suspension of 14 in DMF was treated with n-dodecyl 
iodide in the presence of TBAF at 80°C to give chondroitin ester 15 
with a DS = 0.96.  
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Scheme 10: (a) 1: Dowex 50 WX8 (H+ form), 2: CH3COOCl, MeOH, 
rt, twice, 73%, DS = 0.92; (b) see ref. Valoti et al., 2012; (c) C12H25I, 
TBAF, D F, 80°C, DS = 0.96; (d) α,α-dimethoxytoluene, CSA, DMF, 
80°C, 89% (DS = 0.95) for 16, 97% over two steps from 14 (DS = 
0.96) for 17; (e) (CH3)3SiCl, [(CH3)3Si]2NH, pyridine, 50°C, 88-93% 
(DS =1.03-2); (f) Ac2O, Et3N, DMAP, CH3CN, rt, overnight, DS = 2; 
(g) NaBrO3, Na2S2O4, H2O-ethyl acetate, rt, overnight, 63% over two 
steps (DS = 0.97). 
 
 
Both derivatives 13 and 15 were then regioselectively protected at the 
O-4,6 diol of GalNAc units with a benzylidene ring by treating them 
with α,α-dimethoxytoluene in DMF at 80°C in the presence of CSA as 
catalyst. HSQC-DEPT 2D-NMR integration of integral intensities of 
cross-peaks related to acetyl and benzylidene methine displayed a DS = 
0.95 and 0.96 for 16 and 17, respectively. It was not possible to 
determine the DS for derivatives 16 and 17 by comparison of acetyl  
(δH = 1.77 and 1.73 ppm for 16 and 17, respectively) and benzylidene 
methine signals (δH = 5.51 and 5.48 ppm for 16 and 17, respectively) in 
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1H-NMR spectrum due to overlapping of the formers with CSA signals 
as a contaminant. Methyl ester polysaccharide 14, differently from 
derivative 15 (solubility ~ 10 mg/mL), was completely insoluble in 
CH2Cl2-etheral solvent mixtures, that are usually employed for α-
stereoselective glycosylations. For this reason, O-2,3 diol of GlcA units 
on derivative 14 was trimethylsilylated. Under the same conditions 
already reported for trimethylsilylation of chitosan derivatives 
((CH3)3SiCl2, [(CH3)3Si]2Na in pyridine at rt) (Kurita et al., 1998), no 
derivatization was observed and polysaccharide 16 was collected 
unreacted. By performing the reaction at 50°C overnight, followed by 
precipitation with diisopropyl ether, polysaccharide 18 was obtained 
with a quantitative DS (2.0), but not in pure form. Indeed, traces of 
pyridine were still present and this might have been not compatible 
with the acid-catalyzed fucosylation reaction. As purification of 18 by 
further precipitation or azeotropic distillation failed, it was alternatively 
precipitated from its crude reaction mixture with water, but obtaining in 
this case a lower DS (1.03) as expected due to TMS ether lability in 
aqueous mixtures.  
In order to enhance the number of different fCS and fC polysaccharides 
of the target semi-synthetic library, the semi-synthetic route was 
designed to gain products with Fuc branches linked on either GlcA or 
GalNAc units. The formers could be obtained with fucosylation of 
acceptors 16, 17 and 18 as key step, whereas for gaining the latters, 
polysaccharide acceptor 20 was prepared from 16. 
Firstly, the O-2,3 diol on GlcA units was acetylated with Ac2O and 
Et3N in the presence of a catalytic amount of DMAP affording the 
quantitatively substituted (DS = 2) polysaccharide 19. The DS was 
evaluated by comparison between integration of H-2 and H-3 carbinolic 
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signal (δ = 4.65 and 5.04 ppm, respectively) and benzylidene methine 
one (δ = 5.44 ppm) in the 1H-NMR spectrum (Figure 15).  
 
 
Figure 15: 1H and 1H-13C HSQC-DEPT spectra of polysaccharide 19 
(400 MHz, DMSO-d6, 298 K)  
 
 
Benzylidene ring was then non regioselectively cleaved under oxidative 
conditions (Adinolfi et al., 1999) affording acceptor 20 in 63% yield 
(over two steps from 16) with a quantitative DS (0.97) with either 4-O- 
or 6-O-benzoylated GalNAc units randomly distributed along the 
polymer chain. The DS was evaluated by 1H-NMR integration of the 
H-ortho Bz aromatic signals (δH = 7.86 and 7.95 ppm) with respect to 
the Ac ones (δH = 1.72-1.98 ppm).  
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Figure 16: 1H and 1H-13C HSQC-DEPT spectra of polysaccharide 20 
(400 MHz, DMSO-d6, 298 K). Integral intensities of cross-peaks 
enclosed in dotted circles were integrated for 4-Bz-GalNAc vs. 6-Bz-
GalNAc evaluation  
 
 
The ratio 4-O-/6-O-benzoylated-GalNAc was evaluated to be 1.3 by 
HSQC-DEPT 2D-NMR integration of the 4-Bz-GalNAc and 6-Bz-
GalNAc 6-O-methylene signals (δH/C = 3.29/59.3 and 4.21-4.34/62.9 
ppm, respectively) (Figure 16). Fuc branches were conjugated to 
chondroitin polysaccharide backbone, by glycosylation of suitable 
glycosyl donors as per-O-benzylated fucosyl thioglycoside 25 (Loon, 
1985) and N-phenyl-trifluoroacetimidate 26 (Scheme 11) (Adinolfi et 
al., 2004) that were selected for the presence of a non-partecipating 
ether-type protecting group at position O-2, as required for a 1,2-cis-
stereoselectivity in the glycosylation reaction.  
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Starting from commercially available L-fucose, through a synthetic 
strategy involving a peracetylation, a iodination at anomeric position 
and a thioalkilation in the presence of thiourea ((NH2)2CS), EtI and 
Et3N, derivative 23 was obtained in 53% yield. Successively, acyl 
groups were removed employing typical Zemplén conditions and free 
hydroxyls were, in turn, protected by benzyl groups in the presence of 
BnBr and NaH in DMF, affording glycosyl donor 25 in 75% yield. 
Alternatively, glycosyl donor 26 was obtained in 57% yield, by treating 
per-O-benzylated-L-fucose with trifluoroacetimidoyl chloride 
(CF3(NPh)Cl) in basic conditions. 
Per-O-benzylated fucosyl thioglycoside, as well as the 
trifluoroacetimidate donor were used for the obtainment of fCS 
polysaccharides with per-O-sulfated Fuc branches. 
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Scheme 11: (a) Ac2O, pyridine, rt, quant.; (b) I2, Et3SiH, CH2Cl2, 
40°C; (c) (NH2)2CS, CH3CN, 60°C; EtI, Et3N, rt, 53% (over two steps 
from 21); (d) Na, MeOH, rt, 83%; (e) BnBr, NaH, DMF, rt, 75%; (f) 
CF3(NPh)Cl, NaH, CH2Cl2, 0°C, 57% 
 
 
Although these two glycosyl donors were shown to be efficient in the 
fucosylation of a polysaccharide (see below), the thioglycoside was 
preferred due to its longer shelf life. Therefore, in order to obtain a 
different sulfation pattern on Fuc branches, different protecting groups 
were applied on thioglycoside donors and 2,3-di-O-Bn-4-O-Bz-Fuc 
glycosyl donors 31 (Scheme 12) and 2,4-di-O-Bn-3-O-Bz-Fuc 35 
(Scheme 13). The former was obtained by regioselective protection of 
triol 24 (3-O-silylation, benzylation and de-O-silylation) (Comegna et 
al., 2008) to give 34 (68% overall yield), which was then benzoylated 
to afford 35 in 73% yield. The latter was synthesized from 
fucopyranoside 24 too, by protection of O-3,4-diol and O-2 position by 
isopropylidene ring and benzyl group, respectively. After 
isopropylidene opening under acid conditions, affording 29 in 98% 
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yield, free hydroxyls were benzylated and then benzoylated, obtaining 
fucosyl donor 35 in 73% yield. (a) Fujiwara et al., 2011. b) Loon, 
1985.) These were selected as suitable Fuc donors to allow the access 
to fCSs with 2,3-di-O-sulfated or 2,4-di-O-sulfated Fuc branches, 
respectively. This latter enable was chosen as target because it is one of 
the most commonly found sulfation pattern in natural fCS 
polysaccharides and also identified to give the strongest anticoagulant 
activity, even though results suggesting their independence from the 
different sulfation pattern of Fuc branches were recently published. 
(Santos et al., 2015) 
 
 
Scheme 12: (a) (CH3)2C(OCH3)2, CSA, rt, 98%; (b) BnBr, NaH, DMF, 
rt, 90%; (c) 4:1 v/v TFA/H2O, rt, 98%; (d) Bu2SnO, C6H6/MeOH, 
60°C; BnBr, Bu4NI, 60°C, 95%; (e) BzCl, pyridine, CH2Cl2, rt, 82% 
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Scheme 13: (a) TBDMSCl, ImH, DMF, rt, 77%; (b) BnBr, NaH, DMF, 
rt, 93%; (c) TBAF, THF, MeOH, rt, 95%; (d) BzCl, pyridine, CH2Cl2, 
rt, 73%   
 
 
To the best of our knowledge, the other two sulfation patterns on Fuc 
branches (2,3-di-O-sulfation and 2,3,4-tri-O-sulfation) have never been 
found in natural polysaccharides, and therefore, this semi-synthetic 
work will allow to enlarge the structure-activity relationship 
investigations and could furnish additional standards for the structural 
characterization of fCSs from new natural sources.  
In fucosylations α-stereoselectivity usually relies on the presence of a 
non-partecipating group at O-2 position  (Nigudkar et al., 2015) of a 
glycosyl donor, even if competitive β-glycosylations (Vermeer et al., 
2001) have been found in literature. Novel glycosyl donors for this 
purpose were synthesized. (Abronina et al., 2015) The influence of 
solvent is also fundamental (Nigudkar et al., 2015), since the use of an 
ethereal or nitrilic solvent, rather than CH2Cl2, can direct the 
stereoselective formation of an α- or β-glycosydic bond, respectively. 
Recently, α-glycosylation procedure (fucosylation included) with 
thioglycoside donors was developed in the presence of DMF, that 
displayed a behaviour similar to an ethereral solvent. (Lu et al., 2011). 
Therefore, fucosylation reactions of dodecyl ester polysaccharide 
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acceptor 17 were conducted under homogeneous conditions in 5:3 v/v 
CH2Cl2-DMF or in 3:1 v/v THF-CH2Cl2 (Table 2 for details, entries I, 
II and III). Methyl ester 16 was coupled exclusively in 5:3 v/v CH2Cl2-
DMF (entries IV, V), because the shorter alkyl chain impeded its 
solubility in THF-CH2Cl2 mixtures, whereas silylated polysaccharide 
18 was glycosylated in a ternary mixture of solvents (1:1:1 v/v/v 
CH2Cl2-DME-DMF) ensuring homogenous conditions too (entry VI). 
Also for coupling between fucosyl donors 25, 31, 35 and 
polysaccharide acceptors 16 and 20 (Table 2 for details, entries VII-
XII), glycosylations were conducted under homogeneous conditions 
choosing NIS-TMSOTf as activator system and 5:3 v/v CH2Cl2-DMF 
as solvent mixture. Only the temperature was decreased to -20°C in 
some of the reactions with acceptor 16, because acid-cleavable 
benzylidene groups could be cleaved by TMSOTf at rt (Table 2 for 
details, entries VII, VIII, IX).  
The glycosylated polysaccharide derivatives were obtained by 
precipitation from the reaction mixture with suitable solvents. In the 
case of the coupling reaction between polysaccharide 17 and fucosyl 
donor 26 under conditions of entry II, the acceptor was recovered 
unreacted, probably due to quenching of TMSOTf used as catalyst by 
residual TBAF as an impurity coming from esterification reaction. In 
the other cases, the co-precipitation of part of Fuc byproducts with the 
polysaccharides complicated the 1H-NMR spectra, not allowing a 
correct evaluation of fucosylation degree (DF).   
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Table 2: Glycosylation reactions of chondroitin acceptors 16-18 and 20 
with fucosyl donors 25, 26, 31 and 35. 
 
Entry Acceptor Donor Solvent Product 
Ia 17 25 3:1 v/v 
THF-CH2Cl2 
36-I 
IIb 17 26 3:1 v/v 
THF-CH2Cl2 
36-II 
IIIc 17 26 5:3 v/v 
CH2Cl2-DMF 
36-III 
IVa 16 25 5:3 v/v 
CH2Cl2-DMF 
37-IV 
Vb 16 26 5:3 v/v 
CH2Cl2-DMF 
37-V 
VIa 18 25 1:1:1 v/v 
CH2Cl2-DME-
DMF 
37-VI 
VIId 16 25 5:3 v/v 
CH2Cl2-DMF 
38-VII 
VIIId 16 31 5:3 v/v 
CH2Cl2-DMF 
38-VIII 
IXd 16 35 5:3 v/v 
CH2Cl2-DMF 
38-IX 
Xa 20 25 5:3 v/v 
CH2Cl2-DMF 
39-X 
XIa 20 31 5:3 v/v 
CH2Cl2-DMF 
39-XI 
XIIa 20 35 5:3 v/v 
CH2Cl2-DMF 
39-XII 
aReaction conditions: acceptor, donor (5 eq), NIS (5.5 eq), TMSOTf (5.5 eq), AW-
300 4Å MS, rt, 4h 
bReaction conditions: acceptor, donor (5 eq), TMSOTf (0.1 eq), AW-300 4Å MS, rt, 
4h (inverse procedure)  
cReaction conditions: acceptor, donor (5 eq), TMSOTf (0.5 eq), AW-300 4Å MS, rt, 
4h (inverse procedure)  
dReaction conditions: acceptor, donor (5 eq), NIS (5.5 eq), TMSOTf (5.5 eq), AW-
300 4Å MS, -20°C, 4h 
 
 
Therefore glycosylation derivatives 36-39 were further modified in 
order to transform them into fCSs and investigate their structural 
features, without trying to purify them at this stage. 
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The eight derivatives 36-38 were acetylated, to protect free hydroxyl 
groups that did not couple during the fucosylations, under 
homogeneous conditions with Ac2O in the presence of Et3N and 4-
(dimethylamino)pyridine (DMAP) in CH3CN (Scheme 14). Benzyl 
groups were removed to have free hydroxyls - to be then sulfated - 
under oxidative conditions with NaBrO3 and Na2S2O4 in a H2O-ethyl 
acetate two phase mixture. (Adinolfi et al., 1999) Under these 
conditions benzylidene ring on O-4,6 diol was non regioselectively 
opened, as well as Bn ethers were removed to give derivatives 43-I,III, 
44-IV-VI, 45-VII-IX, possessing Fuc branches on GlcA units and 46-
X-XII possessing Fuc branches with some free hydroxyls and one more 
either at position O-4 or O-6 of GalNAc units randomly distributed on 
the polymer chain. (Bedini et al., 2011)  
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Scheme 14: (a) Ac2O, Et3N, DMAP, CH3CN, rt; (b) Na2S2O4, NaBrO3, 
H2O-ethyl acetate, rt; (c) SO3·py, DMF, 50°C; NaOH, H2O, rt. 
 
 
Benzylidene cleavage was confirmed by the spliting and downfield 
shift of aromatic signals (δH = 7.32 ppm for the benzylidene and δH = 
7.50, 7.65, 7.94 ppm for the resulting benzoate, respectively) in the 1H-
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NMR spectra of polysaccharide derivatives 43-I,III, 44-IV-VI, 45-VII-
IX. After sulfation of the free hydroxyls with SO3·pyridine in DMF at 
50°C, followed by global deprotection under alkaline hydrolytic 
conditions fCS-I, III-XII were obtained. By skipping the sulfation 
reaction on 45-VII, unsulfated fucosylated chondroitin fC-I could be 
also obtained.  
The polysaccharides obtained from glycosylation reactions with 
glycosyl acceptor 20, were subjected to Bn ether oxidative cleavage 
(39-X-XII46-X-XII, Scheme 14), followed by sulfation of the 
deprotected hydroxyls on Fuc and final ester hydrolysis to afford fCS 
X-XII. By skipping the sulfation reaction on 46-I, fC-II was obtained. 
All the polysaccharides were purified by dialysis, filtration on a C-18 
silica gel cartridge and size exclusion chromatography in order to 
eliminate all the low molecular weight byproducts accumulated during 
the semi-synthetic route. 
The DF of semi-synthetic fC-(I,II) and fCS-(I-XII) polysaccharides 
was evaluated through their 1H-NMR spectra, by ratio between Fuc H-6 
methyl (δH = 1.21-1.35 ppm) and GalNAc acetyl signals (2.0-2.10 ppm) 
integrations. No significant variations among fC and fCS 
polysaccharides was observed, as the DF value ranged from 0.14 to 
1.15 (Table 3, for details). Interestingly, no differences was detected 
between polysaccharides branched at GlcA and GalNAc positions (fC-
I, fCS-I-IV,VII-IX and fC-II, fCS-X-XII, respectively), although 
fucosylation reactions were conducted at different temperatures.  
fCS-IV, fCS-V, obtained from methyl ester acceptor 16 had a degree of 
fucosylation of 0.77 and 1.15 respectively, whereas fCS-VII deriving 
from silylated polysaccharide acceptor 18 showed a DF of 0.14. The 
degree of fucosylation of fCSs derived from acceptor 17, instead, had 
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to be calculated in a different way, due to the presence of residual n-
dodecyl chain, also after reiteration of the hydrolysis reaction with 
LiOOH (Lucas et al., 1990), on polysaccharide backbone of fCS-I and 
fCS-III, as showed by a signal at δH = 0.88 ppm in their 
1H-NMR 
spectra attributable to methyl group of the chain. Since their β-(ω-1) 
methylene signals overlap with those of the Fuc methyls, the DF of 
fCS-I and fCS-III had to be calculated by applying the following 
equation: 
 
    
             
  
 
                
           
         
 
fCS-I and fCS-III DF values were similar to those of fCS-IV and fCS-
V ones, nonetheless the former polysaccharides had to be discarded for 
structure-activity relationship investigations due to the incomplete 
replacement of the free carboxylic acid moiety on GlcA units.  
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Table 3: Yield and structural data of fC-I,II and fCS-I-XII 
 
 Yielda DFb α/β ratioc Branching 
sites ratiod 
fC-I 33% 0.34 5.2 0.9e 
fC-II 39% 0.38 3.5 0.9f 
fCS-I 56% 0.60 n.d.i n.d.i 
fCS-III 58% 0.87 n.d.i n.d.i 
fCS-IV 98% 0.77 2.9  40% : 22% : 
38% g,h 
fCS-V 76% 1.15 2.6 33% : 24% : 
43% g,h 
fCS-VI 89% 0.14 n.d.i n.d.i 
fCS-VII 41% 0.51 3.6 0.9e 
fCS-VIII 41% 0.43 5.5   0.6e,g 
fCS-IX 17%  0.44 2.8 1.1e 
fCS-X 47% 0.45 4.3 1.3f 
fCS-XI 38% 0.43 4.0 2.1f 
fCS-XII 40% 0.50 1.4 2.4f 
aMass yield determined with respect to starting glycosyl acceptor (16-18, 20) over 
five steps. 
bDetermined by 1H-NMR integration of Fuc methyl and GalNAc acetyl signals. 
cEstimated by 1H-NMR integration according to Eq.2 
dEstimated by 1H-NMR integration, except where differently indicated. 
e[α-Fuc-(13)-GlcA]/[α-Fuc-(12)-GlcA] branching ratio. 
f[α-Fuc-(16)-GalNAc]/[α-Fuc-(14)-GalNAc] branching ratio. 
gDetermined by HSQC-DEPT integration, due to signals overlapping 
h[α-Fuc-(13)-GlcA]/[α-Fuc-(12)-GlcA]/[α-Fuc-(16)- or α-Fuc-(14)-GalNAc] 
branching  percent ratio. 
iNot determined 
 
 
The α/β stereochemical ratio of Fuc branching was not evaluated by 
integration of α- and β-Fuc anomeric signals, because the latter could 
be unambiguously detected in neither 1H-NMR nor HSQC-DEPT 
spectra due to low intensity and overlapping with signal of α-Fuc (a) 
Hua et al., 2004. b) Mulloy et al., 2000.) or GlcA and GalNAc units. 
Therefore, an indirect estimation of α/β ratio was done by evaluating β-
Fuc branches amount as a difference of H-6 and H-1α Fuc signal 
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integrations – as the former counts for both α- and β-linked Fuc units – 
according to the following equation:  
 
     
             
           
 
             
         
 
The α/β ratio was found to be rather variable, but with α-
stereochemistry clearly predominant in all cases, as expected from the 
DMF effect described above. (Lu et al., 2011) It is worth noting that no 
evident increase in α/β ratio was observed for fucosylation reactions 
with partially benzoylated Fuc donors that gave fCS-VIII-IX and fCS-
XI-XII, in spite of Bz groups at position O-4 and O-3, that are believed 
to enhance the α-stereoselectivity of fucosylation by remote 
participation. (Gerbst et al., 2001) Differently, the lowest α/β ratio was 
observed for fCS-XII, deriving from fucosylation with 3-O-
benzoylated donor 35.  
In order to investigate the regio- and stereochemistry of Fuc branches 
as well as their sulfation pattern, semi-synthetic fCS-IV and fCS-V 
were subjected to a detailed 2D-NMR (COSY, TOCSY, NOESY, 
HSQC-DEPT and HSQC-TOCSY) analysis first, obtaining for them 
very similar 2D-NMR spectra. 
HSQC-DEPT spectrum of fCS-IV (Figure 17 and Table 4) displayed 
three integral intensities of cross-peaks (δH/C = 5.64/98.1, 5.50/98.4, 
and 5.39/96.7 ppm, respectively) in the typical region for anomeric CH 
of a α-linked sulfated Fuc unit. Thus, three different α-linked Fuc 
branches (indicated as α-FucI, α-FucII and α-FucIII, respectively) was 
hypothesized to be present on the chondroitin backbone. Moreover, 
their sulfation pattern was evaluated by COSY and TOCSY spectra 
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(Figures 18 and 19) allowing the assignment of the chemical shift for 
H-2, H-3 and H-4 signals of a α-linked Fuc branches with values very 
similar between each other (δH = 4.51-4.53, 4.51-4.61 and 4.87-4.94 
ppm for H-2, H-3 and H-4, respectively).  
 
 
Figure 17: Zoom of 1H and 1H-13C HSQC-DEPT NMR spectra of fCS-
IV (600 MHz, D2O, 298 K). Integral intensities of cross-peaks enclosed 
in the dotted circles of HSQC-DEPT spectrum were integrated for Fuc 
branching site regio- and stereochemistry as well as GalNAc-4,6-
sulfation assessment 
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Figure 18: Zoom of 1H and COSY NMR spectra of fCS-IV (600 MHz, 
D2O, 298 K)  
 
 
 
Figure 19: Zoom of 1H and TOCSY NMR spectra of fCS-IV (600 
MHz, D2O, 298 K)  
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Figure 20: Zoom of 1H and NOESY NMR spectra of of fCS-IV (600 
MHz, D2O, 298 K)  
 
 
Their downfield shifts suggested a quantitative cleavage of benzyl 
protecting groups on Fuc branches under oxidative conditions that gave 
a 2,3,4-triol (41-IV44-IV, Scheme 14), that was then quantitatively 
sulfated in the subsequent step. The same sulfation pattern and 
stereochemistry of linkage for FucI, FucII and FucIII hypothesized that 
they are differentiated for a distinct branching site on the 
polysaccharide backbone. This was investigated by means of NOESY 
spectrum (Figure 20) that revealed a correlation between FucI signal 
(δH = 5.64 ppm) with a integral intensity of cross-peak at δH = 3.73 
ppm, attributable to H-3 of some GlcA units by means of the other 2D-
NMR spectra and literature data. (Panagos et al., 2014. b) Chen et al., 
2011.)  
In a similar way, FucII signal (δH = 5.50 ppm) was assigned to the  
anomeric CH of a Fuc branch linked at O-2 (δH/C = 3.54/80.3 ppm) of 
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some GlcA units. The presence of both fucosylated GlcA O-2 and O-3 
positions was also confirmed by the correlation between Fuc methyl 
integral intensity of cross-peak (δH/C = 1.31-1.33/17.2 ppm) and Fuc-
CH-5 signals (δH/C = 4.94/67.4 and 4.22/67.7 ppm) in COSY, TOCSY 
and HSQC-TOCSY spectra. Indeed, a marked difference between the 
chemical shift of H-5 atom of O-2 and O-3-linked α-Fuc units has been 
recently highlighted. (Panagos et al., 2014) Two inter-residue 
correlation for FucIII anomeric signal (δH = 5.39 ppm) were showed by 
NOESY spectrum (Figure 20): a major one at δH = 4.21 ppm and a 
minor one at δH = 3.95 ppm. By HSQC-DEPT spectrum, the former 
was associated to O-6 (δC = 67.4 ppm) of some GalNAc units. Since 
the DS for benzylidenation reaction of acceptor 13 was nearly 
quantitative (Scheme 10), a partial acidic cleavage of the benzylidene 
ring mediated by TMSOTf during the fucosylation step may explain 
this finding. The minor NOESY correlation from FucIII anomeric signal 
was not unambiguously assigned, nonetheless the existence of a 
benzylidene cleavage process during glycosylation suggested that O-4 
position of some GalNAc units was fucosylated. Relative integration of 
FucI, FucII, FucIII HSQC-DEPT integral intensities of cross-peaks 
returned an estimate of relative Fuc branching degree at positions 
GlcA-O-3, GlcA-O-2 and GalNAc-(O-4,6), respectively (Table 3).  
The presence in the HSQC-DEPT spectrum (Figure 17) of signals of 
both sulfated (δH/C = 4.75/77.6 ppm) and non-sulfated (δH/C = 4.08-
4.14/67.9-68.9 ppm) CH at position O-4 as well as sulfated (δH/C = 
4.21-4.32/68.2-68.7 ppm) and non-sulfated (δH/C = 3.79/62.4 ppm) CH 
at position O-6 of GalNAc units. (a) Bedini et al., 2011. b) Mucci et al., 
2000.) suggested a typical A,C sulfation pattern on chondroitin 
backbone. This is in agreement with the known non-regioselective 
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oxidative opening of the benzylidene ring to give a free hydroxyl at 
either 4-O- or 6-O-position of GalNAc units (Bedini et al., 2011) before 
sulfation step. By HSQC-DEPT relative integration of GalNAc CH-4 
signal (δH/C = 4.75/77.6 ppm) with respect to the CH-2 signal of 
whichever GalNAc unit (δH/C = 4.02/52.2ppm) a 26% of sulfation 
degree at position O-4 was estimated, whereas evaluation of O-6 
sulfation degree by integration of sulfated GalNAc CH-6 signal (δH/C = 
4.21-4.32/68.2-68.7 ppm) was complicated by overlapping with other 
ones in the HSQC-DEPT spectrum. 
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Table 4: 1H (plain) and 13C (italic) chemical shift attribution of fCS-IV 
(600 MHz, D2O, 298 K) 
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-Fuc2,3,4SI-
(13)-GlcA 
5.64 
98.1 
4.53 
73.6 
4.61 
73.4 
4.94 
80.3 
4.94 
67.4 
1.33 
17.2 
--- 
α-
Fuc2,3,4SII-
(12)-GlcA 
5.50 
98.4 
 
 
4.51 
73.6 
4.87 
80.3 
4.22 
67.7 
1.31 
17.2 
--- 
α-
Fuc2,3,4SIII-
(14 or 6)-
GalNAc 
5.39 
96.7 
4.91 
80.3 
n.d.b n.d.b --- 
 
 
GalNAc6S 
 
 
4.55 
102.2 
 
 
 
 
 
 
4.02 
52.2 
3.82 
81.4 
4.04- 
4.14 
 
67.9- 
68.9 
3.84-
3.96 
 
73.3- 
73.6 
4.21
-
4.32 
 
68.2
-
68.7 
 
 
 
 
Ac 
1.96-
2.05 
23.9 GalNAc4S 3.59 
76.9 
4.75 
77.6 
3.81 
75.8 
3.79 
62.4 
α-
Fuc2,3,4SIII-
(16)-
GalNAc 
n.d.b n.d.b n.d.b 3.84- 
3.96 
 
73.3- 
73.6 
4.15 
67.4 
GlcA  
4.48 
105.6 
3.33 
73.6 
3.53 
74.9 
3.73 
81.3 
 
 
3.71 
77.5 
--- --- 
α-Fuc2,3,4SI-
(13)-GlcA 
3.57 
73.1 
3.73 
82.3 
n.d.b --- --- 
α-
Fuc2,3,4SII-
(12)-GlcA 
4.70 
102.4 
3.54 
80.3 
3.69 
76.1 
3.85 
81.4 
--- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C: (CH3)2CO at δ = 30.9 ppm)] 
aIndicated by italic characters. 
bNot determiable. 
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A 2D-NMR analysis was conducted also on fC-I, fC-II and fCS-VII-
XII in order to investigate the regiochemistry of the Fuc branches, and 
limited to the latter polysaccharides, the sulfate groups distribution. 
HSQC-DEPT spectrum of fC-I (Figure 21) showed at highest chemical 
shift values the presence of two integral intensities of cross-peaks (δH/C 
= 5.38/99.5 and 5.25/100.4 ppm), that were assigned to the anomeric 
CH of the two α-linked Fuc units. The cross-peakes in NOESY 
spectrum related to these signals showed a correlation of the more 
downfield shifted signal (δH = 5.38 ppm) with a integral intensity of 
cross-peak at δH = 3.70 ppm, attributable to GlcA H-3 by means of the 
other 2D-NMR spectra and literature data. (Panagos et al., 2014) In the 
same way, the other H-1 α-Fuc signal (δH = 5.25 ppm) was assigned to 
a branching unit linked at O-2 (δH/C = 3.50/78.6 ppm) of some GlcA 
units. The assignment of Fuc branches site was repeated for fC-II and 
fCS-VII-XII applying the same approach. By the integration of the 
anomeric α-Fuc signal in the 1H-NMR spectra was displayed that 
polysaccharides obtained by glycosylation of acceptor 16 at -20°C (fC-
I and fCS-VII-IX) had no preference for GlcA O-2 or O-3 position, 
with the branching site ratio close to 1 in all cases (Table 3). 
Differently, for the polysaccharides obtained from acceptor 20 (fC-II 
and fCS-X-XII) fucosylation was slightly preferred at O-6 with respect 
to O-4 of GalNAc (6-OH/4-OH ratio of 1:3), but limited to fCS-
XI,XII.  
2D-NMR spectra analysis confirmed that reactions conducted on 
glycosyl acceptor 15 at -20°C gave derivatives possessing Fuc branches 
only at positions O-2 and O-3, avoiding benzylidene cleavage, 
differently from fCS-IV that was obtained from the same acceptor, by 
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conducting fucosylation at rt. Indeed, this reaction gave derivative 
bearing Fuc branch also on GalNAc units.  
 
 
Figure 21: Zoom of 1H and 1H-13C HSQC-DEPT NMR spectra of fC-I 
(600 MHz, D2O, 298K) 
 
 
In the case of fCS polysaccharides, NMR confirmed the Fuc sulfation 
patterns expected from the position of orthogonally cleavable (Bn) and 
permanent (Bz) protecting groups on fucosyl donors 25, 31 and 35 used 
in glycosylations. For example, the cross-peaks related to anomeric α-
Fuc signals in the COSY, TOCSY and NOESY spectra confirmed the 
difference in the sulfation pattern of Fuc units α-linked to O-4 or O-6 
atom of GalNAc residues in fCS-X-XII. Indeed, fucosylation reaction 
with per-O-benzylated thioglycoside 25 afforded fCS-X with α-Fuc 
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branches displaying H-2, H-3 and H-4 signals all downfield shifted for 
O-sulfation (δH = 4.52, 4.70-4.74 and 4.95 ppm, respectively), whereas 
only H-2 and H-3 signals showed a similar shift (δH = 4.53, 4.67-4.69 
ppm, respectively; δH = 4.22 for H-4) in fCS-XI (deriving from 2,3-di-
O-benzylated donor 31, as well as H-2 and H-4 ones in fCS-XII (δH = 
4.41, 4.69 ppm, respectively; δH = 4.07-4.20 ppm for H-3), that was 
obtained by glycosylation with 2,4-di-O-benzylated thioglycoside 35 
(Figure 22). The same NMR analysis was applied to confirm the 
differences in α-Fuc sulfation pattern of fCS-VII-IX. 
 
 
Figure 22: Zoom of TOCSY (black) and NOESY (red) spectra of fCS-
X (left), fCS-XI (middle), fCS-XII (right) (600 MHz, D2O, 298 K) 
 
 
2-D NMR analysis also allowed to define the sulfation pattern in 
residue other than Fuc branches, as already discussed for fCS-IV. For 
example, the HSQC-DEPT spectrum of fCS-X (Figure 23) displayed 
signals of both sulfated (δH/C = 4.22/68.8 pppm) and non-sulfated 
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(fucosylated or not: δH/C = 3.90/69.4 or 3.71-3.85/62.5 ppm, 
respectively) CH2 at postion 6, as well sulfated (δH/C = 4.70/76.1 and 
4.74/77.7 ppm) and non-sulfated (fucosylated or not: δH/C = 4.29/73.8 
or 4.17/68.8 ppm, respectively) CH at position 4 of GalNAc units (a) 
Bedini et al., 2011. b) Mucci et al., 2000.) This was in agreement with 
the non-regioselective distribution of free hydroxyls at either position 4 
or 6 of GalNAc on acceptor 20 together with the their non quantitative 
fucosylation before the sulfation reaction, as already discussed above 
(DF = 0.45, Table 3). An estimation of sulfation degree at position O-4 
and O-6 was possible by HSQC-DEPT integral intensities of cross-
peaks integration. Due to partial overlapping of the integral intensities 
of cross-peaks related to CH2 at position 6 of GalNAc6S and CH at 
position 4 of unsulfated and non-fucosylated GalNAc, the integrations 
were made with respect to the CH-2 integral intensity of cross-peak of 
whichever GalNAc unit (δH/C = 4.01/52.2 ppm). In particular, the 
relative integration of GalNAc4S CH-4 integral intensities of cross-
peaks with the CH-2 one gave a 0.25 degree of sulfation position O-4. 
A 0.33 value was estimated for position O-6, by integrating the integral 
intensities of cross-peaks related to unsulfated GalNAc units (6-O-
fucosylated or not) with respect to the CH-2 one and then applying the 
following equation: 
 
O-6 degree of sulfation 
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Figure 23: Zoom of 1H and 1H-13C HSQC-DEPT spectrum (600 MHz, 
D2O, 298 K) of fCS-X 
 
 
In the case of fCS-VIII and fCS-IX polysaccharides, after a careful 
investigation of the 2D-NMR spectra, a small amount of sulfate groups 
also on GlcA units was detected, as demonstrated by the presence of 
characteristic signals for O-2 and O-3 sulfation at δH/C = 4.11/80.5 
(Gargiulo et al., 2009) and 4.35/82.5 (Bedini et al., 2012) ppm, 
respectively. This was ascribed to a non-quantitative acetylation of 
GlcA hydroxyls (38-VII-IX  42-VII-IX) that left some free alcohol 
moieties ready to be sulfated at the end of the semi-synthetic route 
(Scheme 14). As for GalNAc units, also in the GlcA case sulfation 
degrees at O-2 and O-3 positions could be estimated by integration of 
these integral intensities of cross-peaks with respect to the GalNAc 
CH-2 one in the HSQC-DEPT spectrum (Figure 24).  
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Figure 24: Zoom of 1H and 1H-13C HSQC-DEPT spectrum (600 MHz, 
D2O, 298 K) of fCS-XI 
 
 
Comprehensive tables of NMR assignments for the structural 
characterization of the all obtained fC and fCS polysaccharides are 
characterised in the following pages.   
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Table 5: 1H (plain) and 13C (italic) chemical shift attribution of fC-I 
(D2O, 600 MHz, 298 K) 
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-Fuc-
(12)-GlcA 
5.25 
100.4 
 
3.75 
69.4 
3.71 
73.0 
3.63 
70.7 
4.19 
68.1 
1.19 
16.6 
--- 
α-Fuc-
(13)-GlcA 
5.38 
99.5 
3.81 
73.3 
3.97 
70.4 
4.80 
68.0 
1.22 
16.6 
--- 
GalNAc 4.49 
102.0 
4.00 
52.2 
3.79 
81.6 
4.11 
69.0 
3.68 
76.2 
 
3.69-
3.78 
 
62.4 
 
 
 
Ac: 
2.01 
23.8 
GalNAcb 4.39 
103.0 
3.92, 
4.00 
 
52.2 
3.81, 
3.86 
 
78.1, 
81.6 
4.03, 
4.11 
 
69.0- 
69.4 
n.d.c 
GlcA 4.48 
105.5 
3.34 
73.7 
3.57 
74.9 
3.73 
81.0 
3.68 
77.7 
--- --- 
α-Fuc-
(12)-GlcA 
4.63 
102.9 
3.50 
78.6 
3.78 
76.2 
n.d.c n.d.c --- --- 
α-Fuc-
(13)-GlcA 
4.48 
105.5 
3.54 
75.3 
3.70 
80.9 
n.d.c n.d.c --- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C (CH3)2CO at δ = 2.22 ppm] 
aIndicated by italic character 
bGalNAc unit whose chemical shifts are shifted, probably due to proximal 
fucosylation 
cNot determinable 
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Table 6: 1H (plain) and 13C (italic) chemical shift attribution of fC-II 
(D2O, 600 MHz, 298 K) 
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-Fuc-
(14)-
GalNAc 
5.37 
100.9 
 
 
3.75 
69.4 
3.91 
70.8 
 
 
3.82 
73.0 
 
4.07- 
4.18 
 
68.3 
 
 
 
1.21 
16.6 
--- 
α-Fuc-
(16)-
GalNAc 
4.92 
99.9 
3.85 
70.8 
--- 
GalNAc  
 
 
 
 
4.49 
102.1 
 
3.99 
52.2 
3.79 
81.6 
4.11- 
4.16 
 
68.8- 
69.0 
3.68 
76.3 
 
3.69-
3.78 
 
62.4 
 
 
 
Ac: 
2.01 
23.8 
 
α-Fuc-
(14)-
GalNAc 
4.13  
52.6 
3.93  
81.5 
4.20 
76.7 
n.d.c 
α-Fuc-
(16)-
GalNAc 
n.d.c 3.98 
81.7 
4.11- 
4.16 
 
68.8- 
69.0 
3.89 
74.1 
3.71,3
.86 
 
67.2 
GlcA 4.48 
105.5 
3.34 
73.7 
3.57 
74.9 
3.74 
80.9 
3.68 
77.6 
--- --- 
GlcAb 4.40 
105.5 
3.48 
73.1 
3.64 
76.2 
n.d.c n.d.c --- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C (CH3)2CO at δ = 2.22 ppm] 
aIndicated by italic character 
bGlcA unit whose chemical shifts are shifted, probably due to proximal fucosylation 
cNot determinable 
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Table 7: 1H (plain) and 13C (italic) chemical shift attribution of fCS-
VII (D2O, 600 MHz, 298 K)  
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-Fuc2,3,4S-
(12)-GlcA 
5.51 
98.4 
4.52 
73.5 
4.88 
80.4 
4.27 
67.5 
1.29 
17.1 
--- 
α-Fuc2,3,4S-
(13)-GlcA 
5.64 
98.0 
4.54 
73.5 
4.62 
73.5 
4.94 
80.4 
4.94 
67.5 
1.33 
17.1 
--- 
GalNAc6S  
4.55 
102.2 
 
3.86-
4.01 
 
52.2 
3.84 
81.2 
4.10 
69.4 
3.96 
73.8 
4.21 
68.7 
Ac: 
2.01, 
2.10 
 
23.8 
GalNAc4S 4.01 
76.9 
4.74 
77.5 
3.82 
75.8 
3.78 
62.4 
GlcA 
 
4.50 
105.4 
3.36 
73.5 
3.59 
74.9 
3.74 
82.4 
3.74 
77.7 
--- --- 
α-Fuc2,3,4S-
(12)-GlcA 
4.69 
102.6 
3.54  
80.1 
3.76  
75.7 
3.86 
n.d.b 
3.78 
77.7 
--- --- 
α-Fuc2,3,4S-
(13)-GlcA 
4.50 
105.4 
3.59 
73.2 
3.75 
79.6 
n.d.b n.d.b --- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C (CH3)2CO at δ = 2.22 ppm] 
aIndicated by italic character 
bNot determinable 
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Table 8: 1H (plain) and 13C (italic) chemical shift attribution of fCS-
VIII (D2O, 600 MHz, 298 K)   
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-
Fuc2,3S-
(12)-
GlcA 
5.48, 
5.51 
 
98.7 
4.51 
73.6 
4.46 
76.2 
 
 
4.12 
71.6 
4.21 
67.9 
 
 
1.23 
16.6 
 
--- 
α-
Fuc2,3S-
(13)-
GlcA 
5.21, 
5.26 
 
98.8 
4.43 
73.0 
4.43 
76.2 
4.21 
71.4 
--- 
 
GalNAc6S 
 
4.43- 
4.55 
 
102.0- 
103.3 
 
 
3.83
-
4.01 
52.2 
3.83 
81.4 
4.10 
69.3 
3.89,b
3.96 
 
73.4,b
73.8 
4.21 
 
67.3,b
68.8 
 
Ac: 
2.02, 
2.09 
23.8 
GalNAc4S 4.00 
77.1 
4.74 
77.7 
3.81 
75.8 
3.72-
3.81 
 
62.3 
GlcA 
 
4.49 
105.5 
3.35 
73.6 
3.59 
75.0 
3.74 
82.8 
3.68 
77.6 
--- --- 
α-
Fuc2,3S-
(12)-
GlcA 
4.69 
102.7 
3.54  
80.3 
3.78  
77.0 
n.d.c n.d.c --- --- 
α-
Fuc2,3S-
(13)-
GlcA 
4.49 
105.5 
3.57 
73.5 
3.80 
80.3 
n.d.c n.d.c --- --- 
GlcA3S 4.58 
104.8 
3.54 
73.4 
4.35 
82.5 
3.91 
77.9 
 
3.68 
77.6 
--- --- 
GlcA2S 4.68 
102.7 
4.11 
80.5 
3.79 
76.1 
3.92 
79.3 
--- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C (CH3)2CO at δ = 2.22 ppm]  
aIndicated by italic character 
bSignals related to GalNAc linked to GlcA3S or GlcA2S unit 
cNot determinable 
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Table 9: 1H (plain) and 13C (italic) chemical shift attribution of fCS-IX 
(D2O, 600 MHz, 298 K)   
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-
Fuc2,4S-
(12)-
GlcA 
5.58 
97.8 
4.41 
76.2 
4.16 
68.7 
4.67 
82.1 
4.37 
67.6 
1.26 
16.8 
--- 
α-
Fuc2,4S-
(13)-
GlcA 
5.70 
97.5 
4.41, 
4.48 
76.2 
4.12, 
4.19 
68.0 
4.71 
82.5 
4.85, 
5.00 
67.2, 
67.6 
1.31, 
1.35 
17.1 
--- 
 
 
GalNAc6S 
 
4.43- 
4.55 
102.0- 
103.2 
 
 
3.94-
4.02 
52.2 
3.82 
81.3 
n.d.c 3.81,b 
3.96 
73.1,b 
73.8 
4.18- 
4.22 
67.3,b 
67.8,b 
68.7 
 
Ac: 
2.01, 
2.07 
23.8 
GalNAc4S 4.00 
77.1 
4.74 
77.5 
3.82 
75.8 
3.69-
3.81 
62.4 
GlcA 
 
4.50 
105.4 
3.36 
73.5 
3.58 
75.0 
3.73 
81.2 
3.69 
77.7 
--- --- 
α-
Fuc2,4S-
(12)-
GlcA 
4.65 
102.8 
3.57  
77.7 
3.76  
75.9 
3.86 
n.d.c 
n.d.c --- --- 
α-
Fuc2,4S-
(13)-
GlcA 
4.50 
105.4 
3.58 
73.5 
3.76 
81.3 
n.d.c n.d.c --- --- 
GlcA3S 4.56 
104.8 
3.53 
73.4 
4.35 
82.5 
3.92 
78.1 
 
3.69 
77.7 
--- --- 
GlcA2S 4.66 
102.8 
4.11 
80.5 
3.79 
75.9 
3.88 
n.d.c 
--- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C (CH3)2CO at δ = 2.22 ppm]  
aIndicated by italic character 
bSignals related to GalNAc linked to GlcA3S or GlcA2S unit 
cNot determinable 
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Table 10: 1H (plain) and 13C (italic) chemical shift attribution of fCS-X 
(D2O, 600 MHz, 298 K) 
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-Fuc2,3,4S-
(14)-
GalNAc 
5.79 
97.7 
 
 
4.52 
73.5 
4.74 
73.6 
 
 
4.95 
80.2 
4.15 
68.8 
1.24 
16.5 
--- 
α-Fuc2,3,4S-
(16)-
GalNAc 
5.28 
98.7 
4.70 
73.6 
4.22  
71.7 
1.29  
17.2 
--- 
GalNAc6S  
 
 
 
4.50- 
4.57 
102.6 
 
 
 
 
4.01 
52.2 
3.83 
81.4 
4.17 
68.8 
3.98  
73.9 
 
4.22 
68.8 
 
Ac: 
2.01 
23.8 
α-Fuc2,3,4S-
(14)-
GalNAc6S 
3.78 
81.4 
4.29 
73.8 
n.d.c 
GalNAc4S 4.01 
77.1 
4.74 
77.7 
n.d.c 3.71-
3.85 
62.5 
α-Fuc2,3,4S-
(16)-
GalNAc4S 
n.d.c 4.70 
76.1 
n.d.c 3.90 
69.4 
 
GlcA 
 
4.50 
105.5 
3.36 
73.7 
3.59 
75.0 
3.75 
81.4 
3.81 
76.2 
--- --- 
GlcAb 4.41 
105.9 
3.51, 
3.57 
73.5 
3.78 
76.8 
n.d.c n.d.c --- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C (CH3)2CO at δ = 2.22 ppm]  
aIndicated by italic character 
bGlcA unit whose chemical shifts are shifted, probably due to proximal fucosylation 
cNot determinable 
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Table 11: 1H (plain) and 13C (italic) chemical shift attribution of fCS-
XI (D2O, 600 MHz, 298 K) 
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-Fuc2,3S-
(14)-
GalNAc 
5.79 
97.9 
 
 
4.53 
73.3 
4.69 
76.1 
 
 
4.22 
71.7 
4.08 
68.0 
 
 
1.24 
16.6 
--- 
α-Fuc2,3S-
(16)-
GalNAc 
5.27 
98.7 
4.67 
76.1 
4.17  
68.8 
--- 
GalNAc6S  
 
 
 
4.50- 
4.56 
102.6 
 
 
 
 
4.01 
52.2 
3.83 
81.4 
4.17 
67.9 
3.97  
73.9 
 
4.21 
68.8 
 
Ac: 
2.01 
23.8 
α-Fuc2,3S-
(14)-
GalNAc6S 
n.d.c 4.28 
74.1 
n.d.c 
GalNAc4S 4.00 
77.1 
 
 
4.74 
77.7 
3.82 
76.0 
3.71-
3.84 
62.5 
α-Fuc2,3S-
(16)-
GalNAc4S 
n.d.c n.d.c 3.90 
69.7 
 
GlcA 
 
4.51 
105.5 
3.37 
73.7 
3.61 
75.0 
3.72 
82.5 
3.71 
77.5 
--- --- 
GlcAb 4.42 
105.8 
3.51, 
3.57 
73.5 
3.78 
76.8 
n.d.c n.d.c --- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C (CH3)2CO at δ = 2.22 ppm]  
aIndicated by italic character 
bGlcA unit whose chemical shifts are shifted, probably due to proximal fucosylation 
cNot determinable 
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Table 12: 1H (plain) and 13C (italic) chemical shift attribution of fCS-
XII (D2O, 600 MHz, 298 K) 
 
Residuea 1 2 3 4 5 6 Other 
signals 
α-Fuc2,4S-
(14)-
GalNAc 
5.75 
97.6 
 
 
4.41 
76.3 
4.20 
67.5 
 
 
4.69 
82.0 
4.07 
67.9 
 
 
1.28 
16.8 
--- 
α-Fuc2,4S-
(16)-
GalNAc 
5.23 
98.4 
4.07 
67.9 
4.22  
71.5 
--- 
GalNAc6S  
 
 
 
4.51- 
4.59 
103.0 
 
 
 
 
4.01 
52.4 
3.83 
81.7 
4.16 
68.4 
3.97  
74.0 
 
4.21 
68.8 
 
 
Ac: 
2.01 
23.8 
α-Fuc2,4S-
(14)-
GalNAc6S 
3.79 
81.7 
4.29 
73.8 
n.d.c 
GalNAc4S 4.01 
77.4 
 
 
4.74 
77.7 
3.89 
73.6 
3.70-
3.79 
62.4 
α-Fuc2,4S-
(16)-
GalNAc4S 
n.d.c n.d.c 3.75, 
3.88 
67.2 
 
GlcA 
 
4.54 
105.7 
3.38 
73.5 
3.63 
75.0 
3.78 
81.7 
3.87 
76.0 
--- --- 
GlcAb 4.44 
106.1 
3.52, 
3.62 
73.0,
73.2 
3.83 
76.1 
n.d.c n.d.c --- --- 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C (CH3)2CO at δ = 2.22 ppm]  
aIndicated by italic character 
bGlcA unit whose chemical shifts are shifted, probably due to proximal fucosylation 
cNot determinable 
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2.2.3 Molecular weight evaluation and anticoagulant 
activity of semi-synthetic fucosylated chondroitin sulfate 
High-performance size exclusion chromatography combined with a 
triple detector array (HP-SEC-TDA) (a) La Gatta et al., 2010. b) Bertini 
et al., 2005.) allowed the evaluation of weight-averaged molecular 
mass (Mw), and then the polydispersity (Mw/Mn) for the semi-synthetic 
fC-I-II, fCS-IV,VII-XII (Table 13). It is an index used as a measure of 
a broadness of a molecular weight distribution of a polymer and it was 
lower with respect to the natural one (Mw ~ 55-65 kDa) and the starting 
chondroitin (Mw = 23.7 kDa for fCS-IV) and (Mw = 38 kDa for fC-I,II 
and fCS-VII-XII), presumably due to polysaccharide chain shortening 
during acid-mediated reactions (glycosylation and sulfation). 
Nonetheless, polydispersity was only marginally increased .  
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Table 13: Molecular weight and polydispersity of fC-I-II and fCS-I-
XII 
 
 Mw
a (kDa) Mw/Mn
b 
fC-I 7.3 1.35 
fC-II 6.9 1.35 
fCS-I n.d.c n.d.c 
fCS-III n.d.c n.d.c 
fCS-IV 8.5 1.35 
fCS-V n.d.c n.d.c 
fCS-VI n.d.c n.d.c 
fCS-VII 10.9 1.50 
fCS-VIII 9.4 1.49 
fCS-IX 8.3 1.58 
fCS-X 9.4 1.56 
fCS-XI 8.7 1.45 
fCS-XII 9.9 1.44 
aWeight-averaged molecular mass 
bNumber-averaged molecular mass 
cNot determined 
 
 
Interestingly,  Mw values between 7 and 10 kDa are indicated in the 
literature to be in an optimal range to retain anticoagulant activity (at 
least 6-8 repeating units are required), while minimizing undesirable 
effects – such as platelet aggregation, bleeding, hypotension – exhibited 
by natural high molecular weight fCSs. (a) Wu et al., 2015. b) Zhao et 
al., 2013. c) Wu et al., 2010. d) Sheehan et al., 2006.) 
Semi-synthetic fC-I-II, as well as, fCS-IV, VII-XII were preliminarly 
assayed for anticoagulant activity. AT-dependent activity against factor 
Xa was 600-1000-fold lower than heparin (Table 14), as already 
reported for low molecular mass fCS species obtained by partial 
depolymerisation of natural polysaccharides. (a) Wu et al., 2015. b) 
Panagos et al., 2014. c) Mourão et al., 1996.) The Xa activities (0.1-
0.38 IU/mg) were more than 20-fold higher than CS from shark (0.017 
104 
 
IU/mg), thus confirming that the anticoagulant activity could be mostly 
attributed to Fuc branching units. Surprisingly, fC-I-II, carrying 
unsulfated Fuc branches, displayed a factor Xa activity similar to fCS 
polysaccharides (0.20 and 0.25 IU/mg for fC-I and fC-II, respectively) 
and for fCS-IV.  
 
Table 14: AT-dependent activity against factor Xa 
 
 Activity [IU/mg] 
fC-I 0.20 
fC-II 0.25 
fCS-IV 0.38 
fCS-VII 0.18 
fCS-VIII 0.27 
fCS-IX n.da 
fCS-X 0.26 
fCS-XI 0.33 
fCS-XII 0.23 
Heparin 198 
                                aNot determined 
 
 
A behaviour similar to natural fCS species was found also for the 
reduction of HC-II mediated factor IIa activity (Wu et al., 2015) of 
fCS-VII-XII. Indeed, data were very close to heparin for fCSs with 
Fuc branches on the GlcA units (fCS-VII-IX), regardless of their 
sulfation pattern (Figure 25), whereas two of the three fCS with Fuc 
branches on the GalNAc units (fCS-X-XII), as well as unsulfated 
polysaccharides (fC-I–II), displayed a much reduced anticoaugulant 
activity   
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Figure 25: HC-II-mediated anti factor Ia activity 
 
 
However, many more biological investigations are necessary in order to 
beter characterize the anticoagulant and antithrombotic activities of 
these semi-synthetic polysaccharides, and they are scheduled for the 
near future. 
 
 
2.3 Conclusions 
The formation of unusual interglycosidic acetals involving positions O-
6 of some GalNAc and O-4 of another GalNAc or O-3 of GlcA units 
(along the same polymeric chain or across two strands) of microbial 
sourced chondroitin during the preliminary protection for its 
regioselective sulfation was described. The lability under acid 
conditions of these interglycosidic acetals did not preserve them after 
reaction work-up. Thus, at the end of the semi-synthetic strategy CS-
A,C possessing sulfate groups exclusively on GalNAc units was 
achieved. Conversely, the stabilization in an alkaline environment of 
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the labile interglycosidic acetals during benzylidenation work-up 
afforded at the end of the semi-synthesis CS species possessing sulfate 
groups not only on GalNAc units but also at position O-3 of some GlcA 
units, as already observed for an orthoester-based protection strategy. 
In the latter case, a transient interglycosidic orthoester involving 
position O-3 of some GlcA units and position O-6 of some GalNAc 
could be hypothesized, in analogy to the interglycosidic acetal for the 
one-pot benzylidenation-acetylation route. It is worth noting that the 
detailed understanding of the factors influencing finely tailored 
chemical modifications on microbial sourced chondroitin is rather 
valuable because it allows the preparation of biologically relevant CSs 
from non-animal sources with different, but highly controlled sulfation 
patterns. In particular, CS-A,C is a biomedical ingredient for several 
applications (Yamada et al., 2008), and GlcA-3S-containing CSs – 
usually isolated from squid and king crab cartilages as well as from 
squid liver integuments (a) Kumar Shetty et al., 2009. b) Kinoshita et 
al., 1997. c) Sugahara et al., 1996.) – are also interesting 
biomacromolecules because they promote neurite outgrowth in the 
central nervous system. (Mikami et al., 2006) 
Furthermore, the production of a library of twelve fCS polysaccharides 
with different Fuc sulfation pattern and/or branch position, and two fCs 
with different Fuc linkage site, was obtained from microbial sourced 
chondroitin too, through a semi-synthetic strategy based on the modular 
use of  five different reactions: glycosylation, acetylation, selective 
cleavage of orthogonal protecting groups (Bn and benzylidene), 
sulfation and global deprotection. The key step of the synthetic strategy 
was the glycosylation with differently protected Fuc donors of suitably 
protected chondroitin acceptors. To the best of our knowledge, this is 
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the first example of the obtainment of a library of chemically modified 
polysaccharides by using a O-glycosylation as the key step, a reaction 
that is very well known in the field of oligosaccharide synthesis (Zhu et 
al., 2009) but is almost unexplored for polysaccharides, especially in 
the case of branching at the secondary, less reactive hydroxyl positions.  
The structures of the semi-synthetic fCS and fC polysaccharides were 
fully characterized by 2D NMR spectroscopy, confirming in all cases 
the fucosylation and sulfation patterns expected from the designed 
reaction sequences. A single, well-defined sulfation pattern was found 
for Fuc branches in all the semi-synthesized fCS polysaccharides, 
contrary to the natural ones studied up to now, which display two or 
even more different sulfation patterns within the same polymer chain. 
The obtained NMR data could be useful for structural characterization 
purposes, as they can be employed as standards for comparison with 
data obtained from novel natural fCSs showing a Fuc sulfation pattern 
and/or branching site different from the known ones. More importantly, 
this library of semi-synthetic polysaccharides will allow a wider and 
more accurate structure-activity relationship study of fCSs with respect 
to those performed up to now, that have been limited to only the 
natural, heterogeneous structures found in sea cucumbers. Furthermore, 
by HP-SEC-TDA analysis, a lower molecular mass was found for all 
the obtained polysaccharides with respect to the natural ones. This is 
encouraging for avoiding the adverse effects displayed by the latter, 
while at the same retaining the anticoagulant activity. To confirm this, a 
careful screening of the biological activities of these semi-synthetic fCS 
and fC polysaccharides has been launched. The results will drive 
further chemical efforts towards the obtainment of fCS polysaccharides 
with an even more well-defined structure in terms of Fuc site 
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branching. In particular, the development of further regioselective 
protecting steps for the differentiation of the hydroxyl groups in GlcA 
2,3- or GalNAc 4,6-diols will be pursued, as well as the polysaccharide 
branching with more complex glycosyl donors such as Fuc disaccharide 
ones. The final aim will be the full development of an effective, safe, 
non-animal sourced antithrombotic drug candidate.  
 
 
2.4 Experimental section 
 
2.4.1General methods 
Reagents and solvents were used without further purification, except 
where differently indicated. Unsulfated chondroitin sodium salt was 
obtained at the laboratories of Prof. Chiara Schiraldi group 
(Department of Experimental Medicine, Università della Campania 
Luigi Vanvitelli) by fed-batch fermentation of Escherichia coli K4 
followed by down-stream purification processes performed as recently 
indicated. (Cimini et al., 2010) Centrifugations were performed with an 
Eppendorf Centrifuge 5804 R instrument. Dialyses were conducted on 
Spectra/Por 10 kDa cut-off membranes at 4°C. Freeze-dryings were 
performed with a 5Pascal Lio 5P4 K freeze dryer. The term “pure 
water” refers to water purified by a  i llipore  i lli-Q Gradient system. 
NMR spectra were recorded on a Bruker DRX-400 (1H: 400 MHz, 13C: 
100 MHz), on a Varian INOVA 500 (1H: 500 MHz, 13C: 125 MHz) 
instrument or on a Bruker DRX-600 (1H: 600 MHz, 13C: 150 MHz) 
instrument equipped with a cryo probe, in D2O (acetone as internal 
standard, 1H: (CH3)2CO at δ = 2.22 ppm; 
13C: (CH3)2CO at δ = 31.5 
ppm), CDCl3 (
1H: CHCl3 at δ = 7.26 ppm; 
13C: CDCl3 at δ = 77.0 ppm) 
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or DMSO-d6 (
1H: CHD2SOCD3 at δ = 2.49 ppm; 
13C: CD3SOCD3 at δ 
= 39.5 ppm). Double quantum-filtered phase-sensitive COSY, phase 
sensitive NOESY and TOCSY experiments were performed using 
spectral widths of either 6000 Hz in both dimensions, using data sets of 
4096 × 256 points. Quadrature indirect dimensions were achieved 
through States-TPPI method; spectra were processed applying a cosine 
square function to both dimensions and data matrix was zero-filled by 
factor of 2 before Fourier transformation. TOCSY and NOESY mixing 
times were set to 120 ms and 200 ms, respectively. HSQC-DEPT 
experiments were measured in the 1H-detected mode via single 
quantum coherence with proton decoupling in the 13C domain, using 
data sets of 2048 × 256 points and typically 32 increments. For HMBC 
spectrum, data set consisted of 2048 × 256 points and long range 
constant was set to 8 Hz. In these heteronuclear experiments the data 
matrix was extended to4096 × 2048 points reconstructing 1024 of these 
data points with forward linear prediction extrapolation (30 
coefficients) and zero-filling those remaining. As for HSQC-TOCSY, 
data sets of 2048 × 256 points were used, with 100 increments, mixing 
time was set to 100 ms and spectra were transformed as indicated for 
homonuclear spectra, data matrix were doubled and linear prediction 
applied the new points by using 30 coefficients, Qsine functions were 
used as window function and values selected depended by the best 
resolution obtained. 
Size-exclusion chromatographies were performed on a Bio-Gel P2 
column (0.75 x 67.5 cm, Bio-Rad) using 50 mM ammonium acetate as 
a buffer at a flow rate of 0.2 mL/min. The column eluate was monitored 
continuously with a Knauer K-2310 refractive index refractometer.  
110 
 
A ViscotekTM instrument (Malvern) was used to determine molecular 
mass data.  
 
 
2.4.2 Synthetic procedure for regioselective sulfation of 
chondroitin 
Preparation of chondroitin acid form from chondroitin sodium 
salt: Chondroitin sodium salt (4.600 g, 11.47 mmol repeating unit) was 
dissolved in pure water (140 mL) and passed through a short Dowex 50 
WX8 column (H+ form, 20–50 mesh, approx. 450 cm3). Elution with 
pure water was continued until pH of the eluate was neutral. Freeze-
drying of the collected eluate gave chondroitin (4.208 g, 97%). 
 
One-pot benzylidenation-acetylation on chondroitin (6a): 
Chondroitin (117.1 mg, 0.309 mmol repeating unit) was manually 
chopped and then suspended under Ar atmosphere in DMF (3.1 mL), 
that was freshly dried over 4Å molecular sieves. The mixture was 
vigorously stirred at 80°C for 3 h. If needed, the temperature of the 
mixture was then changed (rt, 50°C or 80°C: see Table 1) and  α,α-
dimethoxytoluene (464  μL, 3.09 mmol), freshly dried over 4Å 
molecular sieves, was added. A 0.21 M solution of CSA in freshly 
dried D F (371  μL,77.9  μmol) was then added and the mixture was 
stirred at 80°C (or 50°C or rt) overnight. The mixture was then treated 
at rt with Et3N (861  μL, 6.18 mmol). After few minutes, CH3CN (5.6 
mL) and then acetic anhydride (2.0 mL, 21.6 mmol) and 4-
(dimethylamino)pyridine (15.1 mg, 0.124 mmol) were added. After 
overnight stirring, the obtained brown solution was treated with 
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diisopropyl ether (11.7 mL). A white solid was obtained. It was isolated 
by centrifugation at 4°C (3000 rpm, 10 min). After overnight 
desiccation under vacuum, polysaccharide 6a (141.4 mg, 87%) was 
obtained as a brown amorphous solid. 
 
Oxidative opening of benzylidene ring (7a): Derivative 6a (122.2 mg, 
0.234 mmol) was suspended in ethyl acetate (2.6 mL) and then treated 
with a 0.27 M solution of NaBrO3 in pure water (2.6 mL, 0.702 mmol). 
A 0.24 M solution of Na2S2O4 in pure water (2.4 mL, 0.576 mmol) was 
added portionwise over a period of 10 min. After overnight stirring at rt 
under visible light irradiation, centrifugation of the mixture at 4°C 
(3000 rpm, 10 min) allowed the isolation of a gummy yellowish 
precipitate that was desiccated under vacuum overnight to give 7a 
(123.7 mg, 98%). 
 
Sulfation and global deprotection (8a): Derivative 7a (144.9 mg, 
0.269 mmol) was suspended in DMF (2.1 mL), that was freshly dried 
over 4Å molecular sieves and then treated with a 1.17 M solution of 
pyridine–sulfur trioxide complex in freshly dried DMF (4.6 mL, 5.382 
mmol). After 1 h stirring at 50°C, the suspension turned into a clear 
solution. Stirring at 50°C was continued overnight, after that a cold, 
saturated NaCl solution in acetone (18.0 mL) was added. The obtained 
yellowish precipitate was collected by centrifugation at 4°C (3000 rpm, 
10 min) and then dissolved in pure water (11.7 mL). The solution was 
stirred at 50°C for 1 h, then cooled to rt and treated with a 15% w/v 
NaOH solution to adjust pH to 13. The solution was stirred for 6 h at rt 
and then 4 M HCl was added until neutralization. Dialysis and 
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subsequent freeze-drying yielded the CS polysaccharide (104.1 mg, 
69%) as a slightly yellow, woolly solid. 
 
Isolation of polysaccharide 9a: Chondroitin (62.4 mg, 0.165 mmol 
repeating unit) was manually chopped and then suspended under Ar 
atmosphere in DMF (3.1 mL), that was freshly dried over 4Å molecular 
sieves. The mixture was vigorously stirred at 80°C for 3 h, then cooled 
to rt and treated with  α,α-dimethoxytoluene (248  μL, 1.65 mmol), that 
was freshly dried over 4Å molecular sieves. A 0.21 M solution of CSA 
in freshly dried D F (209  μL, 43.9  μmol) was then added and the 
mixture was stirred at rt overnight. Et3N (460 μL, 3.30 mmol) and, after 
few minutes, diisopropyl ether (8.0 mL) were then added. The obtained 
precipitate was collected by centrifugation at 4°C (3000 rpm,10 min) 
and dried overnight under vacuum to yield polysaccharide 9a (78.9 mg, 
81%) as a slightly yellow amorphous solid. 
 
 
2.4.3 Synthetic procedure for fucosylated chondroitin 
sulfate polysaccharides  
Chondroitin methyl ester (13): Chondroitin sodium salt from E. coli 
O5:K4:H4 fed-batch fermentation (2.183 g, 5.445 mmol repeating unit) 
was dissolved in pure water (140 mL) and passed through a short 
Dowex 50 WX8 column (H+ form, 20-50 mesh, approx. 450 cm3). 
Elution with pure water was continued until pH of the eluate was 
neutral. Freeze-drying of the collected eluate gave chondroitin (2.010 g, 
5.303 mmol), that was manually chopped and then suspended under Ar 
atmosphere in dry methanol (250 mL). After overnight stirring at rt, a 
0.58 M methanolic solution of acetyl chloride (124 mL, 72.4 mmol) 
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was added via cannula and stirring was continued overnight. The 
reaction was then quenched by neutralization with 1M aqueous 
NaHCO3. The mixture was concentrated by rotoevaporation and then 
freeze-dried. The protocol was repeated to give, after dialysis and 
freeze-drying, chondroitin methyl ester 13 (1.567 g, 73%, DS = 0.92) 
as a white waxy solid. NMR data (400 MHz, D2O) are reported below 
(Table 15) 
 
Table 15: 1H (plain) and 13C (italic) chemical shift attribution of 
derivative 13 
 
Residue 1 2 3 4 5 6 Other signals 
GlcA 4.60 
105.1 
3.39 
72.4 
3.68 
75.4 
3.86 
80.4 
4.10 
74.1 
--- (methyl ester) 
3.85 
54.0 
GalNAc 4.50 
101.6 
3.98 
51.5 
4.09 
80.3 
4.07 
68.3 
3.66 
75.3 
3.77 
61.6 
Ac 
2.02 
23.2 
[Chemical shift expressed in δ relative to internal acetone (1H: (CH3)2CO at δ = 2.22 
ppm; 13C: (CH3)2CO at δ = 30.9 ppm)] 
 
 
Chondroitin n-dodecyl ester (15): A suspension of TBA salt of 
chondroitin 14 (Valoti et al., 2012) (0.962 g, 1.551 mmol repeating 
unit) was suspended in DMF (32 mL) that was freshly dried over 4Å 
MS. TBAF (3.59 mL, 12.40 mmol) was added to give a clear solution 
that was then treated with n-dodecyl iodide (6.3 mL, 25.5 mmol). The 
solution was stirred at 80°C overnight and then treated with diisopropyl 
ether (130 mL) to give a gummy precipitate, that was collected by 
centrifugation and then dried under vacuum overnight to afford an 
approximately 30:70 w/w mixture of 15 and TBAI/TBAF (2.456 g, DS 
= 1). NMR data (400 MHz, DMSO-d6) are reported below (Table 16) 
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Table 16: 1H (plain) and 13C (italic) chemical shift attribution of 
derivative 15 
 
Residue 1 2 3 4 5 6 Other signals 
GlcA 4.45 
103.9 
3.08 
72.3 
3.31 
74.3 
3.52 
80.0 
3.74 
73.3 
--- (dodecyl 
ester) 
α: 4.01, 4.14 
64.5 
β: 1.56 
27.2 
γ-(ω-1): 1.23-
1.26 
28.8 
ω: 0.93 
13.1  
GalNAc 4.38 
101.0 
3.78 
50.9 
3.67 
78.9 
3.69 
66.9 
3.40 
75.0 
3.47 
60.1 
Ac 
1.76 
21.2 
[Chemical shift expressed in δ relative to isotopic impurity of DMSO-d6 (
1H: 
CHD2SOCD3 at δ = 2.49 ppm) in D S O-d6 (
13C: CD3SOCD3 at δ = 39.5 ppm)] 
 
 
Chondroitin methyl ester 4,6-benzylidene (16): Chondroitin methyl 
ester 13 (0.598 g, 1.519 mmol repeating unit) was suspended in DMF 
(30 mL), that was freshly dried over 4Å MS, and stirred at 80°C for 2 
hours. α,α-Dimethoxytoluene (2.3 mL, 15.2 mmol) freshly dried over 
4Å MS and then CSA (88.3 mg, 0.380 mmol) were added. The mixture 
was stirred at 80°C overnight, after that a clear, yellowish solution was 
obtained. It was cooled to rt and treated with diisopropyl ether (72 mL). 
The obtained white precipitate was collected by centrifugation and then 
dried under vacuum overnight. Derivative 16 was obtained as a 
yellowish amorphous solid, as a 74% w/w mixture with CSA and DMF 
(0.878 g, 89%, DS = 0.99). NMR data (400 MHz, DMSO-d6) are 
reported below (Table 17) 
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Table 17: 1H (plain) and 13C (italic) chemical shift attribution of 
derivative 16 
 
Residue 1 2 3 4 5 6 Other 
signals 
GlcA 4.50 
103.4 
3.04 
72.1 
3.39 
73.6 
3.63 
79.4 
3.85 
76.5 
--- (benzylidene 
ring) 
CH: 5.51 
99.5 
Ph: 7.38 
126.1 
(methyl 
ester) 
3.71 
52.0 
GalNAc 4.54 
100.1 
3.86 
50.2 
3.85 
73.3 
4.16 
74.4 
3.61 
65.4 
4.03 
68.2 
Ac 
1.77 
22.7 
[Chemical shift expressed in δ relative to isotopic impurity of D SO-d6 (
1H: 
CHD2SOCD3 at δ = 2.49 ppm) in D S O-d6 (
13C: CD3SOCD3 at δ = 39.5 ppm)] 
 
 
Chondroitin n-dodecyl ester 4,6-benzylidene (17): Chondroitin n-
dodecyl ester 15 (0.237 g approx. 30% w/w pure) was dissolved in 
DMF (12 mL), that was freshly dried over 4Å MS, and stirred at 80°C 
for 2 hours. α,α-Dimethoxytoluene (0.65 mL, 4.34 mmol) freshly dried 
over 4Å MS and then a 0.2 M solution of CSA in freshly dried DMF 
(0.52 mL, 0.104 mmol) were added. The solution was stirred at 80°C 
overnight. It was then cooled to rt and treated with water (40 mL) to 
give a white precipitate that was collected by centrifugation and then 
dried under vacuum overnight. A 86% w/w mixture of derivative 17 
with TBAF and DMF (97.4 mg, 97% over two steps from 14, DS = 
0.96) was obtained as a white amorphous solid. NMR data (400 MHz, 
DMSO-d6) are reported below (Table 18) 
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Table 18: 1H (plain) and 13C (italic) chemical shift attribution of 
derivative 17 
 
Residue 1 2 3 4 5 6 Other 
signals 
GlcA 4.49 
104.4 
3.03 
72.5 
3.37 
73.9 
3.65 
79.3 
3.83 
73.5 
--- (benzylidene 
ring) 
CH: 5.48 
99.9 
Ph: 7.37 
127.4 
(dodecyl 
ester) 
α: 4.01, 4.15 
64.6 
β: 1.56 
27.4 
γ-(ω-1): 1.23-
1.26 
28.7 
ω: 0.93 
13.1  
GalNAc 4.58 
100.4 
3.81 
50.7 
3.83 
76.9 
4.14 
74.7 
3.58 
65.8 
4.03 
68.3 
Ac 
1.73 
22.7 
[Chemical shift expressed in δ relative to isotopic impurity of D SO-d6 (
1H: 
CHD2SOCD3 at δ = 2.49 ppm) in D S O-d6 (
13C: CD3SOCD3 at δ = 39.5 ppm)] 
 
 
Chondroitin methyl ester 4,6-benzylidene 2,3-bis-
trimethylsilylether (18): Polysaccharide 16 (63.2 mg, 74% w/w pure) 
was suspended in pyridine (4 mL). [(CH3)3Si]2NH (274 μL, 1.31 mmol) 
and (CH3)3SiCl (166 μL, 1.31 mmol) were then added. After overnight 
stirring at 50°C, a clear solution was obtained. It was cooled to rt and 
treated with diisopropyl ether (16 mL) to give a yellowish precipitate, 
that was collected by centrifugation and then dried under vacuum 
overnight. A 52:48 w/w mixture of derivative 18 and pyridine (103 mg, 
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88%, DS = 2) was obtained. Alternatively, after overnight stirring at 
50°C, the crude reaction mixture was treated with water (16 mL) to 
afford, after centrifugation and overnight drying, pure polysaccharide 
18 (50.3 mg, 93%, DS = 1.03) as a white precipitate. 
 
Chondroitin derivative (19): Polysaccharide 16 (202 mg, 0.419 
mmol) was treated with CH3CN (4.4 mL) and then with Et3N (1.2 mL), 
Ac2O (2.8 mL) and DMAP (18.8 mg, 0.168 mmol). After overnight 
stirring at rt, a clear solution was obtained. Diisopropyl ether (15 mL) 
was then added to give a yellowish precipitate that was collected by 
centrifugation and then dried under vacuum overnight to afford 
derivative 19 (227 mg, DS = 2) contaminated mostly by Et3N and 
DMAP. NMR data (400 MHz, DMSO-d6) are reported below (Table 
19) 
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Table 19: 1H (plain) and 13C (italic) chemical shift attribution of 
derivative 19 
 
Residue 1 2 3 4 5 6 Other 
signals 
GlcA 4.93 
100.8 
4.65 
70.0 
5.04 
71.7 
3.91 
75.5 
4.10 
73.2 
--- NAc 
1.76 
22.3 
OAc 
1.93 
19.9 
GalNAc 4.34 
99.9 
3.63 
49.9 
3.82 
76.5 
4.18 
73.7 
3.54 
65.1 
4.04 
67.7 
(Benzyliden
e ring) 
CH: 5.44 
99.2 
Ph: 7.35 
127.4 
(Methyl 
ester) 
3.77 
52.5 
[Chemical shift expressed in δ relative to isotopic impurity of D SO-d6 (
1H: 
CHD2SOCD3 at δ = 2.49 ppm) in D S O-d6 (
13C: CD3SOCD3 at δ = 39.5 ppm)] 
 
 
Chondroitin derivative (20): Derivative 19 (96.5 mg) was suspended 
in EtOAc (1.9 mL) and then treated with a 0.27 M solution of NaBrO3 
in pure water (1.9 mL). A 0.24 M solution of Na2S2O4 in pure water 
(1.9 mL) was added portionwise over a period of 10 min. The mixture 
was vigorously stirred at rt overnight under visible light irradiation. The 
yellowish solid was collected by centrifugation and then dried under 
vacuum to give pure polysaccharide 20 (66.9 mg, 63% over two steps 
from 16, DS = 0.97). NMR data (400 MHz, DMSO-d6) are reported 
below (Table 20)  
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Table 20: 1H (plain) and 13C (italic) chemical shift attribution of 
derivative 20 
 
Residue 1 2 3 4 5 6 Other 
signals 
GlcA 
(4-Bz) 
 
 
 
4.93 
99.6 
4.68 
70.2 
 
 
4.99 
71.8 
3.80 
75.7 
 
 
4.04 
72.9 
--- NAc 
1.79 
22.4 
OAc 
1.72- 
1.93 
19.8- 
20.2 
GlcA 
(6-Bz) 
 
4.48 
70.0 
3.88 
75.5 
--- 
GalNAc 
(4-Bz) 
 
4.32 
100.6 
 
3.69 
51.9 
 
4.02 
75.5 
5.41 
68.8 
3.61 
73.2 
3.29 
59.3 
(Benzoyl 
ester) 
Ph: 7.95, 
7.86, 7.66, 
7.52 
128.8, 
128.8, 
132.8, 
128.3 
(Methyl 
ester) 
3.77 
52.5 
GalNAc 
(6-Bz) 
3.90 
73.2 
3.69 
73.2 
4.21, 
4.34 
62.9 
[Chemical shift expressed in δ relative to isotopic impurity of D SO-d6 (
1H: 
CHD2SOCD3 at δ = 2.49 ppm) in D S O-d6 (
13C: CD3SOCD3 at δ = 39.5 ppm)] 
 
 
1,2,3,4-tetra-O-acetyl-L-fucopyranoside (21): Commercially 
available L-fucose (2.55 g, 15.53 mmmol) was suspended in Ac2O 
(6.10 mL) and pyridine (6.10 mL). After overnight stirring at rt, the 
obtained  solution was diluted with CH2Cl2 (100 mL) and washed with 
HCl 0.5 M (100 mL). The organic phase was collected, dried over 
anhydrous Na2SO4, filtered and concentrated obtaining 1,2,3,4-tetra-O-
acetyl-L-fucopyranoside (5.16 g, quant.) 1H NMR (600 MHz, CDCl3, 
mixture of anomers α/β: 35/65): δ α-form = 6.24 (d, J1,2 = 3.1 Hz, 1H, 
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H-1), 5.23-5.29 (m, 3H, H-2, H-3, H-4), 4.27 (q, J5,6 = 6.4 Hz, 1H, H-5) 
2.18 (s, 3H, OCOCH3), 2.15 (s, 3H, OCOCH3), 2.02 (s, 3H, OCOCH3), 
2.00 (s, 3H, OCOCH3), 1.16 (d, J6,5 = 6.4 Hz, 3H, H-6).  
δ β-form = 5.68 (d, J1,2 = 8.3 Hz, 1H, H-1), 5.23-5.29 (m, 3H, H-2, H-3, 
H-4), 5.08 (dd, J3,4 = 3.4 Hz, J3,2 = 10.35 Hz, 1H, H-3), 3.95 (q, J5,6 = 
6.4 Hz, 1H, H-5), 2.20 (s, 3H, OCOCH3), 2.12 (s, 3H, OCOCH3), 2.04 
(s, 3H, OCOCH3), 1.99 (s, 3H, OCOCH3), 1.23 (d, J6,5 = 6.0 Hz, 3H, 
H-6). 
 
2,3,4-tri-O-acetyl-1-iodo-α-L-fucopyranoside (22): Compound 21 
(6.27 g, 18.87 mmol) was dissolved in CH2Cl2 (38.2 mL), treated with 
I2 (7.82 g, 30.80 mmol), Et3SiH (4.3 mL, 26.92 mmol) and stirred for 3 
h at 50°C at reflux. The mixture was then diluted with CH2Cl2 (150 
mL) and washed with a 1:1 v/v solution of NaHCO3/Na2S2O3. The 
organic phase was collected, dried over anhydrous Na2SO4, filtered and 
concentrated obtaining 22 as an oil, for the presence of siloxanes as 
contaminants. The crude product was used in the next step without 
purification. 1H NMR (400 MHz, CDCl3): δ = 7.10 (d, J1,2 = 3.9 Hz, 
1H, H-1), 5.34 (d, J4,3 = 2.4 Hz, 1H, H-4), 5.29 (dd, J3,4 = 3.2 Hz, J3,2 = 
10.2 Hz, 1H, H-3), 4.44 (m 1H, H-2), 4.28 (q, J5,6 = 6.4 Hz, 1H, H-5), 
2.17 (s, OCOCH3, 3H) , 2.11 (s, OCOCH3, 3H) ,2.00 (s, OCOCH3, 
3H), 1.23 (d, J6,5 = 6.4 Hz, 3H, H-6).  
 
Ethyl 2,3,4-tri-O-acetyl-β-L-fucopyranosyl thioglycoside (23): A 
suspension of crude 22 in dry CH3CN (20.0 mL) was treated with 
(NH2)2CS (2.18 g, 28.70 mmol) and stirred for 30 min at 60°C. The 
mixture was cooled to rt, then EtI (3.81 mL, 47.39 mmol) and Et3N 
(10.6 mL, 76.05 mmol) were added. After stirring for 2 h at rt, the 
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yellowish solution was diluted with CH2Cl2 (100 mL) and washed with 
0.1 M HCl (100 mL). The organic phase was collected, dried over 
anhydrous Na2SO4, filtered and concentrated. The obtained residue was 
purified by column chromatography (4:1 to 2:1 v/v hexane-ethyl 
acetate) to afford pure ethyl 2,3,4-tri-O-acetyl-β-L-fucopyranosyl 
thioglycoside (3.37 g, 53% over two steps from 21). 1H NMR (400 
MHz, CDCl3): δ = 5.28 (d, J4,3 = 3.2 Hz, 1H, H-4), 5.23 (t, J2,1 = J2,3 = 
10.0 Hz, 1H, H-2), 5.05 (dd, J3,4 = 3.2 Hz, J3,2 = 10.0 Hz, 1H, H-3), 
4.46 (d, J1,2 = 9.9 Hz, 1H, H-1), 3.83 (q, J5,6 = 6.3 Hz, 1H, H-5), 2.74 
(m, SCH2CH3, 2H), 2.22 (s, OCOCH3, 3H), 2.07 (s, OCOCH3, 3H), 
1.99 (s, OCOCH3, 3H), 1.29 (t, Jvic = 7.4 Hz, SCH2CH3, 3H), 1.23 (d, 
J6,5 = 6.4 Hz, 3H, H-6) 
 
Ethyl β-L-fucopyranosyl thioglycoside (24): Compound 23 (3.34 g, 
9.99 mmol) was suspended in dry MeOH (22.0 mL) and treated with a 
2.35 M solution of Na in dry MeOH (3.15 mL, 7.40 mmol). The yellow 
solution was stirred for 2 h at rt, neutralized with Amberlyst®, filtered 
and concentrated, obtaining pure 24 (1.97 g, 83%) 1H NMR (400 MHz, 
CDCl3): δ = 4.30 (d, J1,2 = 9.4 Hz, 1H, H-1), 3.80 (s, 1H, H-4) 3.68 (q, 
J5,6 = 6.5 Hz, 1H, H-5), 3.62 (m, 2H, H-2, H-3), 2.75 (m, SCH2CH3, 
2H),  1.35 (d, J6,5 = 6.0 Hz, 3H, H-6), 1.32 (t, Jvic = 7.2 Hz, SCH2CH3, 
3H)  
 
Ethyl 2,3,4-tri-O-benzyl-β-L-fucopyranosyl thioglycoside (25): A 
solution of 24 (1.97 g, 8.26 mmol) in DMF that was freshly dried over 
activated 4Å molecular sieves (16.0 mL), was cooled to 0°C and treated 
with BnBr (4.04 mL, 34.08 mmol) and then NaH (60% dispersion in 
mineral oil, 817.9 mg, 34.08 mmol). After 10 min stirring at 0°C, the 
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temperature was raised to rt and the mixture was stirred for 1 hour 
further. The reaction was then quenched by careful addition of water 
(50 mL) at 0°C and in small aliquots, and then of CH2Cl2 (100 mL). 
The organic layer was collected, dried over anhydrous Na2SO4, filtered 
and concentrated to give a residue that was subjected to column 
chromatography (9:1 to 5:1 v/v hexane-ethyl acetate) to afford pure 
ethyl 2,3,4-tri-O-benzyl-β-L-fucopyranosyl thioglycoside (3.15 g, 
75%). 1H-NMR (400 MHz, CDCl3): δ = 7.41-7.22 (m, 15H, H-Ar), 
5.01 (d, Jgem = 11.8 Hz, 1H, OCHHPh), 4.92 (d, Jgem = 10.2 Hz, 1H, 
OCHHPh), 4.82 (Jgem = 10.2 Hz, 1H, OCHHPh), 4.78 (Jgem = 10.2 Hz, 
1H, OCHHPh), 4.76 (Jgem = 11.8 Hz, 1H, OCHHPh) ,4.71 (Jgem = 11.8 
Hz, 1H, OCHHPh), 4.41 (d, J1,2 = 9.6 Hz, 1H, H-1), 3.85 (t, J2,1 = J2,3 = 
9.4 Hz, 1H, H-2), 3.64 (d, J4,3= 2.1 Hz, 1H, H-4), 3.58 (dd, J3,4 = 2.7, 
J3,2 = 9.2 Hz, 1H, H-3), 3.50 (q, J5,6 = 6.4 Hz, 1H, H-5), 2.76 (m, 
SCH2CH3, 2H), 1.33 (t, Jvic = 7.4 Hz, SCH2CH3, 3H), 1.25 (d, J6,5  6.4 
Hz, 3H, H-6).    
 
2,3,4-tri-O-benzyl-L-fucopyranosyl-N-phenyl-trifluoroacetimidate 
(26): A solution of  commercially available 2,3,4-tri -O-benzyl-L-
fucopyranose (3.13 g, 7.20 mmol) in dry CH2Cl2 (43 mL) was cooled to 
0°C and treated with CF3(NPh)Cl (1.618 mL, 12.98 mmol) and then 
NaH (60% dispersion in mineral oil, 345.8 mg, 14.42 mmol). After 3 h 
stirring at 0°C, the mixture was purified through column 
chromatography (toluene 99.9%,  Et3N 0.1%) affording pure compound 
26 (2.49 g, 57%). 1H-NMR data in agreement with literature (Adinolfi 
et al., 2004) 
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Ethyl 3,4-O-isopropylidene-β-L-fucopyranosyl thioglycoside (27): 
Compound 24 (1.87 g, 7.84 mmol) was treated with (CH3)2C(OCH3)2 
(9.95 mL, 80.88 mmol) and with CSA (83.5 mg, 0.36 mmol). After 2h 
stirring at rt, the solution was diluted with CH2Cl2 (75.0 mL) and then 
washed with 1M NaHCO3 (75.0 mL). The organic phase was collected, 
dried over anhydrous Na2SO4, filtered and concentrated to afford pure 
compound 27 (1.91 g, 98%) 1H NMR (600  MHz, CDCl3): 4.20 (d, J1,2 
= 10.2 Hz, 1H, H-1), 4.05 (dd, J4,5 = 2.2 Hz, J4,3 = 5.5 Hz, 1H, H-4), 
4.03 (t, J3,4 = 5.5 Hz, J3,2 = 6.8 Hz, 1H, H-3), 3.87 (dq, J5,4 = 2.2 Hz, 
J5,6 = 6.6 Hz, 1H, H-5), 3.54 (q, J2,3 = 6.8 Hz, J2,1 = 10.2 Hz, 1H, H-2), 
2.74 (m, SCH2CH3, 2H), 1.53 (s, CCH3, 3H), 1.40 (d, J6,5 = 6.4 Hz, 3H, 
H-6), 1.36 (s, CCH3, 3H), 1.31 (t, Jvic = 7.4 Hz, 3H, SCH2CH3) 
 
Ethyl 2-O-benzyl-3,4-O-isopropylidene-β-L-fucopyranosyl 
thioglycoside (28): A solution of 27 (2.15 g, 8.66 mmol) in freshly 
dried N,N-dimethylformamide over activated 4Å molecular sieves (17.5 
mL) was cooled to 0°C and treated with BnBr (1.23 mL, 10.39 mmol) 
and then NaH (60% dispersion in mineral oil, 249.4 mg, 10.39 mmol). 
After 10 min stirring at 0°C, the temperature was raised to rt and the 
mixture was stirred for 1 hour further. The reaction was then quenched 
by careful addition of water (20 mL) at 0°C and in small aliquots, and 
then of CH2Cl2 (100 mL). The organic layer was collected, dried over 
anhydrous Na2SO4, filtered and concentrated to give a residue that was 
subjected to column chromatography (9:1 to 7:1 v/v cyclohexane-ethyl 
acetate) to afford pure ethyl 2-O-benzyl-3,4-O-isopropylidene-β-L-
fucopyranosyl thioglycoside (2.65 g, 90%). 1H NMR (600 MHz, 
CDCl3): δ = 7.43-7.26 (m, 5H, H-Ar), 4.84 (d, Jgem = 11.4 Hz, 1H, 
OCHHPh), 4.76 (d, Jgem = 11.3 Hz, 1H, OCHHPh), 4.38 (d, J1,2 = 9.8 
124 
 
Hz, 1H, H-1), 4.19 (t, J3,4 = 5.6 Hz, J3,2 = 6.7 Hz, 1H, H-3), 4.05 (dd, 
J4,5 = 2.2 Hz, J4,3 = 5.6 Hz, 1H, H-4), 3.81 (dq, J5,4 = 2.2 Hz, J5,6 = 6.6 
Hz, 1H, H-5), 3.43 (q, J2,3 = 6.7 Hz, J2,1 = 9.8  Hz, 1H, H-2), 2.70 (m, 
SCH2CH3, 2H), 1.45 (s, CCH3, 3H), 1.38 (d, J6,5 = 6.5 Hz, 3H, H-6), 
1.36 (s, CCH3, 3H), 1.29 (Jvic = 7.43 Hz, SCH2CH3, 3H) 
 
Ethyl 2-O-benzyl-β-L-fucopyranosyl thioglycoside (29): Compound 
28 (2.64 g, 7.80 mmol) was suspended in a 4:1 v/v TFA/H2O solution 
and stirred for 1 h at rt. The solution was diluted with H2O (200 mL) 
and washed with CH2Cl2 (200 mL). The organic phase was washed 
with 1M NaHCO3 (200 mL), collected, dried over anhydrous Na2SO4, 
filtered and concentrated affording pure ethyl 2-O-benzyl-β-L-
fucopyranosyl thioglycoside (2.28 g, 98%). 1H NMR (600  MHz, 
CDCl3): δ = 7.43-7.30 (m, 5H, H-Ar), 4.97 (d, Jgem = 11.0 Hz, 1H, 
OCHHPh), 4.68 (d, Jgem = 11.1 Hz, 1H, OCHHPh), 4.40 (d, J1,2 = 9.6 
Hz, 1H, H-1), 3.75 (d, J4,3 = 3.3 Hz, 1H, H-4), 3.64-3.60 (m, 2H, H-3, 
H-5), 3.45 (t, J2,1 = J2,3 = 9.3 Hz, 1H, H-2), 2.77 (m, SCH2CH3, 2H), 
1.35-1.29 (m, SCH2CH3, 6H, H-6) 
 
Ethyl 2,3-di-O-benzyl-1-β-L-fucopyranosyl thioglycoside (30): 
Bu2SnO (1.83g, 7.35 mmol) was added to  compound 29 (2.42 g, 8.11 
the mixture was suspended in a 10:1 v/v C6H6/MeOH solution (35.2 
mL) and stirre 60°C. After 3 h the solution was cooled to rt, 
concentrated and then, under Ar atmosphere Bu4NBr (2.26 g, 6.12 
mmol), dry toluene (17.9 mL) and BnBr (738 μL, 61.2 mmol) were 
added. After overnight stirring at 65°C, the solution was cooled to rt, 
concentrated and the residue was purified through column 
chromatography (6:1 to 1:4 v/v hexane-ethyl acetate) affording pure 
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compound 30 (2.15 g, 95%). 1H NMR (600  MHz, CDCl3): δ = 7.41-
7.28 (m, 10H, H-Ar), 4.88 (d, Jgem = 10.2 Hz, 1H, OCHHPh), 4.76 (d, 
Jgem = 10.2 Hz, 1H, OCHHPh), 4.72-4.70 (m, 2H, 2 OCHHPh), 4.39 (d, 
J1,2 = 9.7 Hz, 1H, H-1), 3.82 (s, 1H, H-4), 3.62 (t, J2,1 = J2,3 = 9.6 Hz, 
1H, H-2), 3.56-3.52 (m, 2H, H-3, H-5), 2.81-2.68 (m, SCH2CH3, 2H), 
1.34 (d, J6,5 = 6.4 Hz, 3H, H-6), 1.31 (t, Jvic = 7.4 Hz, 3H, SCH2CH3).  
 
Ethyl 2,3-di-O-benzyl-4-O-benzoyl-β-L-fucopyranosyl thioglycoside 
(31): Compound 30 (2.13 g, 5.48 mmol) was suspended in dry CH2Cl2 
(24.0 mL) and treated with BzCl (958 μL, 8.25 mmol) and  pyridine 
(6.0 mL). After 2h stirring at rt, the solution was diluted with CH2Cl2 
(50.0 mL) and washed with 1.0 M HCl (50.0 mL). The organic phase 
was collected, dried over anhydrous Na2SO4, filtered and concentrated 
affording a residue that was purified through column chromatography 
(12:1 to 6:1 v/v hexane-ethyl acetate), to afford a pure compound 31 
(2.21 g, 82%). 1H NMR (600  MHz, CDCl3): δ=8.14-7.24 (m, 15H, H-
Ar), 5.63 (d, J4,3 = 2.9 Hz, 1H, H-4), 4.85-4.81 (m, 2H, 2 OCHHPh) 
4.77 (d, Jgem = 10.26 Hz, 1H, OCHHPh), 4.57 (d, Jgem = 11.7 Hz, 1H, 
OCHHPh), 4.50 (d, J1,2 = 9.70 Hz, 1H, H-1), 3.77 (q, J5,6 = 6.40 Hz, 
1H, H-5), 3.73 (dd, J3,2 = 9.17 Hz, J3,4 = 3.21 Hz, 1H, H-3),  3.69 (t, J2,1 
= J2,3 = 9.7 Hz, 1H, H-2), 2.81 (m, SCH2CH3, 2H), 1.35 (t, Jvic = 7.4 
Hz, 3H, SCH2CH3), 1.29 (d, J6,5 = 6.4 Hz, 3H, H-6) 
 
Ethyl 3-O-tert-butyldimethylsilyl-β-L-fucopyranosyl thioglycoside 
(32): A solution of compound 24 (1.95 g, 8.18 mmol) in DMF (8.0 mL) 
was treated with ImH (1.59 g, 23.45 mmol) and TBDMSCl (1.93 g, 
12.85 mmol) after cooling to 0°C. After 20 min stirring, the 
temperature was raised to rt and the mixture was stirred for 2 h further. 
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The solution was diluted with AcOEt (100 mL) and washed with H2O 
(100 mL). The organic phase was collected, dried over anhydrous 
Na2SO4, filtered and concentrated to give a residue that was subjected 
to column chromatography (10:1 to 6:1 v/v hexane-ethyl acetate) 
affording pure 32 (2.03 g, 77%) 1H NMR (400 MHz, CDCl3): δ = 4.24 
(d, J1,2 = 9.0 Hz, 1H, H-1), 3.64-3.54 (m, 4H, H-2, H-3, H-4, H-5), 2.81 
(m, SCH2CH3, 2H), 1.36 (d, J6,5 = 6.4 Hz, 3H, H-6), 1.30 (t, Jvic = 7.4 
Hz, 3H, SCH2CH3), 0.92 (s, 9H, SiC(CH3)3), 0.16 (s, 3H, SiCH3), 0.13 
(s, 3H, SiCH3). 
 
Ethyl 2,4-di-O-benzyl-3-O-tert-butyldimethylsilyl-β-L-
fucopyranosyl thioglycoside (33): A solution of 32 (1.80 g, 5.58 
mmol) in DMF that was freshly dried over activated 4Å molecular 
sieves (16.5 mL) was cooled to 0°C and treated with BnBr (1.66 mL, 
13.39 mmol) and then NaH (60% dispersion in mineral oil, 321.2 mg, 
13.39 mmol). After 10 min stirring at 0°C, the temperature was raised 
to rt and the mixture was stirred for 1 hour further. The reaction was 
then quenched by careful addition of water (50 mL) at 0°C and in small 
aliquots, and then of CH2Cl2 (100 mL). The organic layer was 
collected, dried over anhydrous Na2SO4, filtered and concentrated to 
give a residue that was subjected to column chromatography (12:1 to 
8:1 v/v hexane-ethyl acetate) to afford pure ethyl 2,4-di-O-benzyl-3-O-
tert-butyldimethylsilyl-β-L-fucopyranosyl thioglycoside (2.60 g, 93%). 
1H NMR (400 MHz, CDCl3): δ = 7.44-7.29 (m, 10H, H-Ar), 5.10 (d, 
Jgem = 11.4 Hz, 1H, OCHHPh), 4.88 (d, Jgem = 10.2 Hz, 1H, OCHHPh), 
4.74 (d, Jgem = 10.2 Hz, 1H, OCHHPh), 4.63 (d, Jgem = 11.4 Hz, 1H, 
OCHHPh), 4.40 (d, J1,2 = 9.3 Hz, 1H, H-1), 3.76 (dd, J3,2 = 9.0 Hz, J3,4 
= 2.8 Hz, 1H, H-3), 3.73 (t, J2,1 = J2, 3 = 9.3 Hz, 1H, H-2), 3.55 (q, J5,6 = 
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6.4 Hz, 1H, H-5), 3.46 (d, J4,3 = 3.0 Hz, 1H, H-4), 2.81 (m, SCH2CH3, 
2H), 1.29 (t, Jvic = 7.5 Hz, 3H, SCH2CH3), 1.24 (d, J6,5 = 6.2 Hz, 3H, 
H-6), 0.97 (s, 9H, SiC(CH3)3), 0.13 (s, 3H, SiCH3), 0.08 (s, 3H, SiCH3).   
 
Ethyl 2,4-di-O-benzyl-β-L-fucopyranosyl thioglycoside (34): 
Compound 33 (2.57 g, 5.11 mmol) was suspended in THF (37.0 mL) 
and treated with 1.0 M solution of TBAF in THF (12.8 mL). The 
yellowish solution was stirred for 2h at rt and the reaction was 
quenched by concentration at the rotoevaporator, and obtaining a crude 
mixture that was purified trough column chromatography (12:1 to 8:1 
v/v hexane-ethyl acetate). Pure 34 was obtained (1.89 g, 95%). 1H 
NMR (400 MHz, CDCl3): δ = 7.42-7.29 (m, 10H, H-Ar),  4.95 (d, Jgem 
= 10.6 Hz, 1H, OCHHPh), 4.78-4.62 (m 3H, 3 OCHHPh), 4.37 (d, J1,2 
= 9.6 Hz, 1H, H-1), 3.68 (dd, J3,2 = 9.3 Hz, J3,4 = 3.1 Hz, 1H, H-3), 3.53 
(t, J2,1 = J2, 3 = 9.7 Hz, 1H, H-2), 3.50 (d, J4,3 = 3.0 Hz, 1H, H-4), 3.47 
(q, J5,6 = 6.4 Hz, 1H, H-5), 2.81 (m, SCH2CH3, 2H), 1.35 (t, Jvic = 7.4 
Hz, 3H, SCH2CH3), 1.29 (d, J6,5 = 6.4 Hz, 3H, H-6). 
 
Ethyl 2,4-di-O-benzyl-3-O-benzoyl-β-L-fucopyranosyl thioglycoside 
(35): Compound 34 (1.89 g, 4.86 mmol) was dissolved in dry CH2Cl2 
(10.0 mL) and treated with BzCl (849 μL, 7.30 mmol) obtaining a 
yellow solution that was stirred at rt. After 30 min a white precipitate 
was formed. It was dissolved by adding more CH2Cl2 (10.0 mL). The 
reaction was then quenched by addition of MeOH, diluted with CH2Cl2 
(100 mL) and washed with 0.1 M HCl (100 mL). The organic phase 
was collected, dried over anhydrous Na2SO4, filtered and concentrated 
to give a residue that was subjected to column chromatography (12:1 to 
6:1 v/v hexane-ethyl acetate) to afford pure ethyl 2,4-di-O-benzyl-3-O-
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benzoyl-β-L-fucopyranosyl thioglycoside (1.76 g, 73%). 1H NMR (400 
MHz, CDCl3): δ=8.04-7.18 (m, 15H, H-Ar), 5.25 (dd, J3,4 = 3.1 Hz J3,2 
= 9.7 Hz, 1H, H-3), 4.90 (d, Jgem = 10.6 Hz, 1H, OCHHPh), 4.72 (d, 
Jgem = 11.7 Hz, 1H, OCHHPh), 4.69 (d, Jgem = 11.7 Hz, 1H, OCHHPh), 
4.59 (d, Jgem = 10.6 Hz, 1H, OCHHPh), 4.55 (d, J1,2 = 9.6 Hz, 1H, H-1), 
4.01 (t, J2,1 = J2,3 = 9.7 Hz, 1H, H-2), 3.89 (d, J4,3 = 3.1 Hz, 1H, H-4), 
3.74 (q, J5,6 = 6.4 Hz, 1H, H-5), 2.81 (m, SCH2CH3, 2H), 1.35 (t, Jvic = 
7.4 Hz, 3H, SCH2CH3), 1.29 (d, J6,5 = 6.4 Hz, 3H, H-6) 
  
Glycosylation with ethyl 2,3,4-tri-O-benzyl-β-L-fucopyranosyl 
thioglycoside 25. A mixture of polysaccharide 16 (or 17 or 18 or 20) 
(48.4 mg, 0.101 mmol) and fucosyl thioglycoside 25 (241 mg, 0.505 
mmol) was co-evaporated three times with dry toluene (2.5 mL). AW-
300 4Å molecular sieves and then CH2Cl2 (3.4 mL) and DMF (2.5 mL) 
(or THF, or in addition with DME in the case of 17 and 18, 
respectively), that were freshly dried over 4Å molecular sieves, were 
added to the mixture under argon atmosphere. NIS (125 mg, 0.550 
mmol) and then TMSOTf (99 μL, 0.550 mmol) were added. The 
mixture was stirred at rt (or at -20°C) under argon atmosphere for 4 
hours, then the molecular sieves were eliminated by decantation. A few 
drops of triethylamine and then diisopropyl ether (30 mL) were added 
and the mixture was stored at -28°C overnight. The obtained yellowish 
precipitate was collected by centrifugation and then dried under 
vacuum overnight to afford derivative 37-IV (94.6 mg) or 38-VII (at rt 
and -20°C, respectively from 16), 36-I, 37-VI (from 17 and 18, 
respectively) and 39-X (from acceptor 20).  
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Glycosylation with 2,3,4-tri-O-benzyl-L-fucopyranosyl N-phenyl-
trifluoroacetimidate 26. Polysaccharide 16 (or 17) (98.1 mg, 0.204 
mmol) and fucosyl donor 26 (617 mg, 1.02 mmol) were co-evaporated 
three times with dry toluene (5.0 mL) in two separated round-bottomed 
flasks. AW-300 4Å molecular sieves and then DMF (6.0 mL) (or THF), 
that was freshly dried over 4Å molecular sieves, were added to the 
polysaccharide, whereas 4Å molecular sieves and then CH2Cl2 (10.0 
mL), that was freshly dried over 4Å molecular sieves, were added to 
the donor. The mixture containing the polysaccharide was then treated 
with a 0.49M solution of TMSOTf in CH2Cl2 (42 μL, 20.6 μmol), and 
then the mixture containing the donor was immediately added via 
cannula under argon atmosphere. The mixture was stirred at rt for 4 
hours, then the molecular sieves were eliminated by decantation. A few 
drops of triethylamine and then diisopropyl ether (30 mL) were added 
and the mixture was stored at -28°C overnight. The obtained white 
precipitate was collected by centrifugation and then dried under 
vacuum overnight to afford derivative 37-V (153.9 mg, from acceptor 
16) or 36-II,III (from acceptor 17). 
 
Glycosylation with ethyl 2,3-di-O-benzyl-4-O-benzyl-1-β-L-
fucopyranosyl thioglycoside 31. A mixture of polysaccharide 16 (or 
20) (61.9 mg, 0.124 mmol) and fucosyl thioglycoside 31 (317.0 mg, 
0.643 mmol) was co-evaporated three times with dry toluene (2.5 mL). 
AW-300 4Å molecular sieves and then CH2Cl2 (6.28 mL) and DMF 
(3.77 mL), that were freshly dried over 4Å molecular sieves, were 
added to the mixture under argon atmosphere. NIS (158.1 mg, 0.707 
mmol) and then TMSOTf (34.8 μL, 0.193 mmol) were added. The 
mixture was stirred at -20°C (or at rt in the case of polysaccharide 20) 
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under argon atmosphere for 4 hours, then the molecular sieves were 
eliminated by decantation. A few drops of triethylamine and then 
diisopropyl ether (30 mL) were added and the mixture was stored at -
28°C overnight. The obtained yellowish precipitate was collected by 
centrifugation and then dried under vacuum overnight to afford 
derivative 38-VIII (72.9 mg) (or 39-XI in the case of polysaccharide 
acceptor 20). 
 
Glycosylation with ethyl 2,4-di-O-benzyl-3-O-benzoyl-β-L-
fucopyranosyl thioglycoside 35. A mixture of polysaccharide 16 (or 
20) (68.5 mg, 0.138 mmol) and fucosyl thioglycoside 35 (351 mg, 
0.712 mmol) was co-evaporated three times with dry toluene (2.5 mL). 
AW-300 4Å molecular sieves and then CH2Cl2 (6.95 mL) and DMF 
(4.17 mL), that were freshly dried over 4Å molecular sieves, were 
added to the mixture under argon atmosphere. NIS (176.3 mg, 0.783 
mmol) and then TMSOTf (38.5 μL, 0.214 mmol) were added. The 
mixture was stirred at -20°C (or rt in the case of polysaccharide 20) 
under argon atmosphere for 4 hours, then the molecular sieves were 
eliminated by decantation. A few drops of triethylamine and then 
diisopropyl ether (30 mL) were added and the mixture was stored at -
28°C overnight. The obtained yellowish precipitate was collected by 
centrifugation and then dried under vacuum overnight to afford 
derivative 38-IX (52.1 mg) (or 39-XII in the case of polysaccharide 
acceptor 20). 
 
Acetylation. Derivative 37-IV (or 36-I, and 38-VII) (88.4 mg) was 
suspended in CH3CN (2.0 mL) and then Ac2O (650 μL), Et3N (275 μL) 
and DMAP (4.8 mg) were added. After overnight stirring at rt, a clear 
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solution was obtained. In the case of methyl ester derivatives (37-
IV41-IV), diisopropyl ether (15 mL) was added to give a white 
precipitate that was collected by centrifugation and then dried under 
vacuum overnight to afford derivative 41-IV (or 42-VIII) (72.5 mg). In 
the case of dodecyl ester derivatives (36-I40-I), no polysaccharide 
precipitation could be obtained with any solvent. Therefore, the crude 
mixture was concentrated to give a residue that was co-evaporated 
several times with toluene. A brownish oil (381 mg) containing 
polysaccharide 40-I was obtained. It was not further purified, but used 
in the following synthetic step as it was. The same stategy was applied 
for acetylation of 37-V-VI (37-V-VI 41-V-VI), 36-III (36-III40-
III) and 38-IX-X (38-IX-X 42-IX-X) 
 
Oxidative cleavage of benzyl and benzylidene protecting groups. A 
suspension of polysaccharide 41-IV (67.7 mg) in ethyl acetate (800 μL) 
was treated with a 0.27 M solution of NaBrO3 in pure water (800 μL). 
A 0.24 M solution of Na2S2O4 in pure water (750 μL) was added 
portionwise over a period of 10 min. The triphasic mixture was 
vigorously stirred at rt overnight under visible light irradiation. The 
yellowish solid was then collected by centrifugation to afford derivative 
44-IV (36.8 mg). The same strategy was applied for derivatives 40I,III, 
41-V-VI and 42-VII-IX that afforded 43-I,III, 44-V-VI and 45-VII-I, 
respectively.  
 
Sulfation and alkaline deprotection. Derivative 44-IV  (33.3 mg) was 
suspended in DMF (570 μL), that was freshly dried over 4Å molecular 
sieves and then treated with a 1.17 M solution of pyridine–sulfur 
trioxide complex in freshly dried DMF (840 μL). After 2h stirring at 
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50°C the suspension turned into a clear solution. Stirring at 50°C was 
continued overnight. A saturated NaCl solution in acetone (5 mL) was 
added. The obtained yellowish precipitate was collected by 
centrifugation and then dissolved in pure water (7.0 mL). The solution 
was treated with a 15% w/v NaOH solution to adjust pH to 13, stirred 
for 6 h at rt and then 1.0 M HCl was added until neutralization. Dialysis 
and subsequent freeze-drying yielded a slightly yellow solid, that was 
further purified by filtration through a Sep-pak® C-18 cartridge and 
then by size-exclusion chromatography. Freeze-drying of the fractions 
afforded fCS-IV (35.2 mg) as a white waxy solid. The same strategy 
was applied to afford fCS-I,III-XII. 
 
Alkaline deprotection to fC-I-II. Derivative 46-I (or 45-I) (80.4 mg) 
was suspended in pure water (6.0 mL) obtaining a yellowish suspension 
that was treated with a 15% w/v NaOH solution to adjust pH to 13. The 
mixture was stirred for 6 h at rt and then 1.0 M HCl was added until 
neutralization. The reaction was repeated twice. Dialysis and 
subsequent freeze-drying yielded a slightly yellow solid, that was 
further purified by filtration through a Sep-pak® C-18 cartridge and 
then by size-exclusion chromatography. Freeze-drying of the fractions 
afforded fC-I  (31.4 mg) (or fC-II) as a white waxy solid.  
 
 
2.4.4Determination of molecular mass 
Hydrodynamic characterization of fC and fCS samples was performed 
by using the SEC-TDA equipment by Viscotek (Malvern, Italy). The 
chromatographic system consists of two modules: (i) a GPCmax VE 
2001 integrated system composed of a specific pump for gel 
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permeation chromatography, an in-line solvent degasser, and an 
autosampler; and (ii) a TDA305 module (triple detector array) that 
includes a column oven and a triple detector. The latter is the key 
element of the GPC-Viscotek as it is equipped with a refractive index 
(RI) detector, a four-bridge viscosimeter (VIS), and a light scattering 
(LS) detector. The latter consists of a right-angle light scattering 
(RALS) detector and a low-angle light scattering (LALS) detector that 
performed measurements of the scattered light at 7° with respect to the 
incident beam with an optimal signal-to-noise ratio. The OmniSEC 
software program was used for the acquisition and analysis of the 
Viscotek data. Two in series TSK-GEL GMPWXL columns (Tosoh 
Bioscience, Cat. No. 8–08025, hydroxylated polymethacrylate base 
material, 100–1000 Å pore size, 13 μm mean particle size, 7.8×30.0 
cm), preceded by a TSK-GEL guard column GMPWXL (Tosoh 
Bioscience, Cat. No. 08033, 12 μm mean particle size, 6.0×4.0 cm), 
were used. The samples were analyzed at concentrations ranging from 
0.3 to 4 g L−1 to have a column load for each analysis (injection 
volume×sample concentration×intrinsic viscosity) of approximately 0.2 
dL and, at the same time, appreciable LALS and VIS signals when 
analyzing low-molecular-mass species (see equations below). An 
isocratic elution with 0.1 M NaNO3 aqueous solution (pH 7.0) at a flow 
rate of 0.6 mL min−1 was carried out. Analyses were performed at  
40 °C with a running time of 60 min. The molecular mass and size 
distribution, polydispersity, hydrodynamic radius, and intrinsic 
viscosity were derived. For the detected signals, the following 
equations apply: RI signal=K1×dn/dc×C; VIS signal=K2×[η]×C; LALS 
signal=K3×Mw×(dn/dc)
2×C; where [η] is the intrinsic viscosity (dL g−1); 
C is the mass concentration (mg mL−1); dn/dc is the refractive index 
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increment (mL g−1); and K1, K2, and K3 are instrumental constants. 
(Hartmann et al., 2004)  
By solving the equations above, the system allowed the simultaneous 
determination of sample concentration, molecular mass, and intrinsic 
viscosity. (La Gatta et al., 2010) 
 
 
2.4.5 Anticoagulant activity 
AT-dependent antifactor Xa activity was evaluated by a kinetic 
colorimetric method by using a commercial kit (Stachrom Heparin, 
Stago). Heparin was used as the standard for building a calibration 
curve (r2 = 0.976) with 0.1 to 0.5 IUmg-1 active solutions. The sample 
(100 mL) was added to purified bovine AT (100 mL) diluted in Tris 
EDTA buffer (pH 8.4), and the mixture was incubated with factor Xa 
(200 mL) for 2 min at 37 °C. Then, factor Xa chromogenic substrate 
(200 mL) was added. The absorbance was read at 405 nm against a 
blank and was inversely proportional to the concentration of the 
polysaccharides. The anti HC-IIa assay was performed by using a 
sandwich enzyme immunoassay (USCN, Life Science Inc.) according 
to the manufacturer’s protocol 
(http://www.nlbiochemex.com/e90284ga.html). 
 
 
 
 
 
 
 
135 
 
2.5 Bibliography 
Abronina, P.I.; Zinin, A.I.; Romashin, D.A.; Malysheva, N.N.; 
Chizhov, A.O.; Kononov, L.O. Synlett 2015, 26, 2267-2271 
Adinolfi,  .;  adonisi, A.;  avid , A.; Schiattarella, M. Synlett 2004, 
275−278 
Adinolfi, M.; Barone, G.; Guariniello, L.; Iadonisi, A. Tetrahedron 
Lett. 1999, 40, 8439-8441 
Alonso-Lopez, M.; Barbat, J.; Fanton, E.; Fernandez-Mayoralas, A.; 
Gelas, J.; Horton, D.; Martin-Lomas, M.; Penades, S. Tetrahedron 
1987, 43, 1169-1176  
Bachelder, E.M.; Beaudette, T.T.; Braoders, K.E.; Dashe, J.; Fréchet, 
J.M.J. J. Am. Chem. Soc. 2008, 130, 10494-10495 
Barili, P.L.; Catelani, G.; D’Andrea, F.; De  ensis , F.; Falcini, P. 
Carbohyd. Res. 1997, 298, 75-84 
Bedini, E.; Laezza, A.; Iadonisi, A. Eur. J. Org. Chem. 2016, 18, 3018-
3042 
Bedini, E.; Parrilli M. in Chondroitin sulfate: Structure, use and health 
implications, (Ed. Pomin, V.H.), Nova SciencePublishers Inc. New 
York, (NY) 2013, 1–27 
Bedini, E.; De Castro, C.; De Rosa, M.; Di Nola, A.; Restaino, O.F.; 
Schiraldi, C.; Parrilli, M. Chem. Eur. J. 2012, 18, 2123-2130 
Bedini, E.; De Castro, C.; De Rosa, M.; Di Nola, A.; Iadonisi, A.; 
Restaino, O.F.; Schiraldi, C.; Parrilli, M. Angew. Chem. Int. Ed. 2011, 
50, 6160-6163 
Benesova, E.; Lipovova, P.; Dvorakova, H.; Kralova, B. Glycobiology 
2013, 23, 1052−1065  
Bertini, S.; Bisio, A.; Torri, G.; Benzi, D.; Terbojevich, M. 
Biomacromolecules 2005, 6, 168-173 
Bishnoi, M.; Jain, A.; Hurkat, P.; Jain, S.K. Glycoconj. J. 2016, 33, 
693-705 
136 
 
Broaders, K.E.; Cohen, J.A.; Beaudette, T.T.; Bacheler, E.M.; Fréchet, 
J.M.J. Proc. Natl. Acad. Sci. 2009, 106, 5497-5502  
Chen, S.; Xue, C.; Yin, L.; Tang, Q.; Yu, G.; Cha, W. Carbohydr. 
Polym. 2011, 83, 688−696 
Cimini, D.; Restaino, O.F.; Catapano, A.; De Rosa, M.; Schiraldi C. 
Appl. Microbiol. Biotechnol. 2010, 85, 1779-1787 
Cobucci-Ponzano, B.; Conte, F.; Bedini, E.; Corsaro, M.M.; Parrilli, 
M.; Sulzenbacher, G.; Lipski, A.; Dal Piaz, F.; Lepore, L.; Rossi, M.; 
Moracci, M. Chem. Biol. 2009, 16, 1097−1108  
Cobucci-Ponzano, B.; Conte, F.; Mazzone, M.; Bedini, E.; Corsaro, 
M.M.; Rossi, M.; Moracci, M. Biocat. Biotrans 2008, 26, 18−24  
Comegna, D.; Bedini, E.; Parrilli, M. Tetrahedron 2008, 64, 3381-3391 
Comegna, D.; Bedini, E.; Di Nola, A.; Iadonisi, A.; Parrilli, M. 
Carbohydr. Res. 2007, 342, 1021-1029 
Cui, L.; Cohen, J.L.; Chu, C.K.; Wich, P.R.; Kierstead, P.H.; Fréchet, 
J.M.J. J. Am. Chem. Soc. 2012, 134, 15840-15848 
Daly, R.; McCabe, T.; Scanlan, E.M. J. Org. Chem. 2013, 78, 
1080−1090  
Fanton, E.; Gelas, J.; Horton, D.; Karl, H.; Khan, R.; Lee, C.-K.; Patel, 
G. J. Org. Chem. 1981, 46, 4057-4060 
Farkas, E.; Thiem, J.; Ajisaka, K. Carbohydr. Res. 2000, 328, 293−299 
Fascione, M.A.; Turnbull, W.B. Beilstein J. Org. Chem. 2010, 6, 19  
Fonseca,  . .; Oliveira, S.; Pomin,  .H.;  ec awi, A.S.; Arau o,  .G.; 
 our  o , P.A.S. Thromb. Haemost. 2010, 103, 994-1004 
Fonseca, R.J.;  our  o , P.A.S. Thromb. Haemost. 2006, 96, 822-829 
Français, A.; Urban, D.; Beau, J.-M. Angew. Chem. Int. Ed. 2007, 46, 
8862-8665  
Fujiwara, R.; Horito, S. Carbohydr. Res. 2011, 346, 2098−2103  
137 
 
Gao, N.; Lu, F.; Xiao, C.; Yang, L.; Chen, J.; Zhou, K.; Wen, D.; Li, 
Z.; Wu, M.; Jiang, J.; Liu, G.; Zhao, J. Carbohydr. Polym. 2015, 127, 
427-437  
Gargiulo, V.; Lanzetta, R.; Parrilli, M.; De Castro, C. Glycobiology 
2009, 19, 1485-1491 
Gerbst, A.G.; Ustuzhanina, E.N.; Grachev, A.A.; Khatuntseva, E.A.; 
Tsvetkov, D.M.; Whitfield, D.M.; Berces, A.; Nifantiev, N.E. J. 
Carbohydr. Chem. 2001, 20, 821-831 
Glauser, B.F.; Pereira,  .S.;  onteir o,  . .;  our  o , P.A.S. Thromb. 
Haemost. 2008, 100, 420-428 
Guerrini, M.; Beccati, D.; Shriver, Z.; Naggi, A.; Viswanathan, K.; 
Bisio, A.; Capila, I.; Lansing, J.C.; Guglieri, S.; Fraser, B.; Al-Hakim, 
A.; Gunay, N.S.; Zhang, Z.; Robinson, L.; Buhse, L.; Nasr, M.; 
Woodcock, J.; Langer, R.; Venkataraman, G.; Linhardt, R.J.; Casu, B.; 
Torri, G.; Sasisekharan, R. Nat. Biotechnol. 2008, 26, 669–675 
Guerrini, M.; Naggi, A.; Guglieri, S.; Santarsiero, R.; Torri, G. Anal. 
Biochem. 2005, 337, 35-47 
Hartmann, W.K,; Saptharishi, N.; Yang, X.Y.; Mitra, G.; Soman, G. 
Anal. Biochem. 2004, 325, 227–239 
Hua, Y.; Gu, G.; Du, Y. Carbohydr. Res. 2004, 339, 867-872  
Ishimaru, M.; Nagatsuka, M.; Masubuchi, A.; Okazaki, J.; Kurita, K. 
Polym. Bull. 2014, 71, 301−313  
Jacquinet, J.C.; Lopin-Bon, C.; Vibert, A. Chem. Eur. J. 2009, 15, 
9579-9595 
Jaramillo, C.; Fernandez-Mayoralas, A.; Martin-Lomas, M. Carbohydr. 
Res. 1988, 182, 153-159  
Kinoshita, A.; Yamada, S.; Haslam, S.M.; Morris, H.R.; Dell, A.; 
Sugahara, K. J. Biol. Chem. 1997, 272, 19656-19665 
Kishimoto, T.K.; Viswanathan, K.; Ganguly, T.; Elankumaran, S.; 
Smith, S.; Pelzer, K.; Lansing, J.C.; Sriranganathan, N.; Zhao, G.; 
Galcheva-Gargova, Z.; Al-Hakim, A.; Bailey, G.S.; Fraser, B.; Roy, S.; 
Rogers-Cotrone, T.; Buhse, L.F.; Whary, M.; Fox, J.; Nasr, M.; Dal 
Pan, G.J.; Shriver, Z.; Langer, R.S.; Venkataraman, G.; Austen, K.F.; 
138 
 
Woodcock, J.; Sasisekharan, R. New Engl. J. Med. 2008, 358, 2457-
2467  
Kumar Shetty, A.; Kobayashi, T.; Mizumoto, S.; Narumi, M.; Kudo, 
Y.; Yamada, S.; Sugahara, K. Carbohydr. Res. 2009, 344, 1526-1532 
Kurita, K.; Matsumura, Y.; Takahara, H.; Hatta, K.; Shimojoh, M; 
Biomacromolecules 2011, 12, 2267−2274 
Kurita, K.; Akao, H.; Yang, J.; Shimojoh, M. Biomacromolecules 2003, 
4, 1264−1268  
Kurita, K.; Shimada, K.; Nishiyama, Y.; Shimojoh, M.; Nishimura, S. 
Macromolecules 1998, 31, 4764−4769 
La Gatta, A.; De Rosa, M.; Marzaioli, I.; Busico, T.; Schirladi, C. Anal. 
Biochem. 2010, 404, 21-29  
Laezza, A.; Iadonisi, A.; Pirozzi, A.V.A.; Diana, P.; De Rosa, M.; 
Schiraldi, C.; Parrilli, M.; Bedini, E. Chem. Eur. J. 2016, 50, 18215-
18226 
Laezza, A.; Iadonisi, A.; De Castro, C.; De Rosa, M.; Schiraldi, C.; 
Parrilli, M. Bedini, E.  Biomacromolecules 2015, 16, 2237-2245  
Laezza, A.; De Castro, C.; Parrilli, M.; Bedini, E. Carbohyd. Polym. 
2014, 112, 546-555 
Lezyk, M.; Jers, C.; Kjaerulff, L.; Gotfredsen, C.H.; Mikkelsen, M.H.; 
Mikkelsen, J.D. Plos One, 2016, 11, doi: 
10.1371/journal.pone.0147438 
Li, J.; Li, S.; Zhi, Z.; Yan, L.; Ye, X.; Ding, T.; Yan, L.; Linhardt, R.J.; 
Chen, S. Mar. Drugs 2016, 14, 170-183  
Lipták, A.; Jánossy, L.; Borbás, A.; Szejtlic, J. Carbohyd. Res. 2002, 
337, 93-96  
Liu, X.; Hao, J.; Shan, X.; Zhang, X.; Zhao, X.; Li, Q.; Wang, X.; Cai, 
C.; Li, G.; Yu, G. Carbohydr. Polym. 2016, 152, 343-350  
Loon, H. Carbohydr. Res. 1985, 139, 105-113 
Lu, S.-R.; Lai, Y.-H.; Chen, J.-H.; Liu, C.-Y.; Mong, K.-K.T. Angew. 
Chem. Int.Ed. 2011, 50, 7315-7320 
139 
 
Lucas, H.; Hasten, J.E.M.; van Dinther, T.G.; Meuleman, D.G.; van 
Aelst, S.F.; van Boeckel, C.A.A. Tetrahedron 1990, 46, 8207-8228 
Mackman, N. Nature 2008, 451, 914-918 
Manzo, E.; Barone, G.; Parrilli, M. Synlett 2000, 6, 887-889  
Mikami, T.; Sugahara, K. Trends Glycosci. Glycotechnol., 2006, 18, 
165-183 
Monteiro-Machado, M.; Tomaz, M.A.; Fonseca, R.J.C.; Strauch, M.A.; 
Cons, B.L.; Borges, P.A.;  Patrao-Neto, F.C.; Tavares-Henriques, M.S.; 
Teixeira-Cruz, J.M.; Calil-Elias, S.; Cintra, A.C.O.; Martinez, A.M.B.; 
Mour o, P.A.S.; Melo, P.A. Toxicon 2015, 98, 20-33  
 our  o , P.A.S. Mar. Drugs 2015, 13, 2770-2784 
Mour o, P.A.S.; Guimaraes, M.A.M.; Mulloy, B.; Thomas, S.; Gray, E. 
Br. J. Haematol. 1998, 101, 647-652  
Mour o, P.A.S.; Pereira, M.S.; Pav o, M.S.; Mulloy, B.; Tollefsen, 
D.M.; Mowinckel, M.C.; Abildgaard, U. J. Biol. Chem. 1996, 271, 
23973-23984 
Mucci, A.; Schenetti, L.; Volpi, N. Carbohyd. Polym. 2000, 41, 37-45 
 ul ard, L.; Kováč, P.; Glaudemans, C.P. . Carbohyd. Res. 1994, 251, 
213-232 
Mulloy, B.; Mourão, P.A.S.; Gray, E. J. Biotechnol. 2000, 77, 123-135 
Myron, P.; Siddiquee, S.; Al Azad, S. Carbohydr. Polym. 2014, 112, 
173-178 
Nigudkar, S.S.; Demchenko, A.V. Chem. Sci. 2015, 6, 2687-2704 
Panagos, C.; Thomson, D.; Moss, C.; Hughes, A.D.; Kelly, M.S.; Liu, 
Y.; Chai, W.; Venkatasamy, R.; Spina, D.; Page, C.P.; Hogwood, J.; 
Woods, R.J.; Mulloy, B.; Bavington, C.; Uhrin, D. J. Biol. Chem. 2014, 
289, 28284−28298  
Pawar, S.N.; Edgar, K.J. Carbohydr. Polym. 2013, 98, 1288-1296 
P ri on,  .; Lem e , L.; Ferri res, V.; Duval, R.; Plusquellec, D. 
Carbohydr. Res. 2003, 338, 2779−2792  
140 
 
Pomin, V.H. Mar. Drugs 2014, 12, 232-254 
Pomin, V.H.  in Chondroitin sulfate: Structure, use and health 
implications. (Ed. Pomin, V.H.), Nova Science Publishers Inc, New 
York (NY), 2013  
Restaino, O.F.; Cimini, D.; De Rosa, M.; De Castro, C.; Parrilli, M.; 
Schiraldi, C. Electrophoresis 2009, 30, 3877-3883 
Sakairi, N.; Okazaki, Y.; Furukawa, J.; Kuzuhara, H.; Nishi, N.; 
Tokura, S. Bull. Chem. Soc. Jpn. 1998, 71, 679-683  
Sakairi, N.; Nishi, N.; Tokura, S.; Kuzuhara, H. Carbohydr. Res. 1996, 
291, 53-62 
Sakairi, N.; Kuzuhara, H. Carbohydr. Res. 1993, 246, 61-73 
Sakurama, H.; Fushinobu, S.; Masafumi, H.; Yoshida, E.; Honda, Y.; 
Ashida, H.; Kitaoka, M.; Kumagai, H.; Yamamoto, K.; Katayama, T. J. 
Biol. Chem. 2012, 287, 16709−16719  
Santos, G.R.C.; Glauser, B.F.; Parreiras, L.A.; Vilanova, E.; Mourão, 
P.A.S. Glycobiology 2015, 25, 1043-1052 
Schiraldi, C.; Cimini, D.; De Rosa, M. Appl. Microbiol. Biotechnol. 
2010, 87, 1209–1220  
Schmid, U.; Waldmann, H. Chem. Eur. J. 1998, 4, 494−501 
Scott, R.A.; Panitch, A.; Wiley Interdiscip. Rev. Nanomed. 
Nanobiotechnol. 2013, 5, 388-398 
Serna, S.; Yan, S.; Martin-Lomas, M.; Wilson, I.B.H.; Reichardt, N.-C. 
J. Am. Chem. Soc. 2011, 133, 16495−16503  
Sheehan, J.P.; Walke, E.N. Blood 2006, 107, 3876-3882 
Shi, Y.; Meng, Y.; Li. J.; Chen, J.; Liu, Y.; Bai, X. J. Chem. Technol. 
Biotechnol. 2014, 89, 1445–1465 
Sugahara, K.; Yamada, S. Trends Glycosci. Glycotechnol. 2000, 12, 
321-349 
Sugahara, K.; Tanaka, Y.; Yamada, S.; Seno, N.; Kitagawa, H.; 
Haslam, S.M.; Morris, H.R.; Dell, A. J. Biol. Chem. 1996, 271, 26745-
26754 
141 
 
Tamura, J.I.; Tanaka, H.; Nakamura, A.; Takeda, N. Tetrahedron Lett. 
2013, 54, 3940-3943 
Thiem, J.; Elvers, J. Carbohyd. Res. 1978, 60, 63-73 
Ustyuzhanina, N.E.; Bilan, M.I.; Dmitrenok, A.S.; Tsvetkova, E.A.; 
Shashkov, A.S.; Stonik, V.A.; Nifantiev. N.E.; Usov, A.I. Carbohydr. 
Polym. 2016, 153, 399-405  
Ustyuzhanina, N.E.; Fomitskaya, P.A.; Gerbst, A.G.; Dmitrenok, A.S.; 
Nifantiev, N.E. Mar. Drugs 2015, 13, 770-787  
Valoti, E.; Miraglia, N.; Bianchi, D.; Valetti, M.; Bazza, P. US Pat. 
Appl. Publ. 2012, 0295865 
Vermeer, H.J.; van Dijk, C.M.; Kamerling, J.P.; Vliegenthart, J.F.G. 
Eur. J. Org. Chem. 2001, 193−203  
Vinnitskiy, D.Z.; Ustyuzhanina, N.E.; Dmitrenok, A.S.; Shashkov, 
A.S.; Nifantiev, N.E. Carbohydr. Res. 2017, 438, 9-17  
Wada, J.; Honda, Y.; Nagae, M.; Kato, R.; Wakatsuki, S.; Katayama, 
T.; Taniguchi, H.; Kumagai, H.; Kitaoka, M.; Yamamoto, K. FEBS 
Lett. 2008, 582, 3739−3743  
Wu, M.; Wen, D.; Gao, N.; Xiao, C.; Yang, L.; Xu, L.; Lian, W.; Peng, 
W.; Jiang, J.; Zhao, J. Eur. J. Med. Chem. 2015, 92, 257-269  
Wu, M.; Xu, S.; Zhao, J.; Kang, J. Ding, H. Food Chem. 2010, 122, 
716-723  
Yamada, S.; Sugahara, K. Curr. Drug Discovery Technol. 2008, 5, 
289–301 
Yang, J.; Wang, Y.; Jiang, T.; Lv, L.; Zhang, B.; Lv, Z. Int. J. Biol. 
Macromol. 2015, 72, 699-705 
Zhao, L.; Wu, M.; Xiao, C.; Yang, L.; Zhou, L.; Gao, N.; Li, Z.; Chen, 
J.; Chen, J.; Liu, J.; Qin, H.; Zhao, J. Proc. Natl. Acad. Sci. U.S.A. 
2015, 112, 8284-8289 
Zhao, L.; Lai, S.; Huang, R.; Wu, M.; Gao, N.; Xu, L.; Qin, H.; Peng, 
W.; Zhao, J. Carbohydr. Polym. 2013, 98, 1514-1523  
Zhu, X.; Schmidt, R.R. Angew. Chem. Int. Ed. 2009, 48, 1900-1934
 
  
CHAPTER 3 
 
DEPOLYMERIZATION OF SEMI-SYNTHETIC 
FUCOSYLATED CHONDROITIN SULFATE AND 
INTERACTION WITH SELECTINS 
  
145 
 
CHAPTER 3 
 
DEPOLYMERIZATION OF SEMI-SYNTHETIC 
FUCOSYLATED CHONDROITIN SULFATE AND 
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3.1 Introduction 
The biological activities of GAGs require to specify their composition 
in order to identify which is responsible for any of their distinct 
properties. (Toida et al., 2009) For example, a pentasaccharide 
sequence of heparin, responsible for binding with antithrombin, was 
discovered after studies on heparin oligosaccharides. (Munoz et al., 
2004) Moreover, low molecular weight heparins (LMWHs) have been 
used to replace the unfractionated one as anticoagulant and 
antithrombotic drugs due to their reduced side effects. (a) Hirsh et al., 
2004. b) Linhardt 2003. c) Green et al., 1994. d) Matsch et al., 1990. e) 
Monreal et al., 1990.) Among glycosaminoglycans, fucosylated 
chondroitin sulfate is considered as a potential substitute of heparin 
for its anticoagulant and antithrombotic properties acting with both 
a serpin-dependent mechanism and a serpin-independent one, which 
could make fCS active also on cases for which heparin fails. (a) Wu 
et al., 2015. b) Pomin 2014. c) Glauser et al., 2008) However, fCS 
could also cause undesirable effects, such as platelet aggregation, 
factor XII activation and bleeding. (Li et al., 2016) Depolymerized 
fucosylated chondroitin sulfate still display high antithrombotic activity 
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but with less side effects, similarly to the case of unfractionated heparin 
(UFH) and LMWHs (a) Buyue et al., 2009. b) Kitazato et al., 2003. b) 
Kenji et al., 1996.) 
Different methods of GAGs depolymerization, characterized by 
specific advantages and limitations, have been developed up to now. 
(Panagos et al., 2016) Enzymatic depolymerization is the most 
widespread method, nonetheless its high cost and lack of action on 
highly sulfated GAGs limit its use. (Vieira et al., 1991) The 
employment of ultrasound represents, to the best of our knowledge, the 
only mechanical strategy to obtain depolymerized hyaluronic acid 
(Miyazaki et al., 2001) or LMWH oligosaccharides. (Achour et al., 
2013) 
Acid-catalyzed hydrolysis is, instead, a chemical approach for 
polysaccharide depolymerization. In theory, this strategy of 
depolymerization could be suitable for large-scale preparation of low 
molecular fCSs, nonetheless it can easily lead to loss of fucose 
branches or to desulfation, thus influencing the anticoagulant and the 
antithrombotic activity of the depolymerized fCS. (Li et al., 2016)  
Free-radical depolymerization of GAGs using a Fenton-type reaction is, 
among the chemical methods, the most widely used one (a) Li et al., 
2016. b) Liu et al., 2016. c) Panagos et al., 2014. d) Panagos et al., 
2012. Wu et al., 2010.) because it guarantees reproducibility, constant 
composition and control of the extent of depolymerization. (Petit et al., 
2006) 
Since GAGs are characterized by the presence of uronic acid units, they 
could be also submitted to β-elimination of the substituent at O-4 
position, thus breaking the 14 glycosidic bond and forming Δ4,5 
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unsaturated uronic acid residues at non-reducing end of the resulting 
fragments. (Gao et al., 2015)   
In order to evaluate the anticoagulant and the antithrombotic activity of 
fucosylated chondroitin sulfate depolymerized by radical reaction, 
native fCS polysaccharides have been recently extracted from 
Cucumaria frondosa, Thelenota ananas, (Liu et al., 2016) Isostichopus 
badionotus (Li et al., 2016) and Holoturia forskali (Panagos et al., 
2014) and submitted to copper (II) Fenton-type depolymerization as 
described by Wu in 2010, or with suitable modifications thereof. The 
results displayed different activities between depolymerized fCS from 
H. forskali and the other sea cucumbers. 
Since heparin is involved in inhibition of P- and L-selectin binding to 
sialyl Lewis(x) carbohydrate determinant, reducing metastasis and 
inflammation, the fCS polysaccharides extracted from L. grisea (Borsig 
et al., 2007) and from H. forskali were studied for this action as well. 
(Panagos et al., 2014) Natural fCS displayed more potent inhibition 
than heparin in the P- and L-selectin-sialyl Lewis(x) interaction due to 
the presence of fucose branches, that resemble motifs present in sialyl 
Lewis(x) ligand. (Borsig et al., 2007) No inhibition of E-selectin was 
observed, whereas defucosylated polysaccharide abolished this effect 
both in vitro and in vivo, as described for the above-mentioned 
anticoagulant and antithrombotic activities. (a) Pacheco et al., 2000. b) 
 our  o et al., 1996.) Interestingly, fCS oligosaccharides prepared from 
H. forskali by a Fenton-type depolymerization maintained a high 
affinity for P- and L-selectins, but displaying lower adverse effects than 
native fCS. 
In order to evaluate the same inhibition activity of depolymerized 
fucosylated chondroitin sulfate from natural sources, it was planned to 
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submit semi-synthetic fCS polysaccharide (fCS-XII, see Chapter II), 
showing a sulfation pattern different from natural ones to β-eliminative 
depolymerization (Gao et al., 2015) to give a oligosaccharide to be 
tested for its interaction with P- and L-selectins by “ligand-based” 
NMR techniques such as Saturation Transfer Difference (STD). (a) 
Marchetti et al., 2016. b) Lepre et al., 2004. c) Mayer et al., 2001.) This 
one is the widespread method for detection and characterization of 
transient receptor-ligand interactions in solution, due to its efficiency to 
determine the binding epitope of ligands, detecting the region in closer 
contact to the receptor protein. 
A STD spectrum is obtained by the difference between on- and off-
resonance experiments (Figure 26). (Angulo et al., 2011)  
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Figure 26: Schematic representation of STD NMR spectroscopy 
 
 
In the former, selective RF (radio frequency)-pulse train is set for a 
given time (saturation time) to a region of the spectrum with only 
resonances from protein (-4 ppm), whereas the latter is a reference 
spectrum, where saturation rf is applied in an off resonance region from 
both receptor and ligand. 
Once saturated, the receptor transfers the saturation to ligand through 
the 1H-1H cross relaxation pathway, obtaining a difference (STD) 
spectrum that allows to determine the existence of interactions in 
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solution and the binding epitope of ligands, detecting the regions in 
closer contact with the receptor 
 
 
3.2 Results and discussion 
The presence on fCS backbone of uronic acid units led to choose a β-
elimination (Gao et al., 2015) as a suitable depolymerization method. 
Indeed, commercial LMWHs have been obtained by controlled 
chemical or enzymatic β-eliminative depolymerization. (a) Gao et al., 
2015. b) Hirsh et al., 1992.) To this purpose, semi-synthetic fCS-XII 
was firstly subjected to an ion exchange in the presence of 
benzethonium chloride, in order to change the Na+ counterion at 
carboxylate and sulfate groups. The obtained derivative 47 was 
modified at its carboxylic functions through a benzylation reaction with 
benzyl chloride (BnCl) at 35°C, in order to obtain a derivative more 
soluble in aprotic solvent, and that could give more easily a 
depolymerization at the subsequent step. (Gao et al.,2015) Ester 48 was 
obtained in 36% yield with the DS = 0.39 (Figure 27) as evaluated by 
comparison of integration between signals δH = 5.38 and 5.21 ppm 
region (H-1 protons and CH2 atoms) and the CH3 ones (δ = 1.23) of 
fucose branches and then applying the following equation:  
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Figure 27: 1H spectrum of 48 (600 MHz, D2O, 298 K) 
 
 
After a second transalification, the polysaccharide derivative was 
dissolved in DMF and treated with a 0.04 M solution of EtONa in 
ethanol for 30 minutes at rt and then subjected to global alkaline 
deprotection to remove benzyl ester groups and afford dfCS (Scheme 
15).  
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Scheme 15: (a) HyCl, H2O, rt, quant.; (b) BnCl, DMF, 35°C, 
overnight, 36%, DSbenzylation = 0.39; (c) HyCl, H2O, rt; (d) 0.04 M 
EtONa in EtOH, DMF, rt, DS = 0.23; (e) NaOH, H2O, rt, 19% after 
three steps, DS = 0.24 
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After a dialysis and size-exclusion chromatography pure dfCS was 
obtained with a 19% yield and a DS = 0.24 that was evaluated 
comparing the integration of H-4 of unsaturated GlcA (δH = 5.86 ppm) 
and acetyl of GalNAc (δH = 2.05-1.99 ppm).  
In order to investigate the structure of the depolymerized derivatives, a 
detailed 2D-NMR (HSQC-DEPT and HSQC-TOCSY) analysis was 
conducted. HSQC-DEPT spectrum of dfCS (Figure 28) displayed two 
cross peaks (δH/C = 5.22/99.2 and 5.70/99.1 ppm, respectively) in the 
typical region for anomeric CH of a α-linked sulfated Fuc units. Thus, 
two different α-linked Fuc branches linked either at O-6 or at O-4 of 
GalNAc units (see also Chapter II) were still present after the 
depolymerization route, as well as the sulfate groups on fucose (δH = 
4.44 and 4.68 ppm, for H-2 and H-4, respectively) and on GalNAc 
units (δH/C = 4.74/78.9 and 4.21/69.8 ppm for sulfation at CH-4 and 
CH-6, respectively). Moreover, HSQC-DEPT spectrum displayed three 
integral intensities of cross-peaks in the alkene region (δH/C = 
6.02/108.7, 5.96/108.7 and 5.86/109.6 ppm, respectively), that might be 
attributed to three different unsaturated GlcA units probably accounting 
for GlcA units at non reducing terminal linked to 4-O-, 6-O- or non-
fucosylated GalNAc units (Table 21).  
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Figure 28: Zoom of 1H-13C HSQC-DEPT spectrum of dfCS (800 
MHZ, D2O, 298 K)  
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Table 21: 1H (plain) and 13C (italic) chemical shift attribution of dfCS 
(800 MHz, D2O, 298 K)
  
 
Residuea 1 2 3 4 5 6 Other 
signals 
GlcA 4.48 
106.5 
3.36 
74.6 
3.58 
76.1 
3.73 
84.0 
3.65 
79.1 
--- --- 
GalNAc4S  
 
 
 
 
 
4.59-
4.51 
 
103.9-
103.7 
 
 
 
 
4.05- 
3.97 
 
54.0- 
53.1 
4.01 
77.9 
 
 
 
 
4.73 
78.8 
3.87 
74.3 
3.70
-
3.80 
 
63.4 
Ac 
2.05-
1.99 
25.0 
αFuc2,4S-
(16)-
GalNAc4S 
n.d.b n.d.b 3.72
- 
3.55 
 
65.0 
Ac 
2.05-
1.99 
25.0 
GalNac6S 3.82 
82.4 
4.16 
69.7 
3.89 
75.0 
4.21 
69.8 
Ac 
2.05-
1.99 
25.0 
αFuc2,4S-
(14)- 
GalNAc6S 
3.76 
82.8 
n.d.b 3.98 
75.2 
4.20 
69.8 
Ac 
2.05-
1.99 
25.0 
αFuc2,4S-
(16)-
GalNAc 
5.23 
99.2 
4.44 
77.2 
4.13 
68.8 
4.68 
83.1 
4.22 
68.6 
1.27 
18.2 
--- 
αFuc2,4S-
(14)- 
GalNAc 
5.70 
99.1 
4.44 
77.2 
n.d.b n.d.b 4.16 
68.9 
1.26 
18.1 
--- 
ΔGlcAI n.d.b n.d.b n.d.b 6.02 
108.7 
--- --- --- 
ΔGlcAII n.d.b n.d.b n.d.b 5.95 
109.0 
--- --- --- 
ΔGlcAIII 5.18 
103.7 
4.09 
68.2 
3.77 
72.0 
5.86 
109.6 
--- --- --- 
Chemical shift expressed in δ. 
a Indicated by italic characters. 
b Not determinable 
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The depolymerised fCS derivative was subjected to STD experiments 
in collaboration with Dr. Dusan Uhrin research group of University of 
Edinburgh, in order to evaluate its interaction with L- and P-selectins. 
A preliminary analysis was performed on NMR data obtained from 
dfCS demonstrated the contact with L-selectin. By comparison of STD 
spectrum with the 1H-NMR reference spectrum (Figure 29) it was 
possible to suggest the ligand protons that are in the proximity of the 
protein. 
 
Figure 29: Reference 1H-NMR spectrum (bottom) and STD 1D NMR 
spectrum (top) of mixture L-selectin-dfCS. 
 
 
It can be seen that larger STD signals observed belong to CH3 of Fuc 
branches and for Ac of GalNAc, that was present also in the L-selectin 
spectrum, indicating small distances between those ligand protons and 
the receptor surface in the bound state. The data obtained by comparing 
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the relative percentages of saturation received by the diferent ligand 
moieties showed that signal enhancements belonging to GlcA units 
were also present, although these protons received lower transfer of 
magnetization from the protein and thus their individual contributions 
were weaker (see epitope group mapping Figure 30). 
 
 
Figure 30: Chemical structure and epitope binding of dfCS to L-
selectin. 
 
 
Due to the overlapping of signals of diferent units other experiments 
are in progress to beter understand the ligand structure that binds the 
protein. In the case of P-selectin the same experiment was carried out 
and the analysis was performed on the obtained NMR data by 
comparison of STD spectrum with its coresponding reference (Figure 
31). 
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Figure 31: Reference 1H-NMR spectrum (bottom) and STD 1D NMR 
spectrum (top) of mixture P-selectin-dfCS. 
 
 
Larger STD signals were observed in this case for CH3 of Fuc branches 
and for H-2 of GlcA, indicating small distances between those ligand 
protons and the receptor surface in the bound state. The data obtained 
by comparing the relative percentages of saturation received by the 
different ligand moieties showed that signal enhancements belonging to 
Ac of GalNAc, that was present also in the P-selectin spectrum, and to 
H-3 GlcA units were also present, with these protons received high 
transfer of magnetization from the protein and thus their individual 
contributions were strong. (see epitope group mapping Figure 32). 
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Figure 32: Chemical structure and epitope binding of dfCS to P-
selectin. 
 
 
Due to the overlapping of signals of different units, the integrals and 
then percentages are only approximate. Indeed, other experiments are 
in progress to beter understand the ligand structure that binds the 
protein. 
 
 
3.3 Conclusions 
In this chapter, a preliminary strategy for non-degradative β-eliminative 
depolymerization on semi-synthetic fucosylated chondroitin sulfate has 
been reported. Although STD-NMR studies revealed the binding of 
oligosaccharide backbone of dfCS, even if with a slightly smaler 
afinity relative to the that obtained for oligosaccharides prepared from 
the native polysaccharide, (data not shown, personal communication 
Dusan Uhrin). High heterogeneity of the semi-synthetic derivative did 
not alow an exact evaluation of which parts of the ligand are more 
involved in the interaction process. Thus, in order to beter understand 
the relationship between structure and L- and P-selectins interactions, it 
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will be necessary to obtain a less heterogeneous semi-synthetic fCS 
polysaccharide and, in case, also to design a new depolymerization 
method on fCS. 
 
 
3.4 Experimental section 
 
3.4.1 General methods 
Commercial grade reagents and solvents were used without further 
purification. Centrifugations were performed with an Eppendorf 
Centrifuge 5804 R instrument.  
Dialyses were conducted on Spectra/Por 1.0 kDa cut-off membranes at 
4°C. Size-exclusion chromatography was performed on a Bio-Gel P2 
column (0.75 x 67.5 cm, Bio-Rad) using 50 mM ammonium acetate as 
a buffer at a flow rate of 0.2 mL/min. The column eluate was monitored 
continuously with a Knauer K-2310 refractive index refractometer. 
Freeze-dryings were performed with a 5Pascal Lio 5P4 K freeze dryer. 
The term “pure water” refers to water purified by a  illipore  illi-Q 
Gradient system.  
NMR spectra were recorded on a Bruker AVANCE III-800 (1H: 800 
MHz, 13C: 200 MHz) or on a Bruker AVANCE III-600 (1H: 600 MHz, 
13C: 150 MHz) instruments equipped with a TCI cryo probe, in D2O 
(acetone as internal standard, 1H: (CH3)2CO at δ = 2.22 ppm; 
13C: 
(CH3)2CO at δ = 31.5 ppm). HSQC-DEPT and HSQC-TOCSY 
experiments were measured with 1H-detected mode via single quantum 
coherence with 13C adiabatic decoupling of carbon-proton couplings 
using data sets of 2048 × 1024 points and typically 8 and 24 scans, for 
HSQC-DEPT and HSQC-TOCSY, respectively. Mixing time for 
HSQC-TOCSY was set to 40 ms. Quadrature indirect dimensions were 
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achieved through Echo-Antiecho method; spectra were processed 
applying a cosine square function to both dimensions and data matrix 
was zero-filled by factor of 2 before Fourier transformation. Data 
matrix was doubled and linear prediction applied the new points by 
using 32 coefficients; cosine square functions were used as window 
functions and the phase shift selected depended by the best resolution 
obtained. 
 
 
3.4.2 Synthetic procedure 
Transalification: fCS-XII (68.3 mg, 0.079 mmol) was dissolved in 
pure water (2.72 mL) and treated with a 0.16 M aqueous solution of 
benzethonium chloride (2.72 mL, 0.454 mmol). A white precipitate was 
outright formed, collected by centrifugation and then dessicated under 
vacuum affording compound 47 (255.0 mg, quant.) with the presence 
of benzethonium chloride as contaminant. This reaction was repeated 
under the same conditions on derivative 48 
 
Esterification: Compound 47 (254.6 mg, 0.105 mmol) was dissolved 
in D F (3.40 mL) and treated with BnCl (432.0 μL, 3.75 mmol). After 
overnight stirring at 35°C, the mixture was cooled to rt and treated with 
a 3  aqueous solution of sodium acetate (850 μL) and ethanol (7.66 
mL). The obtained white precipitate was collected by centrifugation 
and dessicated under vacuum affording compound 48 (79.8 mg, 36%).  
 
Depolymerization: Derivative 48 (86.3 mg, 0.041 mmol) was 
suspended in DMF (1.0 mL) and treated with a 0.04 M solution (1.0 
mL, 0.04 mmol) of sodium ethoxide in ethanol. After 30 minutes 
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stirring at rt, the mixture was treated with a 1.21M suspension of 
NaOAc in ethanol (3 mL) and the obtained precipitate was collected by 
centrifugation and dessicated under vacuum affording derivative 49 
(1.321 g) 
 
Global deprotection: Compound 49 was dissolved in pure water (3.0 
mL), treated with a 15% w/v NaOH solution and stirred at rt for 30 
minutes. After neutralization with 1.0M solution of HCl, the mixture 
was treated with ethanol and the obtained precipitate was collected by 
centrifugation and dessicated under vacuum obtaining a white solid 
(4.7 mg). The supernatant, after dialysis, and subsequent freeze-drying, 
yielded a white solid, that was further purified by size-exclusion 
chromatography. Freeze-drying of the collected fractions afforded 
dfCS (7.6 mg, 19% after three steps) 
 
 
3.4.3 STD experiments 
The samples were dissolved in 99.9% D2O (540 μl) containing 
deuterated 10 mM NaH2PO4-Na2HPO4 buffer (pH 7.2) to which a stock 
solution of EDTA (20 μl) and TSP was added. The stock solution was 
prepared by dissolving 4 mg of EDTA and 9 mg of TSP in 200 μl of the 
phosphate buffer. The pH was adjusted to 7.2 by adding few drops of a 
concentrated solution of NaOH in D2O. 
STD NMR experiments on the mixtures were performed with 
protein/ligand molar ratios varying from 1:50 to 1:100 using the 
BRUKER stddiffesgp.3 pulse sequence with water suppression via a 
double-pulsed field gradient spin-echo (2 ms sinc pulses) and the 
following parameters: 8, 4 and 1.36 seconds relaxation, presaturation 
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and acquisition times, respectively. The on- and off-resonance 
irradiation at -4 ppm and 30 ppm. The irradiation was achieved by 78 
repetitions of 50 ms Gaussian pulses applied at B1/2 = 180 Hz. 16 
scans were accumulated per one of 128 averaging cycles using one-
scan alternate accumulation into on- and off-resonance spectra. The 
overall spectrometer was 10.6 hours per experiment. 
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CHAPTER 4 
 
SYNTHESIS, CONFORMATIONAL STUDY AND 
ANTIFREEZE ACTIVITY OF THREONINE 
DECORATED MICROBIAL SOURCED 
CHONDROITIN 
 
4.1 Introduction 
In the last two decades many works were published reporting chemical 
derivatizations of carboxylic function of CS to afford different 
derivatives. (a) Bedini et al., 2016. b) Zhao et al., 2015. c) Scott et al., 
2013. d) Weyers et al., 2013. e) Bedini et al., 2012. f) Schiller et al., 
2010.) Ester modified CS polysaccharide were reported, for example, 
in the attachment of three different non-stereoidal anti-inflammatory 
drugs through a PEG-spacer, that was studied as prodrug systems (Peng 
et al., 2006) or carboxylic acid esterification of GlA units in different 
native fCSs has very recently been accomplished with several alkyl 
bromides. (Wu et al., 2015)  
Moreover carboxy group derivatives have also been used to cross-link 
CS polysaccharide chain into networks that are able to adsorb large 
amount of water and have found several biomedical application in the 
field of tissue engineering and regenerative medicine. (Bedini et al., 
2016) 
Among the derivatization reactions, carboxyl group modification with 
amines or hydrazides is very common. Indeed CS polysaccharide has 
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been coupled through amide linkages with several small biomolecules, 
such as tyramine (a) Ni et al., 2015. b) Jin et al., 2013.), histamine (Yu 
et al., 2014), biotin (Altgärde et al., 2013), and cholesterol (Yu et al., 
2013) among others. Moreover, biomacromolecules, such as tissue 
proteins and hyaluronic acid, were coupled too. (a) Yan et al., 2013. b) 
Yu et al., 2013. c) Daamen et al., 2003. d) Kuipers et al., 2000.) 
Nonetheless, to the best of our knowledge no systematic study of how 
the activation conditions of the carboxylic acid of chondroitin or CS 
influence the degree of substitution has been done yet. Furthermore, a 
very variable DS for amidation of such polysaccharides has been 
obtained, with values ranging from 0.01 to 0.88. (Bedini et al., 2016)  
Colwellia psychrerythraea 34H is a psychrophilic Gram-negative 
bacterium found in Arctic marine sediments (Ewert et al., 2013) that 
produces extracellular polysaccharides (a) Methé et al., 2005. b) 
Huston et al., 2004.) with cryoprotectant function and apparent ice-
affinity (a) Ewert et al., 2011. b) Marx et al., 2009.) The adaptation of 
bacteria to low temperature can be regulated by several different 
mechanism, such as the production of cold-active enzymes (Huston et 
al., 2004), as well as, antifreeze proteins (AFPs), antifreeze 
glycoproteins (AFGPs) and cryoprotectants. (Deming, 2009) It has 
been found that C. psychrerythraea 34H antifreeze activity is driven by 
an original, alternative mechanism due to the production of 
polysaccharides with ice recrystallization inhibition activity. (a) Casillo 
et al., 2017. b) Carillo et al., 2015.) One of them, a capsular 
polysaccharide (CPS), is characterized by a GAG-like linear 
tetrasaccharide repeating unit composed of alternating uronic acids and 
N-acetyl-hexosamines (GlcA, GalA, GalNAc and GlcNAc), with a Thr 
decoration on GalA to complete the structure (Figure 33). The CPS was 
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suggested to confer the cryoprotectant activity to the bacterium. 
(Carillo et al., 2015) 
Anti-freeze molecule applications can range from cell, tissue, organ and 
frozen food cryopreservatives as well as cryosurgical aids. The design 
of recrystallization inhibitors that mimic the structure of antifreeze 
natural products is a challenging field in synthetic organic and polymer 
chemistry. Both total synthetic small molecules and macromolecules 
were obtained and then tested for this activity. (a) Balcerzak et al., 
2014. b) Gibson, 2010.) The GAG-like structure of the CPS from C. 
psychrerythraea 34H suggested to regioselectively decorate unsulfated 
chondroitin polysaccharide with a Thr on GlcA units and then assay its 
antifreeze activity. To this aim a semi-synthetic approach was applied 
(Laezza et al., 2017) taking advantage of the high availability of pure 
unsulfated chondroitin from the fed-batch fermentation of Escherichia 
coli K4 followed by a suitable downstream purification. (Cimini et al., 
2010) This polysaccharide was employed, as previously reported in 
Chapter II, as starting material for the obtainment of non-animal 
sourced CS and fucosylated CS polysaccharides through tailored semi-
synthetic strategy (a) Laezza et al., 2016. b) Laezza et al., 2015. c) 
Laezza et al., 2014. d) Bedini et al., 2012. e) Bedini et al., 2011.) In this 
case, it was employed to study the different conditions of carboxylic 
acid activation in order to achieve the highest possible DS of Thr 
decoration of the chondroitin polysaccharide backbone and to evaluate 
the relationship between structure and anti-freeze activity. 
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Figure 33: Repeating units of CS, unsulfated chondroitin (top) and 
CPS from C. psychrerythraea 34H (botom) 
 
 
4.2 Results and discussion 
 
4.2.1 Threonine decoration of chondroitin polysaccharide 
Amide bond formation relies on the activation of carboxylic function. 
By limiting to the most common ones, carboxylic acid activators can be 
classified according to their structure into phosponium (Coste, 2002) 
and uronium/guanidinium salts (Bienert et al., 2002) (that were recently 
applied in order to reduce side reactions of amidation), carbodimides 
(a) Wiliams et al., 1981. b) Mikolajczyk et al., 1981.) and triazines (a) 
Borke et al., 2015. b) D’Este et al., 2014.) 
By looking for example of amidation reactions of GAGs in literature it 
was found that hyaluronic acid was coupled with amines after a GlcA 
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carboxylic function activation not only with EDC/NHS, but also with 
DMTMM (a) D’Este et al., 2014. b) Gemma et al., 2007.) or other 
triazine species, displaying DSs far from a quantitative value. (Borke et 
al., 2015) Moreover, amidation of carboxylic function of GlcA units in 
CS was performed with EDC, or more rarely DCC in the presence or 
not of a protic additive such as HOBt or NHS. (Bedini et al., 2016) Our 
first attempt to decorate microbial sourced chondroitin polysaccharide 
employed threonine methyl ester 50 (Devedjiev et al., 2008) in the 
presence of EDC and NHS in MES buffered water (pH = 6) (Scheme 
16). After overnight reaction at rt, ester cleavage was conducted one-
pot by adding sodium hydroxide. Dialysis and subsequent freeze-drying 
furnished polysaccharide 51-I in 86% mass yield (Table 22), that was 
subjected to 1H NMR analysis for evaluation of Thr amide DS. By 
integration of the CH3 signal of Thr moiety (δH = 1.20 ppm) with 
respect to acetyl one (δH = 2.01 ppm), a 0.14 value was obtained 
(Figure 34). In order to understand the structure-function relationship 
between Thr decoration and antifreeze activity, it was necessary to 
enhance the DS of coupling reaction. Since amidation in the presence 
of phosponium and uronium/guanidinium salts were usually performed 
in DMF, chondroitin was firstly converted into its TBA salt using 
aqueous TBAOH according to a known procedure (Valoti et al., 2012), 
in order to obtain a more soluble polysaccharide in such solvent. A 
clear solution of chondroitin-TBA salt in DMF was then treated at rt 
with a phosphonium salt activator such as pyBOP® in the presence of 
HOBt and DIPEA as a base. The amide coupling was alternatively 
conducted with an uronium salt activator such as TBTU and 2,4,6-
collidine as base. Successive one-pot cleavage of Thr methyl ester, 
dialysis, and freeze-drying, afforded polysaccharides, for which the 
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integration of their 1H-NMR signals alowed DS evaluation. In 
pyBOP®/HOBt case (51-II, Scheme 16) only a slightly increase of DS 
(0.19) with respect to EDC/NHS reaction was observed, whereas a 
much significant enhancement was obtained for polysaccharide 51-III 
(DS = 0.43), nonetheless the coupling reaction was stil very far from 
afording a quantitative Thr decoration. 
 
 
Scheme 16: (a) see ref. Valoti et al., 2012; (b) α,α-dimethoxytoluene, 
CSA, DMF, 80°C, overnight, quant., DS = 1; (I) 1: EDC, NHS, MES, 
H2O, rt, overnight, 2: NaOH, H2O, rt, 86%, DS = 0.14; (II) 1: pyBOP®, 
HOBt, DIPEA, DMF, rt, overnight, 2: NaOH, H2O, rt; 69%, DS = 0.19; 
(II) 1: TBTU, 2-4-6-colidine, DMF, rt, overnight, 2: NaOH, H2O, rt, 
76%, DS = 0.43; (IV) TBTU, 2-4-6-colidine, DMF, rt, overnight, (c) 1: 
NaBrO3, Na2S2O4, H2O-ethyl acetate, rt, overnight, 2: NaOH, H2O, rt, 
51%, DS = 1 
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Table 22: Yield and DS of threonine decorated chondroitin 
polysaccharides 
 
Polysaccharide Mass yield DS 
51-I 86% 0.14 
51-II 69% 0.19 
51-III 76% 0.43 
51-IV 51% 1.00 
 
 
 
 
Figure 34: 1H-NMR spectra (600 MHz, D2O, 298 K) of 
polysaccharides 51-I-IV(I = Integral area) 
 
 
It was hypothesized that low DS values could be due to a strong 
network of hydrogen bonds between carboxylic functions and hydroxyl 
groups of chondroitin, that should be rather efective especialy in an 
aprotic solvent such as DMF. This could impede the activation of 
carboxylic acids in every GlcA unit of the polysaccharide chain. To 
minimize this efect, the protection of some hydroxyl groups of 
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chondroitin was planned by employing a benzylidene ring that was 
installed at 4,6-diol of GalNAc units by reaction with α,α-
dimethoxytoluene in the presence of CSA as acid catalyst, as already 
reported in Chapter II. (Bedini et al., 2011) This chondroitin derivative 
was then subjected to amide coupling with 50 under the activation 
condition that performed best on the unprotected polysaccharide 
(TBTU/2,4,6-collidine). The derivative 52 was then isolated by 
precipitation after addition of diisopropyl ether, as suitable solvent, to 
the reaction mixture. Its 1H-NMR spectrum could not give an exact DS 
evaluation, as methyl signal of linked Thr amide moiety (δH = 1.09 
ppm) partially overlapped with the same kind of signal from free Thr 
amine 50 (δH = 1.02 ppm), that co-precipitated with 52. A global 
deprotection of  52 was performed in two steps, by firstly treating it 
with NaBrO3 and Na2S2O4 in H2O-ethyl acetate mixture to cleave 
oxidatively the benzylidene ring (Adinolfi et al., 1999) affording a 
polysaccharide with Bz esters at position either O-4 or O-6 of GalNAc 
units (Bedini et al., 2011), that were then hydrolysed under alkaline 
aqueous conditions together with Thr methyl ester to give 
polysaccharide 51-IV. To our delight, integration of its 1H-NMR 
spectrum showed a quantitative decoration (DS = 1.00) of GlcA with 
Thr amides (Figure 34). Attribution of chemical shift values of 
polysaccharide 51-IV (Table 23) was possible by analysis of 13C and 
two-dimensional NMR spectra (COSY, TOCSY, NOESY, HSQC-
DEPT) and their comparison with the data reported in the literature for 
unsulfated chondroitin. (Mucci et al., 2000) In particular, the integral 
intensity of cross-peak at δH/C 4.21/61.0 ppm in the HSQC-DEPT 
spectrum (Figure 35) could be associated to the CH group at position α 
of Thr units linked through an amide bond to GlcA carboxylic moieties. 
177 
 
Table 23: 1H (plain) and 13C NMR (italic) chemical shift attribution of 
51-IV 
 
Residue 1 2 3 4 5 6 Other  
 Signals 
GlcA 4.62 
105.0 
3.35 
72.9 
3.62 
74.2 
3.94 
77.1 
4.05 
68.7 
-- 
170.3 
-- 
 
GalNAc 4.42 
100.0 
3.99 
51.6 
3.80 
81.6 
4.07 
74.5 
3.60 
75.6 
3.76-
3.67 
61.7 
NHCOCH3: 
175.7 
NHCOCH3: 
2.01, 23.1  
 α β γ     
COOH: 176.9 Thr 4.21 
61.7 
4.30 
68.4 
1.20 
19.9 
   
NMR experiments conducted in D2O (600 MHz, 298 K). 
Chemical shifts expressed in δ relative to internal acetone [1H: (CH3)2CO at δ =  
2.22 ppm; 13C: (CH3)2CO at δ = 30.9 ppm].  
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Figure 35: 1H and 1H-13C HSQC-DEPT NMR spectra (600 MHz, D2O, 
298 K) of polysaccharide 51-IV 
 
 
4.2.2 Conformational study  
With the aim of determining the three-dimensional arrangement of 51-
IV, an in-depth analysis of their NMR spectra has been performed. The 
NOE connectivities in the NOESY spectra between 1,3-diaxial protons 
[H-1/H-3/H-5 and H-2/H-4 for GlcA(Thr) and H-1/H-3/H-5 for 
GalNAc], unambiguously indicated that both sugar moieties assume the 
classical 4C1 chair conformation. NOESY spectra also showed 
interesting inter-residue NOEs that are diagnostic for the determination 
of the spatial evolution of the polysaccharide. Particularly, strong 
NOEs between H-1 of GlcA(Thr) and H-3 of GalNAc, and between H-
1 of GalNAc and H-4 of GlcA(Thr) indicate the relative spatial 
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orientation of the sugars. The lack of long-range NOEs suggests that 
the overall structure of the polysaccharide is fairly linear. This 
structural information was employed to construct a simplified model of 
the semi-synthetic chondroitin polysaccharide [made up by six 
repetitions of the GlcA(Thr)-GalNAc disaccharide subunit] through 
NMR-restrained simulated annealing (SA) calculations (this work was 
made in collaboration with the group of Prof. Antonio Randazzo at the 
Department of Pharmacy of the University of Naples Federico II). An 
ensemble of 400 isoenergetic structures was calculated featuring for all 
the considered distances a maximum violation of 0.12 Å. Subsequently, 
different conformations of this ensemble were clustered considering the 
position of the sugar ring atoms belonging to the central 4 disaccharide 
subunits with a root-mean-squared difference (rmsd) value of 1.5 Å. 
Clustering of the obtained 400 conformations resulted in 38 different 
conformational families among which cluster 3 represented the 25% of 
the total ensemble demonstrating a good convergence of our 
calculations toward a well-defined structure. For this cluster, the 
representative conformation was considered (i.e. the one closest to the 
centroid of the cluster) for further 310 K molecular dynamics (MD) 
simulations aimed at inspecting the thermodynamic stability in explicit 
solvent. From these calculations (NMR-restrained SA and MD 
simulations), it was clear that the structure adopts a fairly linear 
conformation which is stable over time as demonstrated by plotting of 
the rmsd values during the last 10 ns of the production run. This 
conformation is stabilized by the formation of a series of inter-residue 
H-bond interactions, which are pretty conserved along the 
polysaccharide structure (Figure 36). Interestingly, the calculated 
conformation does recall neither the “zigzag” arrangement of the C. 
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psychrerythraea Thr-decorated CPS (Carillo et al., 2015) nor the 
helical conformation very recently detected for the exopolysaccharide 
(EPS) secreted by the same bacteria and displaying alanine (Ala) amide 
groups on GalA units. (Casillo et al., 2017) Interestingly, the presence 
of a pseudo-helical conformation in EPS allowed entrapping water 
molecules in discrete clefts, where no tetrahedral arrangement was 
detected thereby disfavouring the formation of ice crystals. From these 
considerations, it might be suggested that the linear structure of the 
semi-synthetic Thr-decorated chondroitin polysaccharide 51-IV might 
not be conducive to an antifreeze property. 
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Figure 36: Front (A) and zoomed (B) view of the representative 
structure of the inspected polysaccharide as calculated by restrained SA 
calculations. GlcA(Thr) and GalNAc are represented as green and 
purple sticks. H-bonds are represented as dashed blue lines. C) rmsd 
fluctuations of the studied of the polysaccharide heavy atoms, along the 
last 10 ns of the MD simulation with respect to the conformation 
reported in (A) 
 
 
4.2.3 Antifreeze activity and molecular weight 
determination 
In order to assess the cryoprotective effect of the Thr decorated 
polysaccharides, ice recrystallization inhibition (IRI) activity was 
measured. Antifreeze proteins, antifreeze glycoproteins and several 
synthetic polymers have been shown to be potent ice recrystallization 
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inhibitors. (a) Congdon et al., 2013. b) Gibson, 2010) IRI has been 
linked to survival in frozen environments and can be applied to cellular 
cryopreservation. (Deller et al., 2014) In order to test the IRI activity, a 
modified ‘splat’ assay was used. (Knight et al., 1988) Briefly, 10 μL 
droplets of the polysaccharide in PBS was dropped down a tube onto a 
cooled (∼−70 °C) glass cover slip, and then transferred to a microscope 
set at −6 °C. After 30 min, the mean largest grain size (MLGS) was 
measured and reported relative to a PBS control. It is important to note 
that in this assay, MLGS values below ∼ 20% indicate zero growth (as 
the initial crystals cannot have zero size). The IRI activity of the 
polysaccharides is reported in Figure 37 alongside a negative control 
(PEG) and another polysaccharide, dextran (Mw ~ 40 kDa). Compared 
to PEG, the polysaccharides do have some moderate IRI activity, 
reducing the grain size by up to 40 % compared to PBS alone. The 
activity seems similar to Dextran, which is only a very weak IRI; 
however it should be noted that IRI activity has been observed in nearly 
all systems to increase with molecular weight of the species tested here. 
It was determined by means of the SLS (Schmitz, 1990) in 
collaboration with the group of Prof. Luigi Paduano at the Department 
of Chemical Sciences of the University of Naples Federico II and the 
species that were 35.1±1.7 kDa, 22.4±1.1 kDa and 16.9±0.8 kDa, 
respectively for 51-II-IV. Interestingly, there is a trend that as the 
threonine content increases, the IRI activity is reduced. There have 
been several examples of Thr- and/or Ala-rich (glyco)proteins and 
polysaccharides acting as antifreeze agents in Nature (a) Carillo et al., 
2015. b) Lin et al., 2011. c) Graether et al., 2000) It is clear that Thr 
decorations alone is insufficient for introduce potent IRI activity, and is  
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the observed activity is slightly less than the EPS from C. 
psychrerythraea. 
 
Figure 37: IRI activity of the chondroitin polysaccharide 51-II-IV 
(0.19, 0.43 and 1.00 indicate the DSs of Thr amidation), PEG (negative 
control) and dextran (positive control). Mean largest grain size is 
expressed as a percentage of PBS bufer, and smal MLGS values 
indicate increased IRI activity 
 
 
4.3 Conclusions 
A semi-synthetic mimic of the antifreeze CPS from C. psychrerythraea 
was obtained after decoration of carboxylic function of microbial 
sourced chondroitin with Thr amides. To this aim, several amide 
coupling conditions were screened in order to obtain a quantitative DS 
for Thr decoration. The lower DSs (0.14-0.43) were obtained by 
performing the reaction on underivatized chondroitin, whichever the 
kind of carboxylic acid activator (carbodimide-, phosphonium- or 
uronium-type) was employed, whereas a quantitative DS was displayed 
by performing the reaction on a partialy protected polysaccharide 
derivative. This result was ascribed to a weakening of the hydrogen 
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bond network acting in DMF – the solvent used for the amidation 
reaction – after masking some hydroxyls of the polysaccharide with 
protecting groups.  
The three-dimensional arrangement of the Thr-decorated 
polysaccharide was then investigated by NOESY NMR and SA and 
MD simulations, determining a stable, fairly linear conformation. This 
was rather different from the “zigzag” arrangement determined for the 
CPS from C. psychrerythraea. (Carillo et al., 2015) This difference 
explained the much lower ice recrystallization inhibition activity 
measured for the semi-synthetic polysaccharide with respect to the 
natural one. Indeed, the absence of discrete clefts in the linear structure 
of the former does not allow the entrapment of water molecules in a 
non tetrahedral arrangement in the first hydration shell, that disfavors 
the formation of ice crystals. Therefore, this work demonstrates that in 
spite of several examples of Thr- and/or Ala-rich (glyco)proteins and 
polysaccharides acting as antifreeze agents in Nature (a) Carillo et al., 
2015. b) Lin et al., 2011. c) Graether et al., 2000.), the presence of a 
high number of Thr decorations on the biomacromolecule is not a 
sufficient element for gaining ice recrystallization inhibition activity. 
However, it is worth noting that also the presence of a polysaccharide 
structure with discrete clefts such as in a pseudo-helical conformation 
has been recently demonstrated to be not a sufficient condition alone 
for IRI activity. Indeed, a very recently discovered Thr/Ala free CPS, 
still isolated from C. psychrerythraea and displaying a helical structure, 
does not show any antifreeze activity. (Casillo et al., 2017) 
This finding will help future investigations towards the development of 
(semi-)synthetic polymer mimics of natural antifreeze agents to be 
applied in the cryopreservation field. 
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4.4 Experimental section  
 
4.4.1.General methods 
Commercial grade reagents and solvents were used without further 
purification, except where differently indicated. The term “pure water” 
refers to water purified by a Millipore Milli-Q Gradient system. 
Centrifugations were performed with an Eppendorf Centrifuge 5804R 
instrument at 4°C (4600 g, 10 min). Dialyses were conducted on 
Spectra/Por 3.5 kDa cut-off membranes at 4°C. Size-exclusion 
chromatographies were performed on a Bio-Gel P2 column (0.75 x 
67.5 cm, Bio-Rad) using 50 mM ammonium bicarbonate as a buffer at 
a flow rate of 0.2 mL/min. The column eluates were monitored 
continuously with a Knauer K-2310 refractive index refractometer. 
Freeze-dryings were performed with a 5Pascal Lio 5P 4K freeze dryer. 
NMR spectra were recorded on a Bruker DRX-600 (1H: 600 MHz, 13C: 
150 MHz) instrument equipped with a cryo probe, in D2O (acetone as 
internal standard, 1H: (CH3)2CO at δ 2.22 ppm; 
13C:(CH3)2CO at δ 31.5 
ppm) or DMSO-d6 (
1H: CHD2SOCD3 at δ 2.49 ppm; 
13C: CD3SOCD3 
at δ 39.5 ppm). Gradient-selected COSY, phase sensitive NOESY, and 
TOCSY experiments were performed using spectral widths of 6000 Hz 
in both dimensions, using data sets of 4096 × 256 points. Quadrature 
indirect dimensions were achieved through States-TPPI method; 
spectra were processed applying a cosine square function to both 
dimensions and data matrix was zero-filled by factor of 2 before 
Fourier transformation. TOCSY and NOESY mixing times were set to 
120 and 200 ms, respectively. HSQC-DEPT experiments were 
measured in the 1H-detected mode via single quantum coherence with 
186 
 
proton decoupling in the 13C domain, using data sets of 2048 × 256 
points and typically 32 increments.  
Phosphate-buffered saline (PBS) solution was prepared using 
preformulated tablets (Sigma-Aldrich) in 200 mL of Milli-Q water 
(>18.2 Ω mean resistivity) to give [NaCl] = 0.138  , [KCl] = 0.0027 
M, and pH 7.4. 
SLS measurements were performed with a home-made instrument 
composed by a Photocor compact goniometer, a SMD 6000 Laser 
Quantum 50 mW light source operating at 5325 Å, a photomultiplier 
(PMT-120-OP/B) and a correlator (Flex02-01D) from Correlator.com. 
 
 
4.4.2 Synthetic procedure 
Preparation of polysaccharide 51-I: Chondroitin sodium salt (22.0 
mg, 54.9 μmol) was dissolved in pure water (1.0 mL) and passed 
through a short Dowex 50 WX8 column (H+ form, 20-50 mesh, approx. 
5 cm3). Elution with pure water was continued until pH of the eluate 
was neutral. Freeze-drying of the collected eluate gave chondroitin 
(20.0 mg, 52.8 μmol), that was suspended in pure water (4.0 mL) and 
treated with EDC (22.7 mg, 0.146 mmol) and NHS (8.5 mg, 73.9 
μmol). After 40 min stirring at rt,  ES (40.0 mg, 0.204 mmol) and then 
Thr methyl ester 50 (35.7 mg, 0.264 mmol)  were added and stirring 
was continued overnight. Few drops of 1M NaOH solution were then 
added to adjust pH to 12. After 6 hours stirring at rt, the solution was 
then neutralized with 1M HCl. Dialysis and subsequent freeze-drying 
afforded polysaccharide 51-I (17.2 mg, 86%) as a white waxy solid. 
 
187 
 
Preparation of polysaccharides 51-II and 51-III: Chondroitin TBA 
salt 14 (31.8 mg, 51.3 μmol) – obtained from chondroitin sodium salt 
according to a known procedure (Valoti et al., 2012) – was suspended 
in DMF (2.1 mL) that was freshly dried over activated 4Å molecular 
sieves. The mixture was heated to 80°C and stirred for 3 hours, after 
that a clear solution was obtained. After cooling to rt, in the case of 
obtainment of 51-II the solution was treated with 0.27M solutions of 
pyBOP® and HOBt in freshly dried D F (376 μL each, 0.102 mmol), 
then with a 0.48M solution of 50 in freshly dried D F (300 μL, 0.144 
mmol), and finally with DIPEA (88.8 μL, 0.510 mmol) that was freshly 
dried over activated 4Å molecular sieves. Alternatively, in the case of 
obtainment of 51-III, the solution was treated with a 0.44 M solution of 
TBTU in freshly dried D F (229 μL, 0.101 mmol), then with a 0.48 M 
solution of 50 in freshly dried D F (300 μL, 0.144 mmol), and finally 
with 2,4,6-collidine (66.5 μL, 0.503 mmol) that was freshly dried over 
activated 4Å molecular sieves. Both solutions were stirred at rt 
overnight and then treated with few drops of 1M NaOH aqueous 
solution. After further 6 hours stirring, the solutions were neutralized 
by adding a 1M HCl aqueous solution and then dialyzed and freeze-
dried. Since the 1H-NMR spectrum of both products clearly displayed 
the signals of residual TBA ions, a further purification was made by 
dissolving the polysaccharides in pure water (3.0 mL) and then passing 
the obtained solutions through a short Dowex 50 WX8 column (H+ 
form, 20-50 mesh, approx. 5 cm3). Elution with pure water was 
continued until pH of the eluates was neutral. The obtained solutions 
were then treated with 1M NaOH to adjust the pH to 12 and then 
neutralized by adding 1M HCl. Dialysis and subsequent freeze-drying 
188 
 
of the afforded polysaccharides 51-II (22.0 mg, 69%) and 51-III (24.2 
mg, 76%), respectively, as white waxy solids. 
 
Preparation of polysaccharide 3: Chondroitin in free acid form (56.3 
mg, 0.148 mmol) – obtained from chondroitin sodium salt as indicated 
above for the preparation of 51-I – was suspended in DMF (2.8 mL) 
that was freshly dried over activated 4Å molecular sieves. The mixture 
was heated to 80°C and stirred for 3 hours, after that a clear solution 
was obtained. After cooling to rt, it was treated with α,α-
dimethoxytoluene (222 μL, 1.48 mmol), that was freshly dried over 
activated 4Å molecular sieves, and then with a 0.21M solution of CSA 
in freshly dried D F (178 μL, 37.4 μmol). After overnight stirring at 
80°C, a yellowish solution was obtained. It was cooled to rt and treated 
firstly with Et3N (0.4 mL) and then with diisopropyl ether (10 mL). The 
mixture was cooled to -30°C for 2 hours. A white flocculant solid was 
obtained. It was isolated by centrifugation and then desiccated under 
vacuum overnight to afford 3 (89.0 mg, quant.) as a yellowish 
amorphous solid. 
 
Preparation of polysaccharide 52: A suspension of 3 (27.2 mg, 58.2 
μmol) in freshly dried D F (2.2 mL) was heated at 80°C. After two 
hours stirring, a clear solution was obtained. It was cooled to rt and 
then treated with a 0.44M solution of TBTU in freshly dried DMF (323 
μL, 0.142 mmol), then with a 0.22  solution of 50 in freshly dried 
D F (790 μL, 0.174 mmol), and finally with 2,4,6-collidine (93.8 μL, 
0.709 mmol), that was freshly dried over activated 4Å molecular 
sieves. After overnight stirring at rt, the solution was treated with 
diisopropyl ether (7.0 mL). A white precipitate was obtained. It was 
189 
 
collected by centrifugation and then desiccated under vacuum 
overnight to give 52 (34.8 mg). 
 
Preparation of polysaccharide 51-IV: Derivative 52 (29.9 mg) was 
suspended in ethyl acetate (560 μL) and treated with a 0.27  solution 
of NaBrO3 in pure water (560 μL, 0.151 mmol), and a 0.24  solution 
of Na2S2O4 in pure water (535 μL, 0.128 mmol). The mixture was 
vigorously stirred at rt overnight under visible light irradiation, after 
that it was centrifugated. The supernatant was diluted with water (25 
mL) and ethyl acetate (25 mL). The aqueous phase was collected, 
concentrated, dialyzed and freeze-dried. The obtained white powder 
(11.0 mg) was dissolved in pure water (5.0 mL) and treated with 1M 
HCl to adjust pH to 2. The solution was stirred at 50°C for 1 hour, then 
1M NaOH was added to adjust pH to 12. Further stirring was 
conducted at rt for 6 hours. The solution was then neutralized by adding 
1M HCl, and dialyzed. Freeze-drying afforded a white solid that was 
further purified by filtration through a Sep-pak C-18 cartridge to give 
pure 51-IV (7.5 mg, 51%) as a white waxy solid.  
 
 
4.4.3 Molecular weight determination 
All measurements were performed at (25.00 ± 0.05) °C with 
temperature controlled through the use of a thermostat bath. Stock 
solutions of pure chondroitin and of the derivatives 2b, 2c, 2d were 
prepared at 4.9 10-3 g mL-1, 1.12 10-3 g mL-1, 3.4 10-3 g mL-1 , 1.24 10-3 
g mL-1 respectively. Deionized water filtered (0.22μm) was used in all 
cases.  Molecular weight for each compounds was determinate twice.   
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The mass-average molecular weight, Mw, from the below equation was 
obtained: (Schmitz, 1990) 
 
    
  
   
 
  
        
  
 
 
           
where c is the sample mass concentration, B the second virial 
coefficient,  2 2 2 44ls o Ak n ( dn dc ) / N   where  n0 = 1.33 is the 
refractive index of water, dn dc   = 0.185  is the refractive index 
increment (Paduano et al., 1992), NA is the Avogadro's number, λ is the 
laser wavelength in vacuum, Rθ is the excess Rayleigh ratio at 90°. The 
values of Rθ  were obtained from    2 20 0s s, s,R R ,RR I I / I n / n R    where Is 
is the scattered intensity of the solution, Is,0 is the scattered intensity of 
water, Is,R is the scattering intensity of toluene (the standard) and, nR = 
1.496 and Rθ,R = 2.85 10
-5 cm−1 are the refractive index and the 
Rayleigh ratio of toluene respectively (Kaye et al., 1973), 
 4 2q n / sin( / )    and Rg is the radius of gyration. 
 
 
4.4.4 Conformational study 
A simplified model of the Thr-decorated chondroitin polysaccharide 
51-IV with six repetitions was constructed through the carbohydrate 
builder within the Glycam web server (Woods Group GLYCAM Web; 
Complex Carbohydrate Research Center, University of Georgia, 
Athens, GA, 2005–2014; http://www.glycam.com) while the Thr 
residue attached to the GlcA unit was constructed employing the 
builder module in the Maestro package of the Schroedinger Suite 2014. 
Restrained simulated annealing (SA) calculations were performed on 
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polysaccharide using the AMBER 14.0 package (Case et al., 2014) with 
sugars described by the latest GLYCAM06 force field (GLYCAM_06j-
1). (Kirschner et al., 2008) Parameters for Thr residue were retrieved 
from the ff14sb force field within the AMBER 14.0 package as well as 
missing bond parameters. For annealing simulations, the General Born 
solvation (igb = 2) with monovalent salt concentration corresponding to 
0.1 M was used. The complex was heated to 600 K in the first 5 ps, 
cooled to 100 K for the next 13 ps, and then cooled to 0 K for the last 2 
ps. The temperature of the system was maintained with a varying time 
constant: 0.4 ps during heating, 4 ps during cooling to 100 K, 1 ps for 
the final cooling stage, and then reduced from 0.1–0.05 for the last 
picosecond. The force constants for NOE constraints were increased 
from 3 to 30 kcal mol–1 Å–2 during the first 5 ps and then maintained 
constant for the rest of the simulation. These force constants were 
applied in the form of a parabolic, flat-well energy term. The upper 
distance bounds were retrieved by NOE cross-peak volume integrations 
performed with the iNMR (www.inmr.net), using the NOESY 
experiment collected at mixing time of 100 ms. The NOE volumes 
were then converted to distance restraints after they were calibrated 
using the known fixed distance (H-6a/H-6b of GalNAc). An 
unrestrained energy minimization step completed the SA run. This 
SA/energy minimization procedure was repeated 400 times. SA 
simulations were then analysed by clustering the resulting 
polysaccharide 51-IV conformations through the average linkage 
method and a cluster member cutoff of 1.5 Å root-mean-squared 
difference (rmsd) calculated on the sugars rings atoms belonging to the 
central four dimers. This clustering allowed selecting 38 different 
conformational clusters for which the most populated one had a 
192 
 
frequency of occurrence of 110/400 conformations. Moreover, 
conformations of this latter cluster feature the lowest overall potential 
energy and NMR restraint violations. Thus, the representative structure 
(i.e., the closest to the centroid of the cluster) of this cluster was 
considered for subsequent molecular dynamics (MD) simulations. After 
charge neutralization by the addition of 6 Na+ ions, the complex was 
solvated with 9381 water molecules in a truncated octahedral box of 
pre-equilibrated TIP3P water. (Jorgensen et al., 1983) Several 
equilibration steps were performed comprising minimization of the 
solvent molecules with the polysaccharide fixed, minimization of the 
whole system, and slow heating to 300 K with weak positional 
restraints on M1 atoms under constant-volume conditions. The 
following 20 ns production runs were applied in the NPT ensemble. 
The particle mesh Ewald method (a) Essmann et al., 1995. b) Darden et 
al., 1993.) was used to evaluate the electrostatic interactions with a 
direct space sum cutoff of 10 Å. With the bond lengths involving 
hydrogen atoms kept fixed with the SHAKE algorithm, a time step of 2 
fs was employed. (van Gunsteren et al., 1977) Related conformational 
substates populated during the MD simulation were analyzed with the 
A B E S’s PT A  module. (Shao et al., 2007) To investigate the 
thermodynamic parameters of the water molecules around the 
polysaccharide, the GIST program included in cpptraj module in 
AMBER 14  was used (Roe et al., 2013). We set the GIST grid size to 
0.75 Å3, and set the GIST analysis region to cover the whole 
polysaccharide structure. The box sizes were 90 × 90 × 90 Å3. 
Illustrations of the structures were generated using Chimera. (Pettersen 
et al., 2004) 
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4.4.5 Antifreeze activity 
Ice recrystallisation inhibition was measured using a modified splay 
assay (Knight et al., 1988). A 10 μL sample of polysaccharide or 
polymer dissolved in PBS buffer (pH 7.4) was dropped 1.40 m onto a 
chilled glass coverslip sat on a piece of polished aluminium placed on 
dry ice. Upon hitting the chilled glass coverslip, a wafer with diameter 
of approximately 10 mm and thickness 10 μm was formed 
instantaneously. The glass coverslip was transferred onto the Linkam 
cryostage and held at −8 °C under N2 for 30 minutes. Photographs were 
obtained using an Olympus CX 41 microscope with a UIS-2 
20×/0.45/∞/0–2/FN22 lens and crossed polarizers (Olympus Ltd, 
Southend on sea, UK), equipped with a Canon DSLR 500D digital 
camera. Images were taken of the initial wafer (to ensure that a 
polycrystalline sample had been obtained) and after 30 minutes. Image 
processing was conducted using Image J, which is freely available. In 
brief, ten of the largest ice crystals in the field of view were measured 
and the single largest length in any axis recorded. This was repeated for 
at least three wafers and the average (mean) value was calculated to 
find the largest grain dimension along any axis. The average of this 
value from three individual wafers was calculated to give the mean 
largest grain size (MLGS). This average value was then compared to 
that of a PBS buffer negative control providing a way of quantifying 
the amount of IRI activity. This testing method ensures that positive 
results are only reported if all ice crystals are inhibited, as opposed to a 
average per wafer, which would smooth out the presence of rouge ice 
crystal growth. 
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CHAPTER 5 
 
STUDY OF REGIOSELECTIVE SULFATION OF 
POLYMANNURONIC ACID POLYSACCHARIDE 
 
5.1 Introduction 
Alginate is a particular type of non-branched polysaccharide extracted 
from cel wal of brown seaweeds (Phaeophyceae), and an 
exopolysaccharide of bacteria including Pseudomonas aeruginosa. It is 
characterized by a linear structure consisting of 1,4-linked β-D-
mannuronic acid (M) and its C-5 epimer α-L-guluronic acid (G) (Figure 
38). 
 
Figure 38: 14 ß-D-mannuronic acid (left) and 14 α-L-guluronic 
acid (right) monosaccharide units  
 
 
These units are organized in a block-wise manner with their 
distribution, as wel as, the M/G ratio that could be diferent, depending 
on the species of brown algae. (a) Cong et al., 2014. b) Arlov et al., 
2014. c) Pawar et al., 2012. d) Lee et al., 2012. e) Draget et al., 1997.) 
Sodium alginate was extensively employed in food, cosmetics 
(Chunmei et al., 2009) and its property to strongly interact with 
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divalent cation (although this action seems to be carried out only by G-
blocks) (George et al., 2006) led to calcium cross-linked hydrogels, that 
have been used for pharmaceutical purposes (a) Lee et al., 2012. b) 
Ghidoni et al., 2008. c) Zimmermann et al., 2007.) such as wound 
dressing materials for the treatment of acute or chronic wounds. 
(Boateng et al., 2008) Moreover, the alginates display a crucial role in 
the progression of cystic fibrosis wherein bacterial biofilm formed from 
them are secreted by P. aeruginosa. (Ramsey et al., 2005) 
Monosaccharide composition could strongly influence the geometry of 
the alginate chain (Smidsrød et al., 1990) and any of their potential 
applications. The presence of free hydroxyls and carboxylic groups 
along the backbone makes alginates ideal candidates for chemical 
functionalization. (Yang et al., 2011) This is usually used to enhance 
existing properties (improvement of ionic strength by additional 
covalent cross-linking, increase hydrophobicity of the backbone, 
improve biodegradation) or to introduce completely new properties 
otherwise non existing in the unmodified polysaccharide (afford 
anticoagulant properties, provide chemical/biochemical anchors to 
interact with cell surfaces or bestow temperature dependent 
characteristics such as lower critical solution temperature). (Pawar et 
al., 2012) The free hydroxyl groups of alginate can be chemically 
sulfated in a random way (Fan et al., 2011) affording polysaccharide 
with a similar behaviour to sulfated GAGs such as HS and HP (a) 
Arlov et al., 2014. b) Freeman et al., 2008.) Alginate sulfate, among the 
several biological functions of sulfated polysaccharides, may exhibit 
anticoagulant activity through the inhibition of intrinsic pathway of 
clotting cascade, that is directly related to the degree of sulfation (a) 
Fan et al., 2011. b) Huang et al., 2003.), anti-angiogenic and anti-
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tumour activity. (Cong et al., 2014) It is known that most biological 
functions in sulfated polysaccharides are related to their sulfation 
patern and sequence. (a) Gama, et al., 2006. b) Tadahisa et al., 2006.) 
To the best of our knowledge, until now only methods for a random 
sulfation of alginates have been reported yet, but not for regioselective 
ones. This is a gap that should be urgently filed in. Indeed, a semi-
synthetic sulfated alginate derivative PSS has been employed as anti-
cardiovascular disease drug for nearly three decades in China, with no 
control of sulfate groups placement on the polysaccharide, in spite of 
the influence of DS on sulfated alginate activity (Arlov et al., 2014) and 
of the reported cases of bleeding and anaphylaxis associated to PSS. 
(Xue et al., 2016) Moreover, low molecular weight PSS derivatives 
(FPS) were recently evaluated for anticoagulant and antithrombotic 
activities displaying a good correlation between the molecular weight 
and the biological activities. (Xin et al., 2016) 
Due to incomplete solubility and highly heterogeneous structure of both 
G- and M-rich natural alginic acids the strategy to obtain a 
regioselectively sulfated polysaccharide was applied to the structuraly 
simplest alginic acid, that is β-polymannuronic acid. This 
polysaccharide consists of a 4)-β-D-ManA-(1 backbone (Figure 
39), with a more homogeneous structure and a lower quantity of α-L-
GulA units usualy below 10-15% than al the other alginic acids. 
 
 
Figure 39: Polymannuronic acid repeating unit 
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This last property confers a higher solubility to this polysaccharide with 
respect to all the other alginic acids. 
 
 
5.2 Results and discussion 
Strategies for alginate modifications depend on three important 
parameters, such as solubility, reactivity and characterization. 
As regards solubility, alginates may be dissolved in aqueous, organic or 
mixed aqueous-organic media at a variable extent that could influence 
derivative substitution pattern. Furthermore, alginates can be 
chemically modified at secondary hydroxyl positions O-2 and O-3 (a) 
Arlov et al., 2014. b) Cong et al., 2014. c) Fan et al., 2011.) or at the 
carboxylic acid group at C-6 position. (a) Pawar et al., 2012. b) Yang et 
al., 2011. c) Vallée et al., 2009.) 
Selective modification of either C-2 or C-3 hydroxyl group is 
challenging due to their minor reactivity differences and, moreover, it 
may be controlled in terms of selective modification of M or G 
residues. The comprehension of the substitution pattern needs several 
alginate samples with a different range of M/G ratios. Moreover, a lack 
of commercial availability of alginates with controlled G/M sequences 
may impede complete structural characterization of derivatives because 
of the complex nature of the polysaccharide backbone. 
The starting material for the regioselective sulfation strategy was 
commercially available polymannuronic acid that presented 85% of M 
residues. It was protected at diol O-2,3 by either application of an 
orthoester or benzylidene ring. (Bedini et al., 2012)  
In the orthoester case, protection was repeated twice (showing no 
increase of degree of substitution), by stirring overnight at rt a DMF 
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suspension of polysaccharide in the presence of PhC(OCH3)3 or 
CH3C(OCH3)3 and CSA as catalyst, followed by one-pot ring opening 
to liberate the equatorial position O-3, as one could hypothesize from 
the regiochemistry of orthoester opening on monosaccharide cis-diols 
(Mukhopadhyay et al., 2003) and 55 and 56 were obtained in 68% and 
57% yield, respectively. It was not possible to evaluate neither the DS 
nor the regioselectivity due to the presence of impurities that gave 
signals overlapped to the polysaccharide ones in the NMR spectra. 
Thus, both derivatives 55 and 56 were further treated with SO3·pyridine 
in DMF at 50°C, to sulfate the free hydroxyl at position O-3 of 
polysaccharide backbone, followed by global alkaline deprotection in 
order to remove acyl protecting groups at position O-2 of 
polymannuronic acid (Scheme 17).  
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Scheme 17: (a) PhC(OCH3)3 or CH3C(OCH3)3, DMF, CSA, rt; (b) 
H2O, rt, 68% for 55, 57%, for 56; (c) 1: SO3·py, DMF, 50°C, 2: NaOH, 
H2O, rt, 98%, 75%, for AlgS-I and AlgS-II, respectively. 
 
 
AlgS-I and AlgS-II were obtained in 98% and 75% yield from the 
intermediate partialy protected polysaccharides, respectively and their 
regiochemistry of sulfation was preliminary evaluated by 13C-NMR 
analysis, obtaining for them very similar spectra, that were compared 
with the 13C-NMR spectrum of starting  polymannuronic acid (Figure 
40). 
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Figure 40: Zoom of 13C-NMR spectrum of unprotected 
polymannuronic acid (400 MHz, D2O, 298 K) 
 
 
The latter displayed four signals at δC = 72.1, 73.4 , 77.9 and 79.8 ppm, 
that were ascribed to C-2, C-3, C-5 and C-4, respectively. Instead, the 
13C-NMR spectrum of AlgS-I (Figure 41), displayed two downshifted 
signals (δC = 76.6 and 78.9 ppm), that were hypothesized to belong to 
the downshift resonances of C-2 and C-3 of ManA units due to 
sulfation step in the semi-synthetic route. (Cong et al., 2014) 
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Figure 41: Zoom of 13C-NMR spectrum of AlgS-I (400 MHz, D2O, 
298 K) 
 
 
After sulfation, the carbon substituted by the sulfate ester groups 
shifted to a lower field, meanwhile the adjacent carbons generally 
shifted to slightly higher fields, (Grasdalen, 1983) as proved by the 
shift of C-4 signal of polymannuronic acid polysaccharide from δC = 
79.8 ppm to δC = 77.1 ppm, that might indicate the sulfation of the 
adjacent C-3.  or eover, the signal at δC = 70.0 ppm could be ascribed 
to the shift of non sulfated C-2, adjacent to sulfated C-3. The just 
mentioned results suggested that the protection by orthoester ring was 
not quantitative because sulfate groups were found not exclusively at 
O-3 position as predictable. Therefore, it was necessary to change the 
semi-synthetic strategy by choosing a benzylidene ring as cyclic 
protecting group, in order to obtain a regioselectively sulfated 
polysaccharide. 
For the purpose of obtaining a more soluble derivative in aprotic 
solvent polymannuronic acid was firstly derivatized at its carboxylic 
function. Carboxyl-modified alginate esters were obtained by treating a 
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tetrabutylammonium alginate salt DMF solution with suitably 
synthesized n-alkyl iodides in the presence of  TBAF at 80°C. (Pawar 
et al., 2013) Due to the presence of TBAF and n-alkyl iodides as 
contaminants, and the overlapping of their α-methylene signals with 
those related to TBA alginate salt ones, it was not possible to evaluate 
correctly the DS by 1H-NMR. However, the semi-synthetic route was 
carried on because it was not strictly necessary to gain a quantitative 
esterification for obtaining an alginate derivative that was soluble in 
aprotic solvents.  
Derivatives 57 and 58 carrying a n-dodecyl or a n-butyl ester moiety, 
respectively were protected at O-2,3 diol with a benzylidene ring, by 
treating them with α,α-dimethoxytoluene in DMF at 80°C in the 
presence of CSA as catalyst. 
1H-NMR integration of signals related to anomeric protons and 
benzylidene methine displayed a DS = 0.99 for 59 and 0.71 and for 60, 
respectively. 
Benzylidene ring was, then, regioselectively cleaved under oxidative 
conditions (Adinolfi et al., 1999) for derivative 59, affording 
polysaccharide 61 in 58% yield with a  DS = 1, and supposedly giving 
2-O-benzoylated ManA units. The DS was evaluated by 1H-NMR 
integration of the H-ortho Bz aromatic signals (δH = 7.86 and 7.95 
ppm) with repect to the carbinolic and anomeric ones (δH = 5.33-3.67 
ppm). On the contrary, for derivative 60 the free hydroxyls that did not 
couple during the benzylidene step were acetylated with Ac2O and 
Et3N in the presence of a catalytic amount of DMAP affording 62 in 
68% with a DS = 0.65. This was evaluated by comparison between 
integration of polysaccharide carbinolic and anomeric signals (δ = 5.56-
4.17 ppm) and Ac one (δ = 2.08 ppm) in the 1H-NMR spectrum. This 
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latter compound was submitted to oxidative opening of benzylidene 
ring with NaBrO3 and Na2S2O4 in a H2O-ethyl acetate two phase 
mixture (Adinolfi et al., 1999) affording 63. Benzylidene cleavage was 
confirmed in this case by the splitting and downfield shift of aromatic 
signals (δH = 7.32 ppm for the benzylidene and δH = 7.50, 7.65, 7.94 
ppm for the resulting benzoate).  
Sulfation of free hydroxyls at 3-O-position of ManA units with SO3·py 
complex in DMF at 50°C, followed by an alkaline hydrolysis (that was 
repeated three times only for n-dodecyl ester derivative) of Ac, Bz and 
ester groups afforded AlgS-III and AlgS-IV (Scheme 18).  
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Scheme 18: (a) C12H25I or C4H9I, TBAF, DMF, 80°C; (b) α,α-
dimethoxytoluene, CSA, DMF, 80°C, (45%, 44%,  DSbenzylidenation = 
0.99, 0.71 for 59 and 60, respectively); (c) Ac2O, Et3N, DMAP, 
CH3CN, rt, overnight, 59%, DS = 0.65 for 62; (d) NaBrO3, Na2S2O4, 
H2O-ethyl acetate, rt, overnight, 58%, 71%, DS = 1 for 61 and 63 
respectively), (e) 1: SO3·py, DMF, 50°C, 2: NaOH, H2O, rt., 27% for 
AlgS-III 
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The sulfation pattern was evaluated by 13C-NMR analysis, obtaining 
for both of them very similar spectra (Figure 42). 
 
 
 
Figure 42: Zoom of 13C-NMR spectrum of AlgS-III (400 MHz, D2O, 
298 K) 
 
 
The 13C-N   spectrum showed peaks at δC = 75.0, 71.9 and 77.4 ppm 
that were hypothesized to belong to sulfated, non-sulfated C-3 and C-4 
respectively (Arlov et al., 2014).  or eover, the signal at δC = 70.3 ppm 
could be ascribed to shifted C-2 for the presence of sulfated C-3, giving 
a preliminary hypothesis of a regioselective sulfation of 
polymannuronic acid. Although one can find discordant data found in 
literature about the sulfation of alginates (a) Arlov et al., 2014. b) Cong 
et al., 2014. c) Quanca et al., 2013.), the obtained results encouraged us 
to pursue the employment of benzylidene group in the protection step 
of the semi-synthetic route towards regioselectively sulfated alginates 
that need to be optimized yet.  
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5.3 Conclusions 
The study of regioselective sulfation of a commercially available 
polymannuronic acid polysaccharide, produced compounds with 
different sulfation patterns. The protection of O-2,3-diol on 
polysaccharide backbone, by an orthoester ring produced 
polymannuronic acid with sulfate groups either at position O-2 or at 
positions O-2 and O-3. Key reaction for a regioselective derivatization 
might be, then, a quantitative protection of O-2,3-diol on 
polysaccharide backbone by a suitable non-labile cyclic protecting 
group, that was preliminarily tested, in this study, by using a 
benzylidene ring protection. Further optimization on such protecting 
group will be applied in order to obtain a suitable regioselectively 
sulfated algnate to be fully charachterized and studied in details, also 
evaluating the relationship between biological function and structure.  
 
 
5.4 Experimental section 
 
5.4.1 General methods 
Commercial grade reagents and solvents were used without further 
purification, except where differently indicated. The term “pure water” 
refers to water purified by a Millipore Milli-Q Gradient system. 
Centrifugations were performed with an Eppendorf Centrifuge 5804R 
instrument at 4°C (4600 g, 10 min). Dialyses were conducted on 
Spectra/Por 3.5 kDa cut-off membranes at 4°C. Freeze-dryings were 
performed with a 5Pascal Lio 5P 4K freeze dryer. NMR spectra were 
recorded on a Bruker DRX-400 (1H: 400 MHz, 13C: 100 MHz) 
instrument or Bruker DRX-600 (1H: 600 MHz, 13C: 150 MHz) 
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instrument equipped with a cryo probe, in D2O (acetone as internal 
standard, 1H: (CH3)2CO at δ = 2.22 ppm; 
13C: (CH3)2CO at δ = 31.5 
ppm) or DMSO-d6 (
1H: CHD2SOCD3 at δ = 2.49 ppm; 
13C: CD3SOCD3 
at δ = 39.5 ppm). 
 
 
5.4.2 Synthetic procedure  
Orthoesterification and one-pot orthoester opening: Commercially 
available polymannuronic acid (85.0 mg, 0.44 mmol) was suspended in 
DMF (4.12 mL) that was freshly dried over activated 4Å molecular 
sieves. The mixture was treated with PhC(OCH3)3 (725 μL, 4.22 
mmol), CSA (140 mg, 0.60 mmol) and stirred overnight at rt. The 
yellowish solution was treated with H2O (15 mL) and a white 
precipitate was obtained. The mixture was stirred for 2 h at rt, dialyzed 
then freeze-dried, obtaining 55 as white solid (88.4 mg, 68%). 
Alternatively this reaction was conducted on commercially available 
polymannuronic acid using CH3C(OCH3)3 (1.59mL, 12.6 mmol) as 
protecting group, obtaining 56 as white solid (84.7 mg, 57%).  
 
Sulfation and global deprotection: Derivative 55 (40.0 mg, 0.1337 
mmol) was suspended in DMF (5.80 mL) that was freshly dried over 
activated 4 Å molecular sieves and treated with 1.10 M solution of 
SO3.py in freshly dried DMF (2.44 mL, 2.674 mmol). After overnight 
stirring at 50°C the mixture was cooled to rt and treated with NaCl 
saturated acetone (8.0 mL), then to -30°C for 2 hours. A white 
flocculant solid was obtained. It was isolated by centrifugation, 
dissolved in H2O (5 mL) and 1.0 M NaOH was added to adjust pH to 
12. Further stirring was conducted at rt for 6 hours. The solution was 
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then neutralized by adding 1.0M HCl, and dialyzed. Freeze-drying 
afforded AlgS-I (32.6 mg, 98%) as a white solid. The reaction was 
repeated in the same conditions on compound 56 to afford AlgS-II. 
 
n-Dodecyl iodide: Sodium iodide (2.38 g, 15.88 mmol) was dissolved 
in acetone (26 mL), treated with C12H25Br (1.91 mL, 7.95 mmol) and 
stirred at 60°C for 3 h at reflux. The mixture was cooled to rt, then 
diluted in n-hexane (100 mL) and washed with H2O. The organic phase 
was collected, dried over anhydrous Na2SO4, filtered and concentrated 
affording a yellowish oil (2.28 g 48%). 
 
n-Butyl iodide: 1-Butanol (3.70 mL, 40.4 mmol) was treated with HI 
(9.0 mL, 119.7 mmol) and stirred at reflux for 4 h at 120°C. After 
cooling the mixture to 0°C, it was washed with cold H2O. The organic 
phase was collected, dried over anhydrous Na2SO4, filtered, affording 
then an oil (3.14 g, 42%) that was directly stored at -28°C.  
 
Tetrabutylammonium salt of polymannuronic acid: Commercially 
available polymannuronic acid (176.5 mg, 0.919 mmol) was suspended 
in H2O (1.71 mL) and tetrabutylammonium hydroxide (40% w/w in 
MeOH) was added to adjust pH to 10. The mixture was freeze-dried, 
obtaining polysaccharide as a brown solid (217.6 mg, 55%) 
 
n-Dodecyl ester of polymannuronic TBA salt: Tetrabutylammonium 
salt of polymannuronic acid (193.4 mg, 0.446 mmol) was suspended in 
DMF (12.80 mL) that was freshly dried over activated 4 Å molecular 
sieves, obtaining a brownish suspension that was treated with 1.0 M 
TBAF solution in THF (1.03 mL, 1.03 mmol), in order to obtain a 
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better solubility. In the end n-dodecyl iodide (1.82 mL, 7.38 mmol) was 
added and after overnight stirring at 80°C, the mixture, that appared as 
a suspension, was cooled to rt and treated with diisopropyl ether (28 
mL). A brown flocculant solid was obtained. It was isolated by 
centrifugation and then desiccated under vacuum overnight to afford 57 
(222.4 mg) with TBAF and DMF as contaminant. The reaction was 
repeated twice. 
 
n-Butyl ester of polymannuronic TBA salt: Tetrabutylammonium 
salt of polymannuronic acid (57.7 mg, 0.133 mmol) was suspended in 
freshly dried DMF (3.80 mL) over activated 4Å molecular sieves, 
obtaining a brownish suspension that was treated with 1.0 M TBAF 
solution in THF (634.4 μL, 0.6344 mmol) in order to obtain a higher 
solubility. In the end, n-butyl iodide (249.0 μL, 2.20 mmol) was added 
and after overnight stirring at 80°C, the mixture was cooled to rt and 
treated with a diisopropyl ether/AcOEt (1:1 v/v) solution (32 mL). A 
white precipitate was obtained, collected by centrifugation and 
desiccated under vacuum overnight, affording derivative 58 with TBAF 
and DMF in large amount as contaminant. The compound was 
dissolved in DMF and treated with AcOEt (20 mL) obtaining a 
precipitate that was collected by centrifugation and desiccated under 
vacuum overnight, affording purified derivative 58 (33.0 mg, 100%)  
 
Benzylidenation: A suspension of 57 (128.2 mg, 0.336 mmol) (or 58) 
in freshly dried DMF over activated 4Å molecular sieves (8.50 mL) 
was heated at 80°C for 3 hours, obtaining a brownish suspension. The 
mixture was cooled to rt and treated with α,α-dimethoxytoluene (504.3 
μL, 3.36 mmol), that was freshly dried over activated 4Å molecular 
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sieves, and then with a 0.21 M solution of CSA in freshly dried DMF 
(404.2 μL, 84.0 μmol). After overnight stirring to 80°C, the obtained 
brownish solution was cooled to rt and treated with H2O (28.8 mL), 
(either AcOEt or a 1:1 v/v solution of n-hexane/AcOEt in the case of n-
dodecyl ester and n-butyl ester derivatives, respectively) then the 
formed precipitate was collected by centrifugation and desiccated under 
vacuum overnight to afford 59  (or 60) (71.8 mg, 45%)  
 
Acetylation: Derivative 60 (18.8 mg, 75.7 μmol) was treated with Et3N 
(209.0 μL) and suspended in CH3CN (116.0 μL). Ac2O (497.0 μL) and 
DMAP (3.36 mg) were added and after overnight stirring at rt, the 
mixture was treated with a 1:1 v/v solution of Hexane/EtOAc. The 
obtained brownish precipitate was collected by centrifugation and 
dessicated under vacuum overnight to afford compound 62 (14.8 mg, 
59%).  
 
Oxidative opening: Derivative 59 (62.7 mg, 0.140 mmol) was 
suspended in ethyl acetate (1.54 mL) and treated with a 0.27 M solution 
of NaBrO3 in pure water (1.54 mL, 0.411 mmol), and a 0.24 M solution 
of Na2S2O4 in pure water (1.46 mL, 0.345 mmol). The mixture was 
vigorously stirred at rt overnight under visible light irradiation, after 
that it was centrifugated and the precipitate was desiccated under 
vacuum affording 61 (12.1 mg). The supernatant was diluted with 
water (25 mL) and washed with ethyl acetate (25 mL). The organic 
layer was collected, dried with anhydrous Na2SO4, filtered and 
concentrated and added to the precipitate, affording a total amount of 
derivative of 37.4 mg (58%). The reaction was conducted in the same 
way on compound 62 to afford 63 
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Sulfation and global alkaline deprotection: Derivative 61 (30.6 mg, 
0.066 mmol) (or 63) was suspended in DMF (524.6 μL), that was 
freshly dried over 4Å molecular sieves and then treated with a 1.17 M 
solution of SO3·py in freshly dried DMF (1.13 mL). After overnight 
stirring at 50°C the suspension turned into a clear solution and it was 
cooled to rt, diluted with pure water (7.0 mL) and treated with a 1.0 M 
NaHCO3 solution to adjust pH to 7. The obtained yellowish precipitate 
was collected by centrifugation and then dissolved in pure water (20.0 
mL). The solution was treated with a 15% w/v NaOH solution to adjust 
pH to 13. The solution was stirred for 6 h at rt and then 1.0 M HCl was 
added until neutralization. The reaction was repeated twice and dialysis 
and subsequent freeze-drying yielded AlgS-III (or AlgS-IV) as a white 
solid (7.4 mg, 27%).  
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PhD Course Activity Summary 
Candidate:                   Supervisor:                        Assessor:                                   
Antonio Laezza     Dr. Emiliano Bedini         Dr. Flavio Cermola                       
  
1) Attended Courses: 
 Zorn, R. “Neutron Scattering”, 27-30/10/2015; 3 CFU 
 Duilio, A. “Produzione ricombinante di proteine naturali e 
mutanti”, 20-24/07/2015; 3 CFU 
  ont esarchio, D. “Sintesi, struttura ed applicazioni di 
oligonucleotidi naturali e modificati”, from 04-13/02/2015; 3 
CFU 
 Naviglio, D. “Tecniche estrattive solido-liquido impiegate nella 
preparazione del campione per l’analisi chimica e nella 
produzione di estratti per usi industriali”, 09-17/12/2014; 3 CFU 
 Parrilli,  . “Glicoscienza”, 17-24/07/2014; 3 CFU 
 Pucci, P. ”Corso Avanzato di Spettrometria di Massa”, from 
30/06/2014 to 4/07/2014; 4 CFU 
 
2) Attended Seminars: 
Title Speaker Date Place 
Chemical biology 
and medicinal 
chemistry of 
glycosphingolipid 
Prof. 
Herman 
Overkleeft 
19/12/16 University of 
Naples 
Federico II 
Basics of detergents 
formulations and 
challenge 
Dr. Giulia 
Bianchetti 
16/03/2016 University of 
Naples 
Federico II 
224 
 
Innovative 
approaches for 
polysaccharide-based 
vaccines 
Prof. 
Francesco 
Berti 
20/11/2015 University of 
Naples 
Federico II 
The bacterial cell 
wall by liquid state 
and DNP solid state 
NMR 
Prof. Jean-
Pierre Simorre 
29/06/2015 University of 
Naples 
Federico II 
Sugar engineering: 
Building new 
therapeutics with 
glycosyltransferase 
enzymes 
Prof. Paul De 
Angelis 
03/06/2015 CNR 
Pharmaceutical 
companies: External 
manufacturing and 
quality assurance 
Prof. 
Domenico 
Demasi 
25/05/2015 University of 
Naples 
Federico II 
Lectins from 
bacteria and fungi: 
therapeutical targets 
and research tools 
Prof. Anne 
Imberty 
15/05/2015 University of 
Naples 
Federico II 
Matrix 
Metalloproteinases: 
Inter-domain 
flexibility and 
recognition of 
substrates 
Prof. Marco 
Fragai 
08/05/2015 University of 
Naples 
Federico II 
European Large 
Facilities: Neutron and 
Synchrotron sources  
Prof. Serge 
Pérez 
06/05/2015 University of 
Naples Federico 
II 
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New chiral catalysts 
derived from Fe(II) 
and Bi(III) for 
asymmetric synthesis 
Prof. Thierry 
Ollevier  
15/12/2014 University of 
Naples 
Federico II 
Le fitotossine: 
un’avventura luga 40 
anni 
Prof. Antonio 
Evidente 
10/12/2014 University of 
Naples 
Federico II 
Rediscovering the 
levan polysaccharide 
Prof. Ebru 
Toksoy Öner  
28/10/2014 University of 
Naples 
Federico II 
Incontro con la 
Peroni. Azienda 
leader birraia 
Dr. Luigi 
Serino 
12/05/2014 University of 
Naples 
Federico II 
 
3) Attended Integration Exams (for candidates not graduated 
in Chemical Science): 
Title Professor Date 
/ / / 
/ / / 
 
4) Visiting periods in Institutions different from University of 
Naples “Federico II”: 
Host 
Institution 
Country Start Date End Date 
University of 
Edinburgh 
United 
Kingdom 
01/05/2016 31/07/2016 
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5) Publications (include submitted and in preparation): 
 
 Laezza, A.; Brodaczewska, N.; Uhrin, D.; Iadonisi, A.; 
Bedini, E. “Depolymerization of semi-synthetic 
fucosylated chondroitin sulfate and interaction with 
selectins”, in preparation 
 
 Laezza, A.; Casillo, A.; Cosconati, A.; Biggs, C.I.; 
Fabozzi, A.; Paduano, L.; Iadonisi, A.; Novellino, E.; 
Gibson, M.I.; Randazzo, A.; Corsaro, M.M.; Bedini E. 
“Decoration of chondroitin polysaccharide with 
threonine: synthesis, conformational study and 
antifreeze activity”, 2017, submitted 
 
 Bedini, E.; Laezza, A.; Parrilli, M.; Iadonisi, A. 
“Chemical methods for the selective sulfation and 
desulfation of polysaccharides”, 2017, submitted 
 
 Laezza, A.; Iadonisi, A.; Pirozzi, A.V.A.; Diana, P.; De 
Rosa, M.; Schiraldi, C.; Parrilli,  .; Bedini, E. “A 
modular approach to a library of semi-synthetic 
fucosylated chondroitin sulfate polysaccharides with 
different sulfation and fucosylation pattern”,Chem. Eur. 
J. 2016, 50, 18215-18226 
 
 Bedini, E.; Laezza, A.; Iadonisi, A. “Chemical 
derivatization of sulfated glycosaminoglycans”, Eur. J. 
Org. Chem. 2016, 18, 3018-3042 
 
 Laezza, A.; Iadonisi, A.; De Castro, C.; De Rosa, M.; 
Schiraldi, C.; Parrilli, M.; Bedini, E. “Chemical 
fucosylation of a polysaccharide: a semi-synthetic 
access to fucosylated chondroitin sulfate”, 
Biomacromolecules 2015, 16, 2237-2245 
 
 Laezza, A.; De Castro, C.; Parrilli,  .;  Bedini, E. “Inter 
vs. intraglycosidic acetal linkages control sulfation 
pattern in semi-synthetic chondroitin sulfate”, 
Carbohydr. Polym. 2014, 112, 546-55 
 
227 
 
6) Attended congresses/workshops/summer 
schools/contribution: 
 
 BMMC VII - 7th Baltic Meeting on Microbial 
Carbohydrates; 25-29/09/2016, Guestrow (Germany). 
Oral communication: A semi-synthetic strategy to 
fucosylated chondroitin sulfate from microbial sourced 
chondroitin (Laezza, A.; Iadonisi, A.; De Castro, C.; De 
Rosa, M.; Schiraldi, C.; Parrilli, M.; Bedini, E.) 
 
 Challenge in Organic Synthesis: Efficient Processes for 
Novel Applications; 11-12/12/2015, Naples (Italy) 
 
 4th EPNOE International Polysaccharide Conference; 
19-22/10/2015, Warsaw (Poland). Oral 
communication: A semi-synthetic strategy to 
fucosylated chondroitin polysaccharides from microbial 
sourced chondroitin (Laezza, A.; Iadonisi, A.; De 
Castro, C.; De Rosa, M.; Schiraldi, C.; Parrilli, M.; 
Bedini, E.) 
 
 Physics and Chemistry in Polysaccharide Science: From 
Molecules to Materials; 18/10/2015, Warsaw (Poland) 
 
 COST Action BM1003 Final Meeting: Microbial cell 
surface determines of virulence, antibiotic resistance and 
inflammation in different pathologies; 13-14/10/2014, 
SS. Marcellino e Festo, University of Naples Federico II 
 
 XIV Convegno-Scuola sulla Chimica dei Carboidrati; 
22-25/06/2014, Pontignano (Italy). Poster 
communication: A semi-synthetic approach to 
fucosylated chondroitin sulfate from microbial derived 
chondroitin (Laezza, A.; Marzaioli, A.M.; De Castro, C.; 
Parrilli, M.; Bedini, E.) 
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 COST Traning School BM1003: Microbial cell surface 
determinants of virulence, as targets for new 
therapeutics in Cystic Fibrosis; 03-05/06/2014; 
University of Naples Federico II, Complesso di Monte 
Sant’Angelo. 
 
 
